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ABSTRACT 
Cardio-metabolic risk factors are the aggregates of conditions that increase the susceptibility of 
developing cardio-metabolic diseases such as cardiovascular diseases (CVD) and diabetes. This 
includes insulin resistance, obesity, hyperglyceamia, dyslipoproteinemia, hyperinsulinemia and 
hypertension. This condition are worsen by smoking and physical inactivity as they mostly are not 
easily detected 
This was a cross-sectional survey of 403 commercial taxi drivers at ten different taxi ranks in 
BCMM. The study utilized a convenient sampling technique for the participants of the study. The 
WHO STEPwise approach was used for data collection. The WHO STEPwise questionnaire was 
used for a face-to-face interview. Socio-demographic (sex, age, marital status, driving experience, 
income) and behavioural characteristics (smoking, alcohol consumption, consumption of sweet 
drinks, physical activity, and dietary intake) of participants were obtained. Also, objective reports 
concerning anthropometric measurements (weight, height, waist and hip circumference), blood 
pressure and biochemical measurement that is the blood glucose measurement. All 
anthropometric measurements were taken following a standard procedure using a Lufkin non-
extensible flexible anthropometric tape (W606PM), Rosscraft, Canada and a SECA weighing 
scale and stadiometer (Hamburg, Germany). Blood pressure was checked also in accordance with 
standard protocols using a Medic+ Digital Blood Pressure Monitor Model 1219 (Hamburg, 
Germany). A validated ACCU-CHEK glucose monitoring apparatus (Mannheim, Germany) was 
used for blood glucose measurement. 
Overweight and obesity was defined as a body mass index (BMI) of 25.0 kg/m2 –29.9 kg/m2 and≥ 
30 kg/m2, respectively. Pre-hypertension was defined according JNC-8 criteria a systolic blood 
pressure of 120- 139 mmHg and diastolic of BP 80-89 mmHg while hypertension was defined as 
an average of two systolic BP ≥140mmHg and/or diastolic BP of ≥90mmHg or a history of 
hypertension or anti hypertensive medication use. Diabetes status was determined using the 
fasting blood glucose (FBG) test and defined as a FBG ≥ 7.0mmol/L or self-reports of history or 
current diabetes medication use (treatment), while pre-diabetes was defined as a FBG of 5.6-
6.9mmol/L. Awareness of diabetes was defined as self-reported history of diabetes among the 
people with diabetes. Metabolic syndrome status was determined according to the National 
Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria 
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Descriptive statistics (frequency, percentages, mean and standard deviation) were used for 
categorical variables. Inferential statistics (Bivariate and multivariate analysis) were used to 
determine the prevalence and determinants of obesity, hypertension and diabetes and their 95% 
confidence interval (95%). A p-value of < 0.05 was considered statistically significant. Pairwise 
correlations and Kappa statistics were used to assess the relationship and agreement among 
makers of abdominal obesity. Statistical Package for Social Sciences (SPSS) was used for data 
analysis. 
The mean age of the participants was 43.3 (SD12.5) years. The prevalence of overweight and 
obesity was 34.0% and 38.0%, respectively. Age, marital status, period of driving, not-smoking, 
hypertension and diabetes were significantly associated with obesity. In logistic regression 
analysis, after adjusting for confounding factors, only age (OR 1.6, CI 1.0-2.7), hypertension (OR 
3.6, CI 2.3-5.7) and non-smoking (OR 2.0, CI 1.3-3.1) were the independent and significant 
determinants of obesity. The prevalence rates of abdominal obesity  by waist circumference 
(WC), waist-hip-ratio (WHR), waist-to-height ratio (WHtR) and neck circumference (NC) were 
61.5%, 67.5%, 80.1% and 65.3%, respectively. A strong correlations exists between WHR and 
WC (>0.64); and WHtR and WC (>0.62). There exists a good agreement between WC and WHR. 
Also, a moderate agreement exists between WC and WHtR, WC and NC, WHR and WHtR, and 
WHtR and NC. The prevalence of above normal body composition for participants with 
hypertension was 71.0%, 65.9%, 63.2% and 66.5% by WC, WHR, WHtR and NC, respectively. 
For diabetes, the prevalence was 20.6%, 19.4%, 17.0% and 18.6% by WC, WHR, WHtR and NC, 
respectively. Waist circumference was a stronger predictor of hypertension and diabetics, with 
odds ratio of 3.7 (95 % CI: 2.3-6.1 and 3.1 (95 % CI: 1.6-6.0), compared to NC, with odds ratio of 
1.7 (95 % CI: 1.1-2.8). 
The prevalence of pre-hypertension was 33.7% and hypertension was 57.0%.  Age, marital status, 
level of education, period of driving, obesity, alcohol, sweet drinks consumption and diabetes 
were significantly associated with hypertension. After adjusting for confounders, age >35 years 
(P=0.004), obesity and alcohol use (P<0.001), period of driving >5years (p=0.028) and diabetes 
(P=0.003) were significant predictors of hypertension. 
Prevalence of pre-diabetes and diabetes was 17% and 16%, respectively. Of those who were 
diabetic (n=63), the majority were aware of their diabetes status (n=43) and were on treatment 
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(n=30). Age, marital status, level of education, period of driving, obesity, sweet drinks 
consumption, physical activities and hypertension were significantly associated with diabetes. 
Only age >35 (AOR= 3.6, CI 1.2-11.1), ever married (AOR= 3.3, CI 1.5-7.0) and hypertension 
(AOR= 3.4, CI 1.7-6.8) were the independent predictors of diabetes after adjusting for 
confounders. 
The prevalence of metabolic syndrome was 22%. Age, marital status, level of education, physical 
inactivity and period of driving were significantly associated with metabolic syndrome. After 
adjusting for confounders, only age above 35 years (Adjusted Odd Ratio [AOR] =3.8, CI=1.4-
9.5), ever married (AOR=3.0, CI=1.6-5.3) and period of driving above five years (AOR= 2.4, 
CI=1.2-4.7) were the significant and independent predictors of metabolic syndrome. 
About 30% of the participants were daily smokers, 37% consume alcohol regularly and only 18% 
were physically active, while 82% were physically inactive. 
In conclusion, there was a high prevalence of obesity, hypertension and diabetes among the 
commercial drivers in this setting, which is associated with unhealthy lifestyles (smoking, 
excessive alcohol consumption, physical inactivity). Interventions aimed at promoting 
cardiovascular health of commercial drivers such as health education and workplace screening, 
should prioritize weight reduction, healthy eating and physical activity in this population. 
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CHAPTER ONE 
INTRODUCTION 
1.1 BACKGROUND TO THE STUDY 
Non-communicable diseases (NCDs) are diseases of long duration with slow progression and 
which do not resolve themselves spontaneously, also known as chronic diseases (World Health 
Organization, 2011c). There are five major NCDs with the first four being the major cause of 
morbidity and mortality. These are cardiovascular diseases (hypertension, stroke, coronary heart 
disease, congestive heart failure), cancer, chronic respiratory diseases (asthma, chronic 
obstructive pulmonary diseases, respiratory allergies), diabetes and mental illness (Bloom et al., 
2011:8). Non-communicable diseases account for 70% of global mortality yearly among people 
within the ages of 30  and 69 years; and more than 80% of this mortality occurs in low and 
middle income countries (LMICs) (World Health Organization, 2011e; World Health 
Organization, 2017c).  
The global epidemic of non-communicable diseases over the past few decades  is concerning 
(Terzic & Waldman, 2011:225), as it accounts for seven in every 10 global deaths; and the WHO 
estimates a 17% increase in the burden of non-communicable diseases (World Health 
Organization, 2013a). Apparently, NCDs also account for and increase the disability-adjusted 
life-years (DALYs) rate (Naghavi & Forouzanfar, 2013:s95). Nations are faced with the burden 
of diseases, which non-communicable diseases are a part of, and which have become a surging 
burden, thus placing it as one of the items on the 2030 agenda for sustainable development goals 
(SDGs). The SDG stipulates as one of its objectives, to reduce by one third premature mortality 
from non-communicable diseases (United Nations Development Programme, 2017:2). Non 
communicable diseases account for the majority of global deaths, when compared with injuries, 
communicable diseases, maternal, perinatal and nutritional health conditions (Hunter & Reddy 
2013:1336). It is projected that increases in NCDs will account for almost three-quarters of all 
deaths worldwide by 2020 (World Health Organization, 2017b). According to the (United 
Nations Development Programme, 2013) report, non-communicable disease accounts for 60% of 
the world‘s recorded mortality. The burden of NCDs poses direct and indirect costs on 
individuals, households and governments, especially in low and middle-income countries 
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(Kankeu et al., 2013). In recent times, non-communicable diseases have been investigated by 
WHO, the World Bank and UNDP (World Health Organization, 2014e; World Bank, 2011; 
United Nations Development Programme, 2013). This signals the health, economic and social 
implications of NCDs (Reubi et al., 2016:184; Stuckler, 2008:291; Miranda et al., 2008). These 
diseases have been tagged or identified as health and economically threatening, which has 
become a source of concern to health and economic organizations, as well as governments. For 
instance, in some parts of the developing countries, the annual cost effect of chronic disease 
management ranges from US$ 3 billion to US$ 72 billion. Notably, NCDs often bring about co-
morbidities that make cost estimations and projections impossible. Hence, it  becomes an 
economic burden when budgets cannot be planned accurately (Bloom et al., 2011:11).  
Non communicable diseases are the largest health burden facing developing countries (Islam et 
al., 2014:82). About eighty percent of deaths due to NCDs occur in low-and middle-income 
countries (LMICs) (World Health Organization, 2011b; World Health Organization, 2011a); and 
this is concurrent with the burden of infectious diseases, such as the Human Acquired 
Immunodeficiency Syndrome (HIV/AIDS), malaria and tuberculosis among many others (Islam 
et al., 2014:84; Remais et al., 2013:223). In the past, NCDs were regarded as diseases of the rich 
countries, but this has surprisingly, recently become a significant disease in even the poor 
countries(World Health Organization, 2017b). NCDs have been disproportionately more 
prevalent in LMICs than in the high income countries (HICs), due to delays in implementing 
preventative measures and the inherently weak health systems prevailing in these countries 
(Samb et al., 2010). The World Health Organization (2014d), reported that 28% of NCDs occur 
in high income countries as compared with the 48% rate in LMICs occurring among adults. It 
accounted for 80% of DALYs attributable to non-communicable diseases in 2012 in LMICs. 
Conversely, the situation  is better and seems under control in HICs (World Health Organization, 
2014a). In Sub-Saharan Africa (SSA), the high and increasing risk factors of non-communicable 
diseases are attributed to epidemiological and nutritional transition (Dalal et al., 2011:894; 
McAloon et al., 2016:262). In 2010, non-communicable diseases caused over two million 
mortalities (Lim et al., 2012; Naghavi et al., 2013:s95). Low middle income countries exhibit 
vulnerability to NCDs, in the sense that the majority of the activities and risk factors in these 
countries promote NCDs, ranging from urbanization to lifestyle behaviours (Remais et al., 
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2013:222; Nyirenda, 2016:158; Allen et al., 2017:e285; Allender et al., 2010:300). To combat 
the burden of NCDs, a multi-sectoral approach is crucial. It is imperative to use the model 
applied by HICs to reduce the accelerated rise of non-communicable diseases in LMICs, and 
more specifically, in sub Saharan Africa, with the ever-rising statistics of NCDs. The health 
system cannot solely solve the problem of NCDs (Juma et al., 2016; Stuckler, 2008), as a multi-
dimensional approach is needed. 
South Africa is faced with the quadruple burden of diseases as a developing nation, and non-
communicable diseases are predominantly on the increase (Hofman, 2014:647; Pillay-van Wyk 
et al., 2016:e642; Mayosi et al., 2009:935). In South Africa (SA), with 27% probability of death 
between the ages of 30-70 years, NCDs account for 43% of total mortality (World Health 
Organization, 2014e). South Africa is one of the SSA countries with high age-standardized death 
rates (ASDRs), due to a higher NCDs rates in LMICs than those in  high income countries 
(Abegunde et al., 2007:1930). About 38.9% of deaths in 2010 were associated with non-
communicable diseases with ASDRs of 287, 114, 58, and 52 per 100 000 for the following: 
CVDs, cancers, chronic respiratory diseases and diabetes mellitus (DM) respectively (Nojilana et 
al., 2016a:477).  Although a decrease was observed in the rate, it is yet to meet the recommended 
and estimated 2% decrease success rate of NCDs annually, while fluctuations were also observed 
(Nojilana et al., 2016b:437). The majority of the premature deaths are targeted towards the age 
range of 30 -70 years of age; coupled with the burden of HIV/AIDS mortality (Pillay-van Wyk et 
al., 2017:168). The challenge of the NCDs burden has been identified in South Africa, but 
appropriate policies, health services, human resources, surveillance and screening, information 
and of course finances are insufficient to combat NCDs in the country (Bradshaw et al., 2011).  
Cardio-metabolic risk factors account for the global burden of diseases (GBD) and mortality 
(Danaei et al., 2014). Some of these non-communicable diseases are the end result of the 
aggregates of cardio-metabolic risk factors. Among factors driving non communicable diseases 
are population ageing, urbanization, lifestyle, socio-economic changes all of which fuel NCD 
risk factors and increases the disease burden, especially in developing countries (Dalal et al., 
2011:886), which could be particularly applicable to South Africa. In resolving the global burden 
of NCDs, Kroll et al. (2015:1253), states that surveillance is one important tool for early 
detection and diagnosis of NCDs for better prevention and control, wherein interventions can be 
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made. Supporting this, Ebrahim et al. (2013) maintained that constant research, and repeating 
studies for comparison, could discern what needs to be known about resolving the challenge of 
NCDs. This is one of the strategies used in HICs. Tackling NCDs should be focused on the 
diseases and on implementing relevant interventions. 
Commercial drivers are a high-risk population for cardio-metabolic diseases (CMDs) and health 
problems. Of course, several studies have proven that the prevalence of predisposing factors is 
high among commercial drivers. Commercial drivers in South Africa are independent owners or 
hired drivers of motor vehicles for commercial purpose. The driving profession has a great 
impact in the transportation industry and is of great benefit to the public and their safety 
(Sangaleti et al., 2014). As such, there is a need to pay attention to drivers’ health. The 
commercial taxi drivers are involved in many routine activities that impact on their health. For 
instance, their lengthy working hours on the road, unpredicted schedules, physical inactivity and 
a scarce option for a healthy diet results in overweight and obesity (Lim & Chia, 2015: 9; Rosso 
et al., 2015: 212; Thiese et al., 2015: 662). Commercial drivers often engage in the consumption 
of unhealthy, readily available food items. With the habit of eating away from home; they eat 
less fruits and vegetables and more  heavy, stomach-filling meals (Nagler et al., 2013: 6; 
Lakshman et al., 2014). Commercial drivers fall far short of the WHO recommended daily 
amount of physical activity, namely moderate intensity activity of 150 minutes per week and 
vigorous intensity activity of 75minutes per week (World Health Organisation, 2016), as they sit 
behind the wheel all through the day. Hence, the existence of non-communicable disease cannot 
be ruled out among them. Chapman and Naweed (2015), opined that, chronic diseases such as 
diabetes and cardiovascular diseases are associated with unhealthy lifestyle, and are considered a 
burden to individuals, communities and the larger society with serious undesirable effects on the 
transportation industry. As such, it is advisable that commercial drivers should be in a good state 
of health to function optimally, prevent disability and be productive (Sangaleti et al., 2014). 
 
1.2 STATEMENT OF THE PROBLEM 
Cardio-metabolic risk factors are conditions which significantly enhance the possibilities of 
developing non-communicable diseases (NCD) for example cardiovascular disease and diabetes 
mellitus. Non-communicable diseases (NCDs) account for about 29% of deaths and 11% 
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because of CVDs in South Africa (WHO 2011). More than two thirds of Africans with diabetes 
remain undiagnosed (International Diabetes Federation, 2015:68). Predominantly, commercial 
taxi drivers are male, and many are under the age of fifty years, and without health insurance. 
These are attributes that are often associated with poor health practices. Circumstances common 
to commercial taxi drivers contribute to their risk profile: drivers routinely work long hours with 
frequent shift changes and irregular time for meals and relaxation, and thus they are subject to 
high stress levels, due to uncertain income and traffic congestion. They are at a relatively high-
risk for violence and homicide, and are exposed to toxic materials and exhaust fumes on a 
regular basis. Probably because commercial taxi drivers are a relatively autonomous and hard to-
reach group, there is a gap in knowledge about their health.  
Despite the increase in the overall number of commercial taxi drivers and the importance of the 
taxi industry as a source of employment in South Africa, research has hardly been conducted on 
the risk factors for the cardio metabolic health of commercial taxi drivers in South Africa. 
Existing studies focus on HIV/AIDS, violence, sexual behaviour, musculoskeletal system 
disorders and stress. By contrast, the cardio metabolic risk profiling of taxi drivers has been 
studied in recent years in Brazil(Sangaleti et al., 2014), Hong Kong (Siu et al., 2012), Australia 
(Abu Dabrh et al., 2014), Korea(Shin et al., 2013), Iran (Saberi et al., 2011; Izadi et al., 2013), 
Nigeria (Tobin et al., 2013; Olusegun & Ikeoluwapo, 2016; Erhiano et al., 2015) and India 
(Satheesh & Veena, 2013; Lakshman et al., 2014a; Borle & Jadhao, 2015) 
Given that commercial taxi drivers occupy an important role in the transport industry; this 
contributes to the growth of the economy by the nature of the services they provide. Their health 
should not be downplayed, but rather profiled for proper planning. Anecdotally, commercial taxi 
drivers in South Africa exhibit poor lifestyle health behaviours, in terms of sedentarism, 
excessive alcohol consumption, smoking and other risky health behaviours. However, unlike 
other population groups in South Africa, their physical and biomarker risks regarding health 
assessment have not been as well documented in South Africa as elsewhere. As such, 
understanding the magnitude of the problem is necessary to inform health policy-makers to take 
appropriate intervention strategies in designing health programmes tailored to the needs of this 
special population. This study could form a benchmark for future research on this global health 
problem; as information on cardio metabolic risk factors among South African commercial taxi 
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drivers is lacking. Therefore, the present study will examine the prevalence and correlates of 
cardio metabolic risk factors among commercial taxi drivers in the Buffalo city metropolitan 
municipality (BCMM)  
 
1.3 AIM AND OBJECTIVES  
The overall aim of the study is to examine the prevalence and correlates of CMRFs among 
commercial taxi drivers in the Buffalo city metropolitan municipality area, Eastern Cape 
Province, to inform public health policy concerning the preventative measures for the associated 
risk factors among commercial drivers. 
The specific objectives of the study are to: 
 Determine the prevalence and risk factors of overweight and obesity among commercial 
drivers in BCMM. 
 Determine the prevalence and risk factors of hypertension and pre-hypertension among 
commercial drivers in BCMM. 
 Determine the prevalence and risk factors of diabetes Mellitus type 2 and pre-diabetes among 
commercial drivers in BCMM. 
 Assess age, duration of driving, educational level, socio-economic differences in CMRFs risk 
factors and prevalence rates among commercial drivers in BCMM; and 
 Examine the association of CMRFs risk factors with lifestyle characteristics (smoking, 
alcohol consumption, physical activity, dietary intake) among commercial drivers in the East 
London metropolitan area. 
 
1.4 RESEARCH QUESTIONS 
 What are the prevalence and risk factors of overweight and obesity among commercial 
drivers in BCMM? 
 What are the prevalence and risk factors of hypertension and pre-hypertension among 
commercial drivers in BCMM? 
 What are the prevalence and risk factors of type 2 diabetes mellitus and pre-diabetes among 
commercial drivers in BCMM? 
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 Would age, duration of driving, educational level, and other socio-economic variables predict 
the risk of CMRFs among commercial taxi drivers in BCMM? 
 Would smoking, alcohol consumption, physical activity, and dietary intake have any 
significant effect on the risk of developing CMRFs among commercial drivers in BCMM?  
 
1.5 SIGNIFICANCE OF THE STUDY 
Continuous surveillance of the prevalence of NCDs as well as their associated risk factors is the 
first step in curbing their increase. As recommended by the World Health Organization (WHO), 
surveillance is vital in the formulation of public health policy and the implementation of 
prevention strategies for non-communicable diseases (World Health Organization, 2003b). The 
findings of the study will be instrumental in the development of public health policies tailored to 
the prevention of cardio-metabolic diseases among this seemingly, neglected population. In 
addition, findings from this study will assist in identifying individuals at risk, and this is essential 
in the planning and implementation of cost-effective prevention programmes. Besides, the 
findings will create awareness of the health conditions of commercial drivers in BCMM, South 
Africa, which will be useful in health surveillance of the group.  
 
1.6 SCOPE OR DELIMITATION OF THE STUDY 
The focus of the study will be the commercial taxi drivers under the South Africa National Taxi 
Council (SANTACO), in Buffalo City Metropolitan Municipality, above the age of 20 years. The 
NCDs of interest are cardiovascular diseases and diabetes. The independent variables of interest 
include social and demographic characteristics of the drivers. The dependent variables of interest 
are cardio-metabolic risk factors namely; hypertension, diabetes, overweight and obesity, alcohol 
use, smoking, physical inactivity and metabolic syndrome. 
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1.7 THEORETICAL FRAMEWORK 
1.7.1 The Health Promotion Model 
The Health Promotion Model (HPM) proposed by Pender (1982; revised, 1996) was designed to 
be a complementary counterpart to models of health protection. This defines health as a positive 
dynamic state rather than simply the absence of disease. Health promotion is directed at 
increasing a patient's level of well-being. The health promotion model describes the 
multidimensional nature of persons as they interact within their environment in pursuit of health 
The model has three components; 
Individual characteristics and experiences: this describes prior related behaviour, the 
frequency of the same or similar health behaviours in the past and personal factors (biological, 
psychological, socio-cultural); general characteristics of the individual that influence health 
behaviour such as age, personality structure, race, ethnicity, and socioeconomic status. 
Behaviour-Specific Cognitions and Affect: this describes the perceived benefits of action, 
perceived barriers to action, perceived self-efficacy, activity-related effects, interpersonal 
influences (family, peers, and providers), and situational influences (options, demand 
characteristics, aesthetics), commitment to a plan of action and immediate competing demands 
and preferences. 
Behavioural Outcome and Health Promoting Behaviour: the desired behavioural end-point or 
outcome of health decision-making and preparation for action (Pender, 2011) 
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Behavioural Specific Cognition 
And Affect 
 
 
Individual Character 
And Experiences Behavioural Outcome 
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Figure 1.1: Extract from Pender Health Promotion Model 
 
1.7.2 Application of the model to the study 
Some characteristic behaviours and experiences constantly have an effect on an individual’s 
health. This could either promote or demote their health status. Having self-knowledge and 
knowing the advantages of healthy living influences action positively, while perceived barriers 
such as (affordability of alcohol and cigarette and expensive healthy meal) block action towards 
a healthy lifestyle among individuals. Influences from health workers, family and friends via; 
health education, health screening, family support and personal observation of healthy behaviour 
motivates the individual towards adherence to actions for living healthily. Situational influences 
such as increased cost of unhealthy substances, and affordability of healthy and health initiatives 
for different categories of people will also bring greater interest in individuals towards health- 
promoting behaviours with beneficial outcomes. 
Knowledge on the benefit of 
healthy lifestyles. 
Attitudes towards healthy 
lifestyle 
Interpersonal influences e.g. 
family health workers and 
friends 
Situational influences high 
cost of unhealthy substances 
due to taxation,  
Self-efficacy and 
commitment to plan action 
Health promotion measures  
Quit smoking  
Reduce alcohol intake 
Physical activity  
Healthy diet with less fat 
Consumption of fruits and 
vegetable  
Adequate sleep 
Age  
Gender  
Ethnicity 
Duration of driving 
Hours of sleep 
Physical inactivity  
Educational level  
Socio-economic level 
Impulsiveness  
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1.8 DEFINITION OF KEY OPERATIONAL TERMS 
The following terms are defined as used in this study: 
Cardio-metabolic diseases: These are a group of cardiovascular and metabolic diseases. 
Cardio-metabolic risk factors: These are predisposing factors which cluster together to 
increase the chances of developing type 2 diabetes mellitus or cardiovascular diseases. 
Commercial driver: This is a person licensed and permitted by the Department of Transport, 
under a registered association, to convey passengers or property for commercial purposes and for 
profit. 
Determinants: They are factors that predispose a disease condition. 
Non-communicable diseases: They are non-infectious, chronic diseases that progress slowly.  
Metabolic syndrome: Is the clustering of three or more cardio-metabolic risk factors. 
Obesity: Is the excessive accumulation of total or central body fat. 
Prevalence: The generality of a disease condition. It is a statistical concept referring to the 
number of cases of a disease that are present in a population at a given time, that is the total 
number of individuals in a population who have a disease or health condition at a specific period, 
usually expressed as a percentage of the population. 
Screening: Is a way of checking the vital signs of diseases before they become symptomatic.  
Also, it is checking the probability of a person having an abnormal health condition which has 
not been diagnosed yet. 
 
 
 
 
11 
 
1.9 CHAPTER OUTLINE  
Chapter one includes the background to the study, the problem statement, aim, objectives, 
research questions, significance of the study, theoretical frame work and the definition of 
operational terms. It also includes the outline of the study. 
Chapter two focuses on the literature review. This chapter discusses the definition of cardio-
metabolic risk factors, cardiovascular diseases and diabetes mellitus.It also describes the global 
burden and prevalence of cardio-metabolic disease in South Africa, particularly among drivers. 
 Chapter three describes the research methodology that is used in this study. This includes the 
study design used, the population settings, sampling and sampling size, the research instruments, 
validity and reliability of the instrument, ethical consideration and the pilot study. The 
description of the data collection process, anthropometric, blood pressure and blood glucose 
measurements, administration of the questionnaire and the definition of the risk factors is 
discussed. Lastly, data analysis is described. 
Chapter four presents the results of the study and the discussion. 
In chapter five, the summary of the study, its findings, limitations and strengths of the study is 
described. Finally, conclusions, recommendations and suggestions for further studies are made. 
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CHAPTER TWO 
LITERATURE REVIEW 
2.1 INTRODUCTION 
This chapter provides a relevant literature review on cardio-metabolic risk factors and diseases, 
as well as the underlying factors for its prevalence, particularly regarding commercial drivers. 
 
2.2  OVERVIEW OF THE SOUTH AFRICAN TRANSPORT INDUSTRY AND 
DRIVING 
The transport industry, regardless of the role definition (individual, associations, company), 
plays an important and notable role in the public. The industry empowers people through job 
creation and economic improvement. It also serves as a major source of mobility, and is 
accessible to all levels of socio-economic status. The motivating reason of being in a taxi driving 
job for some drivers varies from lack of education to an inability to get desired employment 
(Bawa & Srivastav, 2013; Facey, 2003:255). The Minibus taxi drivers in South Africa are a 
group of private or individual owners of vehicles used for public transit. This group is 
responsible to the Department of Transport, although the driving business is not directly run by 
the transport industry in South Africa, there is a working relationship between the department 
and the drivers’ association that often runs the driving business. The efficiency of the transport 
association brings about economic and social benefits for the country (Rodrigue & Notteboom, 
2017). Transportation is an important aspect of an individual’s social life, as transport services 
are needed to provide mobility of goods and humans, which creates completeness of an 
individual’s daily activities. A country with no form of mobility remains static because, 
economic growth, local, national, and the international network and business will be hindered. 
According to the South Africa National Taxi Council (SANTACO), about five million people are 
being transported daily. This comprises approximately 70% of the workforce in the country 
(Oxford, 2013). This portrays the social and economic importance of the transport industry for 
the public and the government (Rodrigue et al., 2017). Thus, the taxi drivers’ health should be 
prioritised.  
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Commercial drivers are a group of people who convey passengers from one place to another. 
Being a taxi driver requires no formal education. However, proper skill in driving is required 
through testing to obtain a driving license (Federal Motor Carrier Safety Association (FMCSA), 
2017) and guidance (Mayhew & Simpson, 2002:ii7). The nature of the work of commercial taxi 
drivers is characterized by irregular sleep patterns, prolonged sitting behind the wheel, irregular 
eating habits, a lack of physical exercise and other dangerous lifestyle behaviours (Yang et al., 
2014).  
Bawa et al.’s (2013) study among taxi drivers in Mumbai, India, revealed that the majority of the 
taxi drivers were from lower socioeconomic status groups, working over eight hours every day; 
and 89% of those had one or more morbidities. Facey (2003:256), describes commercial driving 
as precarious work, which predisposes the drivers to a lot of economic uncertainty, stress and 
unhealthy behaviours that promote disease. Because of the stress and hazards of the job, drivers 
exhibit workplace absenteeism due to health-related issues (Brunoro et al., 2015:329). 
Furthermore, the educational standard of most commercial drivers is low (Ozoh et al., 2014), 
thus affecting their health literacy in terms of promotion of healthy habits (van der Heide et al., 
2013). 
The workplace burden is expanding with world population growth. The commercial drivers’ 
workplace environment is not conducive for promoting healthy living. Hannerz and Tüchsen 
(2001), reported in their study that professional drivers, compared with other men have greater 
risk of developing diseases that affect all the systems and organs of the body. Commercial 
drivers also have a higher risk of having chronic and infectious diseases, due to their exposure to 
various forms of diseases and illnesses (Hirata et al., 2012; Aslam. et al., 2015:863). Driving is a 
stressful activity (Brunoro et al., 2015: 331); due to the shifting nature of the job, and hours spent 
behind the wheel. Road traffic accidents (forty six percent) were a major cause for the rise in 
mortality due to injuries in the period from 1990 to 2010. Other contributory factors were non-
communicable diseases such as hypertension, diabetes mellitus (DM) and obesity (Lozano et al., 
2012:2096). 
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2.3 CARDIO-METABOLIC RISK FACTORS  
The inception of cardio-metabolic risk screening arose from the first Framingham Heart Study in 
1948, which was undertaken to identify individuals at risk of cardio-metabolic diseases 
(Mahmood et al., 2014). Cardio-metabolic risk factors (CMRFs) are multiple factors (type 2 
diabetes mellitus, hypertension) that complicates into cardiovascular diseases and metabolic 
disease process. These factors combine greatly towards bringing about cardiovascular diseases 
and type 2 diabetes mellitus. They encompass the traditional (hypertension, dyslipidemia, etc.) as 
well as the emerging risk factors such as abdominal obesity (Leiter et al., 2011:e1; Chatterjee et 
al., 2012:389). Cardio-metabolic risk factors are clusters of various factors such as tobacco use, 
hypertension (HTN), dyslipidemia, low physical activity, high fasting plasma glucose level and 
high body mass index (BMI) (Leiter et al., 2011:e1; Brunzell et al., 2008:811). These were the 
cause of about 67% of cardiovascular diseases and diabetes mortality worldwide in 2010 (Danaei 
et al., 2014:634). Cardio-metabolic risk factors (CMRFs) strengthen the chances of 
cardiovascular illnesses and death (Leiter et al., 2011). Cardio-metabolic risk factors are 
interwoven, such that developing one of the risk factors increases the risk of developing another. 
Identifying cardio-metabolic risk factors in clinical practice for preventing and managing non-
communicable disease is essential.  
Cardio-metabolic risk factors can be classified into modifiable and non-modifiable risk factors, 
which should be screened for and treated promptly. Physical inactivity or smoking together with 
one or more risk factors increases cardio-metabolic risk (Wang, 2015). The non-modifiable risk 
factors include age, race and ethnicity, gender, and family history; while modifiable risk factors 
include obesity, inflammation, hypertension (Chiang et al., 2013:735), smoking, physical 
inactivity, unhealthy diet, insulin resistance, dyslipidemia and hyperglycemia (Wang, 2015). 
High blood pressure, obesity, high glucose level and cholesterol are the four leading metabolic 
risk factors, which further result in complications (Danaei et al., 2014:636). 
 
2.4 CARDIO-METABOLIC DISEASES 
Cardio-metabolic diseases in this study are referred to as cardiovascular diseases and diabetes 
mellitus.  
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2.4.1 DIABETES MELLITUS 
Diabetes Mellitus is a progressive metabolic disorder and also an endocrine disorder whereby 
there is impairment of the pancreatic beta cell function, causing a deficiency in insulin secretion 
and insulin resistance also causing hyperglycemia (Ozougwu et al., 2013:46). Diabetes is a 
chronic metabolic or endocrine disorder characterized by a raised sugar level, evidenced by 
polyphagia, polydipsia and polyuria (World Health Organization, 2016a:11). This often occurs in 
the beta cell of the islet of langerhan or pancreatic cell. It is basically a metabolic disorder that 
occurs as a result of insulin action, insulin secretion or both (World Health Organization, 
2016a:11). Pathogenetically, diabetes mellitus occurs as a result of insulin action and reactions 
that is, the inability of the pancreas to produce sufficient adequate insulin or when there is no 
response to the insulin produced (International Diabetes Federation, 2015:12). It can also be 
described as difficulty in the metabolism of glucose or carbohydrates. 
Pre-diabetes describes a state of uncertainty, and a precursor to the development of type 2 
diabetes mellitus. It characterized a condition in which blood glucose levels are higher than the 
optimal level, but not enough to be classified as type 2 diabetes mellitus  (International Diabetes 
Federation, 2015:26). Buysschaert and Bergman (2011:290), opined that pre-diabetes is better 
diagnosed and managed as a disease entity rather than as a stage of type 2 diabetes mellitus, to 
better treatment and prevent deterioration to type 2 diabetes. The authors further stated that 
developing diabetes from the pre-diabetes stage could be within a short period of time or a longer 
period. Colberg et al. (2016: 2065), defines glucose intolerance as an intermediate stage, 
characterized by hyperglycemia, but at a level lower than what qualifies for the diagnosis of 
diabetes. Pre diabetes predisposes a person to type 2 diabetes mellitus; which is a risk factor 
(Buysschaert et al., 2011:294). It also increases the chances of developing cardiovascular 
diseases (Colberg et al., 2016:2065). It presents with the opportunity to take preventive measures 
against type 2 diabetes mellitus, if there is awareness about the condition. 
Diabetes mellitus increases the risk of diseases and co-morbidities such as metabolic syndrome, 
obesity, HIV and sickle cell diseases resulting in serious micro vascular and macro vascular 
complications (Kengne et al., 2013:982). Diabetes increases blood pressure. This occurs as a 
result of these processes decreasing the blood vessels' ability to stretch, increasing the amount of 
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fluid in the body and changing the way the body manages insulin (Barhum, 2017). Managing 
diabetes mellitus requires a multidisciplinary approach which has not been put in place yet, 
especially in Africa, by means of this approach, the current increased prevalence of diabetes can 
be reduced, or the burden combated.  
2.4.1.1 The burden of diabetes mellitus 
Diabetes is a major global public health issue. The United States of America (USA) is ranked as 
the leading country with the highest prevalence of diabetes among the developed nations, with 
about twelve to fourteen percent of the USA adults live with DM (Menke et al., 2015). There 
were 242 million increases in the number of individuals affected with diabetes from 1980 to 
2014 (Roglic, 2016). A global projection of the prevalence of diabetes was a  54% increase from 
2010 to 2030 (Shaw et al., 2010:10), while Guariguata et al. (2014:144) study, predicted an 
increase in diabetes from 382 million in 2013 to 592 million in 2035, highlighting a major 
increase in low and middle income countries (LMICs). Poorly controlled diabetes or 
uncontrolled diabetes complications is the basic cause of mortality, when compared with well-
treated diabetes (Bhutani & Bhutani, 2014). In 2012, about 1.5million and 2.2 million premature 
deaths  from diabetes and pre-diabetes were recorded (Roglic, 2016). The persistent increase of 
diabetes in developing countries can disturb the economic growth of a country due to its 
economic burden on the individual, the health care systems and the country at large 
(International Diabetes Federation, 2015:58).  
 
2.4.1.3 Type 2 Diabetes Mellitus in Sub-Saharan Africa 
Type 2 Diabetes Mellitus is the major form of diagnosed diabetes (Wu et al., 2014:1185), 
previously perceived as a disease of predominantly rich nations. It is now growing rapidly in 
developing nations (Gill, 2014:249). Baleta and Mitchell (2014: 687), projected that in 2030, 
type 2 DM will affect 49.7 million persons in Sub-Saharan Africa (SSA). This is gradually 
becoming the case, though there are variations in the prevalence of Type 2 Diabetes Mellitus 
(T2DM) in Africa. The prevalence of diabetes in SSA ranges from as low as 2.7% to 28.2% in 
2012 (Erasmus et al., 2012: 842). An estimated 14.2 million adults have diabetes in Africa and 
more than two thirds of the people in Africa are undiagnosed or are unaware of their blood 
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glucose levels (International Diabetes Federation, 2015:70). Diabetes is now common not only 
among the urban communities, but also in the rural areas in Africa (International Diabetes 
Federation, 2015:78). The burden of non-communicable diseases has been quite a challenge 
posing a threat to health in Africa. According to IDF (2015:48), one in 11 adults was affected by 
diabetes in 2015, and one in 10 adults will be affected by 2040. This implies that 415 million of 
the world’s population of adults were affected, and these will increase to 642 million by 2040. 
Mortality attributable to diabetes in Africa is about a million (Peer et al., 2013:6). Annually, in 
SSA, US$67.03 billion, or US$8836 is expended on each individual with diabetes (Hall et al., 
2011:569). Some of the challenges in battling the increasing prevalence of diabetes are 
ignorance, poverty and the huge economic cost of managing DM (Buowari, 2013:135). 
 
2.4.1.3 Diabetes mellitus in South Africa 
Diabetes mellitus affects two in 10 adults in South Africa (Shisana et al., 2013:94). In Sub-
Saharan African countries, South Africa is one of the countries with a high prevalence of 
diabetes. It was estimated that, in 2013, 8.3% of the population were living with diabetes 
(Guariguata et al., 2014:139). Also, according to (International Diabetes Federation, 2015) 2.3 
million persons have diabetes in South Africa (SA), and this figure is expected to increase by 
2035 (International Diabetes Federation, 2017). According to (Guariguata et al., 2014:139), the 
national prevalence of diabetes in South Africa is 8.3%, with an expected increase to 9.9% by 
2035, thus projecting South Africa as the country with the second highest prevalence with 
diabetes in Africa. Bertram et al. (2013:208), indicated in their study that there was an increase 
of diabetes from 5.5% in 2000 to 9% in 2009. Also, there are about 2 million cases of diabetes in 
South Africa with about 55% undiagnosed cases. It has accounted for 78,900 years of life lost 
due to disability (YLD), attributable to diabetes, while the majority of the YLD (64%) was due to 
DM alone (Bertram et al., 2013: 206). There is a low awareness rate and an increased prevalence 
of diabetes in South Africa. Among different population studies, the report of the DM rate 
among coloured groups in the Western Cape was 28.2%, in which over half of the people were 
not aware of the disease condition (Erasmus et al., 2012: 842) unlike black South Africans in 
Cape Town which showed a prevalence rate of 13.1% with 57.9% awareness rate (Peer et al., 
2012). The disease condition is also predominant in the Eastern Cape Province of the country 
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(Owolabi et al., 2016). Diabetes mellitus is one of the leading causes of morbidity and mortality 
in South Africa (Pillay-van Wyk et al., 2017:168). 
 
2.4.1.4 The burden of diabetes mellitus among commercial drivers 
Occupational activities of commercial drivers do have an impact on public road users that is 
other private drivers, pedestrians and perhaps roadside sellers. By the nature of their occupation, 
they are prone to a high-risk of diabetes mellitus, among other different cardio-metabolic risk 
factors. A recent study in the United Kingdom, reported that 43% of commercial drivers had type 
2 DM or pre-diabetes (Varela-Mato et al., 2017). Siu et al. (2012:62), reported in their study that 
8.1% had undiagnosed DM and a 10% prevalence of diabetes among drivers in Hong Kong. In 
Nigeria, Odeyinka &Ajayi (2017) reported that 3.4%  of drivers had type 2 diabetes mellitus. In 
Iran, 6.3%, 9.1% and 7.0% (Tofangchiha et al., 2014; Saberi et al., 2011:8; Izadi et al., 2013:23) 
of the drivers had type 2 DM. Also, in Brazil, 16.4%, 11.0%, and 2.8% (Sangaleti et al., 
2014:1063; Reis et al., 2017:485; Hirata et al., 2012) were reported to have diabetes mellitus. 
Likewise, in China, 8.8% of them were diagnosed with type 2 diabetes mellitus (Yang et al., 
2014). Commercial drivers in developing countries such as Iran and Brazil (Tofangchiha et al., 
2014; Reis et al., 2017) and developed countries like Hong Kong (Siu et al., 2012) presented 
with different prevalence values of diabetes. Prevalence rate varies, based on the type of vehicle 
and perhaps the length of trips being made. Tofangchiha et al. (2014), in their three-year cross-
sectional study reported that commercial drivers have poorly controlled diabetes mellitus. 
Risk factors associated with the high prevalence of diabetes among commercial drivers were 
found to be obesity, high blood pressure, hyperlipidemia, age, a family history of DM and a 
family history of CVD (Siu et al., 2012:65; Izadi et al., 2013; Sangaleti et al., 2014:1069). Being 
married, a history of hypertension, high waist circumference and blood pressure also increases 
risk of developing pre-diabetes (Siu et al., 2012:63). 
Also specific to diabetes, in a similar way as hypertension, unhealthy behaviour and job-related 
behaviour accounts for causes of diseases among commercial drivers (Krueger et al., 2007). 
These factors are: long working hours; unstable  schedules, often conflicting with circadian 
rhythms; poor locations for sleep; limited exercise; prolonged sitting; an unhealthy diet; traffic 
and delivery schedule-related stress, and environmental stressors like noise, heat, cold, and lack 
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of ventilation (Krueger et al., 2007; Knipling, 2015). While there are studies on the prevalence, 
awareness, treatment and determinants of diabetes and pre-diabetes among commercial taxi 
drivers in other countries, such information is lacking in South Africa. 
2.4.2 CARDIOVASCULAR DISEASES  
Cardiovascular diseases (CVDs) are a group of  heart and blood vessel diseases, which occur as a 
result of plaque formed in the arterial walls, hence causing narrowing of the arterial wall 
passages, making blood flow to the  circulatory system difficult (American Heart Association, 
2017). CVDs can also be described as various diseases of the circulatory system and congenital 
CVDs as well (Lloyd-Jones et al., 2010a:e55) that include hypertension, cerebrovascular disease 
(stroke), coronary artery disease (heart attacks), peripheral artery disease,  rheumatic heart 
disease, congenital disease and heart failure (World Health Organization, 2017a). Cardiovascular 
diseases can also be defined as a health related issue due to a deviation from cardiovascular 
health (Lloyd-Jones et al., 2010b:586). Ischemic heart disease and stroke are the commonest 
form of CVDs.  
Cardiovascular diseases are one of the major public health problems in the world. They are the 
major cause of disability, morbidity and mortality among the NCDs worldwide (Lim et al., 2012; 
Mendis et al., 2011). Cardiovascular diseases are the cause of 31% of all death globally, killing 
about 17.3 million people per year; and they are the number one global cause of death in the 
developing and the non-developed countries (World Health Organization [WHO], 2016; 
International Alliance for Responsible Drinking [IARD], 2016). Cardiovascular diseases are 
attributable to one in every four deaths (Lozano et al., 2012:2096). Although these 
cardiovascular diseases are preventable, they contribute to disabilities and death globally. It is 
was reported as causing 393.8 million (14.4%) of total global DALYs lost in 2012 (McAloon et 
al., 2016:257), and years of life lost (YLL) (World Health Organization, 2014a). According to 
WHO in 2012, CVDs were the major cause of mortality comprising about 17.6 million persons 
globally (World Health Organization, 2014b).  
Cardiovascular diseases have also grown and thus have become an economic burden. According 
to Lloyd-Jones et al. (2010a:e48), in the United States in 2010, an estimated US$ 503.2 billion 
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was expended on CVD directly and indirectly, and in Europe the annual economic cost is €192 
billion (Allender et al., 2008). This represents the cost burden in the developed countries. 
In recent times, developing countries or low-and middle-income countries (LMICs) are faced 
with the challenge of CVDs of non-communicable diseases (Sarki et al., 2015:7). Cardiovascular 
diseases were the cause of 31% of deaths globally in 2015 and 37% of deaths in low-and middle-
income countries (World Health Organization, 2017a). It also accounted for three quarters of 
deaths in these countries, favouring an increasing burden of CVDs in LMICs (Roth et al., 2015b; 
Roth et al., 2015a). Kwan et al. (2016:2565), stated that cardiovascular diseases predominate in 
the poorest billion of the poorest countries in the world. LMICs are suffering a great deal from 
the burden of CVDs, that have been reported to be subsiding in HICs or developing countries, 
with substantial difference in the age standardized rate of CVDs in LMICs, compared to HICs 
(Celermajer et al., 2012:1208). Stroke and ischemic heart disease are the leading causes of 
DALYs, due to CVDs (Forouzanfar et al., 2017:172). 
Sub-Saharan Africa is saddled with the public health burden of CVDs, although, there is sparse 
surveillance data to depict the real burden of CVDs in SSA. Cardiovascular diseases account for 
8.8% of all deaths, and 3.5% of DALYs in Sub-Saharan Africa (Moran et al., 2013:3). Unlike 
other parts of the world, younger age groups are mostly affected (Moran et al., 2013:3), which 
was previously, unobtainable (Peltzer & Phaswana-Mafuya, 2013:68). Cardiovascular diseases, 
after HIV/AIDS is the leading cause of death in South Africa (Msemburi et al., 2014; Norman et 
al., 2007a). CVDs in South Africa has the highest age-standardised death rates (ASDRs) and 
stroke, which is the leading CVD and mortality affecting the country (Nojilana et al., 2016a), 
accounts for 215 daily deaths in South Africa (Byrne et al., 2016). 
 
2.4.1 Risk factors for cardiovascular diseases 
There are various factors of CVDs which are also categorized as modifiable and non-modifiable 
risk factors. They  are but not limited to modifiable (tobacco smoking, alcohol abuse, obesity, 
lack of physical activity, dietary habits, elevated blood pressure, type 2 diabetes, dyslipidemias 
and non-modifiable age, gender, ethnicity, family history of CVDs (Reiner et al., 2011:1773; 
McAloon et al., 2016:259; Chatterjee et al., 2012:389). It has been postulated that a family 
history of CVDs will increase the risk of developing cardiovascular diseases (Imes & Lewis, 
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2014:117; Cohen et al., 2014:1215); and lack of exercise is attributable to the development of 
different types of chronic disease (Booth et al., 2012:1149; Reddigan et al., 2011:1429), and 
obesity (Patel et al., 2016:71). There are different scoring tools that are utilised to estimate the 
risk of CVDs in people namely the Framingham and the Systematic Coronary Risk Evaluation 
SCORE projects (D’Agostino et al., 2008; D'Agostino Sr et al., 2001; Conroy et al., 2003). 
Blood pressure, total cholesterol, high density lipoprotein (HDL) cholesterol, smoking, age and 
blood pressure medications are the assessment variables incorporated in the Framingham risk 
scoring (Wilson et al., 1998; Grundy et al., 1999) which aids the evaluation of cardiovascular 
risk in individuals. 
 
2.4.2 Cardiovascular diseases among commercial drivers  
Studies have shown that commercial drivers are more likely to have CVDs risks, and the CVD 
risk increases the likelihood of road accidents occurring (Fatigue Alcohol. N.T.S. Board editor, 
1990; Ronna et al., 2016:32). As such, it is a public health issue as pedestrians and other road 
users are affected by it. Ronna et al. (2016), in their study in the United States, reported an 
average of 8.9% on the Framingham scoring-based risk of CVDs among drivers, with more than 
one third of the drivers (38.9%) having CVD risk of ≥ 9%. Clustering of CVD risk among 
drivers in various settings, ranging from 16.4% to 72.6% (Sangaleti et al., 2014; Hirata et al., 
2012; Mansur et al., 2015; Shin et al., 2013). In Sweden, drivers, had about twice the odds of 
developing myocardial infarction (Bigert et al., 2003:333). Robinson and Burnett (2005), found 
that CVDs like IHD, acute myocardial infarction (AMI), and other forms of heart diseases were 
major causes of death among drivers in the USA. Studies conducted in India, reported that 
cardiovascular diseases were part of the health complaint of drivers, while coronary artery 
diseases (CAD) and ischemia accounted for most of motor vehicle accidents (MVA) (Yesurajan 
& Indra, 2017; Koppad et al., 2012). Even in the midst of the burden of CVDs among drivers, 
interventions tailored towards reduction of the burden were not effective, due to occupational 
demand and the nature of the job (Ronna et al., 2016;33). 
Basically, commercial drivers in the process of their occupational activities go through 
physiological processes and stresses, which increase their chances of developing cardiovascular 
diseases (Belkić K et al., 1998; Biglari et al., 2016). This strongly increases the risk of 
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cardiovascular diseases (Hirata et al., 2012). Furthermore, the lifestyle activities and exhibition 
of a modifiable risk factor common among commercial drivers in their workplace promotes risk 
factor clustering, which increases CVD development (Blumenthal et al., 2002; Hirata et al., 
2012). CVDs such as coronary heart disease have the potential to incapacitate drivers while 
driving, thereby causing road traffic accidents and sudden death (Blumenthal et al., 2002:14). 
Psychosocial and work stress predisposes a person to cardiovascular diseases (Chandola et al., 
2008:644; Chandola et al., 2006). The work of the drivers is by nature stressful. For example, 
irregular schedules, traffic stress due to congestion, financial instability, lack of social support, 
and job-passenger responsibility among others, are the risk factors for the development of CVDs 
among commercial drivers. The aforementioned factors increases the mechanism of stress 
progression to the development of various CVDs as stressors promote development of CVDs 
(Kivimäki & Kawachi, 2015; Apantaku-Onayemi et al., 2012; Antoun et al., 2017; Biglari et al., 
2016). Other related risk factors are constant exposure to noise, thermal exposure and air and 
environmental pollution (Belkic et al., 1992; Kristensen, 1989a; Kristensen, 1989b). Shown in 
Figure 2.1, is the interrelation of work, personal and environmental factors cascading to risk 
factors, with health and driver outcomes (Crizzle et al., 2017). 
Figure 2.1: Interplay of Work, Personal and Environmental Factors on Health and Driver 
Outcomes. (Crizzle et al., 2017) 
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2.5 CARDIO-METABOLIC RISK FACTORS  
 
2.5.1 OVERWEIGHT AND OBESITY 
Overweight and obesity also referred to as adiposity, could be defined simply as the 
accumulation of extra or excess fat in the body, leading to excess body weight (Del Parigi, 
2010). Excess weight is dangerous to health (World Health Organization, 2011d). The American 
Heart Foundation (2014), defined obesity as the accumulation of body fat in the waist region, 
which increases the risk of disease.  
Obesity is a global health problem, occurring in both high income and low and middle-income 
countries (Ford et al., 2017; Borrell & Samuel, 2014; Ng et al., 2014a:771; World Health 
Organization, 2003a:vi). In 2014, 39% and 13% of the world’s population were overweight and 
obese, respectively (World Health Organization, 2016b). South Africa is one of the countries 
with a high prevalence of obesity (Shukla et al., 2014). In a Demographic and Health Survey 
conducted in 1998, 29.2% of men and 56.6% of women were overweight or obese (Puoane et al., 
2002:1041) and the National Department of Health (NDoH) et al. (2017) reported a 68% and 
31% increase in the prevalence of overweight or obesity among women and men, respectively. 
Obesity is linked with the development non-communicable diseases (Amarya et al., 2014); 
diabetes (Eckel et al., 2011), cardiovascular diseases (CVD), cancer (Basen-Engquist & Chang, 
2011), renal problems (Silva Junior et al., 2017) and dyslipidaemia (Klop et al., 2013). The 
burden of obesity is largely driven by nutritional transition (Popkin et al., 2012:7) and 
urbanization (Ford et al., 2017:149; Malik et al., 2013:14), attributed to consummation of 
processed, fasts foods, in neglect of traditional food rich in fibre with low caloric and rich 
nutritional content; and lack of physical activity (World Health Organization, 2016b; Scott et al., 
2012:11; Balakumara et al., 2016:603; Ford et al., 2017;149). Over the years, efforts being made 
to curb the rising menace of obesity seem to have been futile obviously by the increasing reports 
of obesity especially in countries with low or middle socio-demographic index (Afshin et al., 
2017:13). Generally, overweight and obesity is greatly increasing among every individual both 
children and adults, however, females tend to be more obese than males among adults (Ali & 
Crowther, 2009:83; Afshin et al., 2017;16). 
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Commercial drivers are particularly at increased risk of obesity because of the high rate of 
unhealthy lifestyle behaviour and dietary practices (Sieber et al., 2014:623; Hirata et al., 2012). 
Also, prolonged exposure to work-related stress has been identified as another contributing 
factor to the obesity burden found among commercial drivers (Pop et al., 2015:31). Obesity 
among commercial drivers is associated with several co-morbidities, musculoskeletal problems, 
sleep apnea, increased risk of accidents, accident or disease related injuries and mortality 
(Marcinkiewicz & Szosland, 2010:177; Hirata et al., 2012; Anderson et al., 2012; Zhu et al., 
2006:737; Abu Dabrh et al., 2014; Thiese et al., 2015:662; Mozafari et al., 2015:432; Rice & 
Zhu, 2013). Although obesity has been extensively studied, much of the research has focused on 
other population groups. Contrastingly, obesity among commercial drivers has been reported in 
several countries (Udayar et al., 2015; Montazerifar et al., 2016; Elshatarat & Burgel, 2016; 
Thiese et al., 2015; Sieber et al., 2014). 
Commercial drivers do exhibit a high rate of obesity, even when compared with their colleagues 
in the same working environment. In a Pakistan study, commercial drivers and conductors (who 
are known to more active) both exhibited a high rate of obesity prevalence however; commercial 
drivers had a higher body mass index 65.5% compared to 32.4% among conductors. Correlating 
obesity with waist circumference the prevalence of obesity was higher among commercial 
drivers (43.7%) than the conductors (18.9%). Likewise, for waist to hip ratio (WHR>1)  which 
was 18.8% and 2.0% among commercial drivers and conductors respectively (Aslam M. et al., 
2015:861). Similarly, Joshi et al. (2013) reported a relatively high prevalence of overweight, 
obesity and central obesity among commercial drivers (43.3%, 22.2%, 23.8%) as compared with 
conductors (28.1%, 16.25,18.1%) in Belgaum, India. Crizzle et al. (2017) also reviewed that 
most drivers are obese. These are expressive of the burden of obesity and its complications 
among commercial drivers, even though these are in countries reported to have high rates of 
obesity as compared to global prevalence (Ng et al., 2014a: 772). However, overweight and 
obesity, not a rare problem in the general population of South Africa, is never reported regarding 
commercial drivers.  
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2.5.1.1 Measures of Obesity  
Body mass index (BMI) is commonly used to define total obesity in clinical practice, academic 
research, and public health perspective (Wu et al., 2014:100). BMI is not an accurate measure of 
obesity, especially relating to fat distribution (Burkhauser & Cawley, 2008; Pi-Sunyer, 2013). 
Notwithstanding the disadvantages of BMI in distinguishing between fat mass and fat-free mass, 
it has been widely used to screen for health risks in populations because it is inexpensive, non-
invasive and suitable for large-scale surveys (Goon et al., 2017:578). However, scholars 
proposed different measurements for obesity based on the region of the body where the fat is 
accumulated; which BMI could not measure. Hence studies began to incorporate the measures 
such as neck circumference (Aswathappa et al., 2014; Aswathappa et al., 2013), waist 
circumference (Pouliot et al., 1994), waist to hip ratio, and waist to height (Ashwell et al., 2012; 
Ashwell & Gibson, 2016; Ashwell & Gibson, 2014). 
Waist circumference a measure of central obesity cut off point was established by international 
Diabetes Foundation, IDF as ≥94 cm  and ≥80 cm for Africans, though waist circumference 
according to NCEP-ATP III gave a larger cut-off, regardless of ethnicity being ≥120 cm for men 
and ≥88cm. Neck circumference was also added as a parameter for measurement of obesity. This 
is a very simple method of determining obesity. These measures of abdominal obesity are better 
predictors of cardio-metabolic risk factors (Ware et al., 2014:900; Liang et al., 2013:e145). Some 
other sophisticated measures of obesity are underwater weighing for body composition, magnetic 
resonance imaging (MRI), computerized tomography (CT), dual-energy x-ray absorptiometry 
(DEXA), bioelectric impedance analysis (BIA) and air displacement plethysmography (ADP) for 
anatomical distribution. Prospective dietary records, a measure of energy consumed and energy 
can also be measured (WHO, 2000:7).  
 
2.5.1.2 The global prevalence of obesity  
According to the World Health Organization (2017d), in 2016, more than 1.9 billion adults were 
overweight and obese, out of which over 650 million were obese. Recently, more than one in two 
adults are obese, contrary to the one in five that was reported in 2015 by the Organisation for 
Economic Co-operation and Development (OECD) countries (Organisation for Economic Co-
operation and Development, 2017). The prevalence of obesity varies between countries and 
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regions within countries. Quite a lot of countries are suffering from the problem of obesity with a 
global estimation of over 300 million people suffering from obesity, (World Health 
Organization, 2017). In the GBD 2015 study, a global estimate of over 107 million children and 
about 604 million adults were reported as obese (Afshin et al., 2017:13). Countries with the 
highest rate of adult obesity were the United States and China (Afshin et al., 2017:19; Finucane, 
2011). In 2015, it also accounted for the mortality of four million (Afshin et al., 2017:22). 
 
2.5.1.3 Obesity in Low and Middle Income Countries 
Overweight and obesity have been concentrated in developing countries, mostly among 
underprivileged persons, urban areas and in females. This condition is not increasing without  
diseases being attributable to it (Ellulu et al., 2014). Ellulu et al. (2014), reported that 44% of 
diabetes mellitus is attributable to obesity in these countries. Its prevalence in LMICs where it 
was increasing was estimated to be 36.9% in men and 38% in women. Obesity is increasing and 
spreading its roots throughout the world (Ford et al., 2017:146). Countries such as India, Nepal 
and Bangladesh, which were previously battling with the problem of under-nutrition, are now 
experiencing a dramatic increase in the prevalence of obesity. Obesity is also increasing in Sub-
Saharan African countries (Ajayi et al., 2016). In SSA, overweight and obesity is prevalent 
throughout the five regions, and increasing. According to Agyemang et al. (2015) the five 
countries with the highest prevalence of obesity in  SSA are the Seychelles (64 %), Mauritius 
(44.8 %), Cameroon (43.9 %), Botswana (41.6 %), and South Africa (41 %).  While some parts 
like Uganda, Zambia and a part of Nigeria have a relatively low prevalence of obesity (Kengne 
et al., 2013:981),  However the number of countries with high prevalence rate surpasses those 
with low prevalence, it was predicted that increased BMI in Africa and South Asia will later 
outrun the prevalence of those in the developed countries (Bhurosy & Jeewon, 2014) 
There are quite a lot of factors that increase the body mass index in Africa. (Agyemang et al. 
(2015); Kruger et al. (2007:493), spelt out the risk factors for obesity as socio-demographic 
status (the female gender often has higher rates of obesity than the male gender). Marital status 
also increases the likelihood of being obese, especially among the parous female. Also, 
socioeconomic status applies (Alaba & Chola, 2014:3400), whereby wealth increases the rate of 
obesity in some parts, whereas by contrast, in some parts, the poor had greater prevalence of 
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obesity. Education accounts for increase obesity rate among persons with a low level of 
education. Furthermore, body perception increases body weight, and this is dependent on 
individual cultures, some cultures perceiving being overweight as a sign of beauty and wealth, 
while seeing  normal stature as a sign of being unhealthy. Lifestyle factors contribute immensely 
to the increasing burden of overweight and obesity. The habits of smoking, high alcohol 
consumption, low physical activity level, and unhealthy food consumption lacking adequate 
nutrients and vitamins; all have a positive association towards being overweight or obese. 
Another factor is a lack of sleep, a lack of rest and unhealthy eating patterns such as consumption 
of heavy meals or low nutrient meals (Chaput et al., 2011:1294).  
 
2.5.1.4 Obesity in South Africa 
Obesity is the sixth risk factor for the global burden of disease and mortality and the third risk 
factor in Southern Africa (Lim et al., 2012). South Africa is one of the countries with a high 
prevalence of obesity (Shukla et al., 2014). Also in Sub-Saharan Africa, SA has the highest 
prevalence of obesity with 42% prevalence rate among women (Ng et al., 2014a; Peer et al., 
2014a). In the Demographic and Health Survey conducted in 1998, 29.2% men and 56.6% 
women were overweight or obese (Puoane et al., 2002) and the National Department of Health 
(NDoH) et al. (2017) reported a 68% and 31% increase in the prevalence of overweight or 
obesity among women and men, respectively. With the high prevalence of obesity already 
recorded  in south Africa, prevalence continued to increase (Cois & Day, 2015:46; Shisana., 
2013:135). Prevalence of obesity by race was found to be higher among the black population 
than among other races in south Africa (Kruger et al., 2007). This is pronounced among black 
women and among  white men (National Department of Health (NDoH) et al., 2017). 
Population-based studies have shown that obesity is a significant health problem in South Africa 
evident by its reported prevalence. In the Eastern Cape Province there is a total  prevalence of 
70.0%; overweight (24.0%) and obesity (46.0%) was reported (Owolabi et al., 2017a). In the 
Free State, (Prinsloo et al., 2011), reported 76.3% overweight and obesity  
The trend towards a high calorie diet and physical inactivity among South Africans is the cause 
of the burden of obesity in the country (Kruger et al., 2007:493). These have resulted in the 
neglect of traditionally healthy diets towards the adoption of processed, unhealthy, readily 
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available foods and beverages with high calorie levels and less nutritional content combined with 
a lack of physical activity (World Health Organization, 2016b; Scott et al., 2012; Balakumara et 
al., 2016; Ford et al., 2017). Socio-economic circumstances after the post-apartheid transition 
(1994) have changed drastically and rapidly, and with it, the living conditions of the South 
African population. These changes included nutrition and physical activity which are the leading 
predictors of obesity in the country (Cois et al., 2015:46). Obesity has increased dramatically 
over the last decade in the South African population. 
 
2.5.2 HYPERTENSION 
Hypertension is one of the major risks for CVDs as it relates to all cardiovascular diseases. This 
becomes a risk as soon as blood pressure exceeds normal blood pressure levels (Forouzanfar et 
al., 2017). Hypertension is a leading modifiable risk factor for cardiovascular diseases and an 
independent risk factor for morbidity and mortality; which often go unnoticed as a result of its 
asymptomatic nature (Echouffo-Tcheugui et al., 2015:751; Roth et al., 2015b; Tibazarwa & 
Damasceno, 2014:530). It is also the leading risk factor for the Global Burden of Diseases 
(GBD) and a 7.0% cause of global disability-adjusted life year (DALYS) (Lim et al., 
2012:2224); accounting for 9 million annual deaths in the world (Lim et al., 2012). Globally, 
there is an increasing prevalence of hypertension, even in economically disadvantaged countries 
(Van de Vijver et al., 2013). In 2000, the global estimate of people with hypertension was 972 
million (26.4%), with majority 639 million from developing countries (Kearney et al., 2005). In 
2015, about 900 million adults were diagnosed with high blood pressure (Huffman & Lloyd-
Jones, 2017).  
Hypertension is the one established causal factor for CVDs (Kaplan et al., 2010; Giles, 2006; 
Giles et al., 2009:611), especially high systolic blood pressure (Mourad, 2008). It is associated 
with all other cardio-metabolic risk factors like obesity, dyslipidemia (Neves et al., 2013). 
Hypertension also has a relationship with diabetes as they share a common mechanism and risk 
factors with diabetes, however the link is not clear, but it is paramount to treat the disease 
conditions simultaneously (Cheung & Li, 2012:163; Wise, 2015; Dokken, 2008). There is almost 
a 60% risk of developing diabetes among individuals with hypertension (Wise, 2015). It could 
also worsen diabetes condition in already-diagnosed persons. As such, there was a controversy 
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about the targeted control normal blood pressure level for individuals with diabetes which is 
<130/80mmHg (Bangalore et al., 2011:2806). However, according to the statement by the 
American Society for Hypertension (ASH) and the International society of Hypertension (ISH), 
this guideline has not been proved to be beneficial (Weber et al., 2014:15). (Prospective Studies 
Collaboration, 2009) reported that, hypertension is one of the factors that accounted for a strong 
correlation of high body mass index with ischaemic heart disease. 
 
2.5.2.1 Hypertension in Low and Middle Income Countries 
Until recent times hypertension was regarded as a disease of the affluent countries in the world 
(Cappuccio & Miller, 2016:300). There is an increasing prevalence of hypertension in LMICs, 
ranging from 19.2%-54.9% in selected LMICs (Irazola et al., 2016:54; Sarki et al., 2015). Most 
of the morbidity and mortality in LMICs is related to hypertension. The majority of individuals 
with hypertension in LMICs remain undiagnosed and poorly controlled, probably as a result of 
the non-availability of health awareness programmes, particularly in rural settings (Lemogoum, 
2014:555; Dewhurst & Walker, 2016:221). 
Ataklte et al. (2014:291), reported a pooled prevalence of hypertension ranging from 7% to 56% 
in Sub-Saharan African countries. Not considering the risk and consequences of this disease 
there was a low level of awareness, treatment and control levels especially in SSA  (Ataklte et 
al., 2014:295). Also, an estimated prevalence of hypertension was reported to be 125.5 million 
people are expected to be diagnosed with hypertension by 2025 (Ogah & Rayner, 2013). The 
prevalence of hypertension in SSA is projected to increase to 216.8 million cases by 2030 
(Adeloye & Basquill, 2014). 
 
2.5.2.2 Hypertension in Sub-Sahara Africa 
In SSA, high blood pressure increases yearly, affecting most countries. Although the rise in 
hypertension differs from country to country, based on location, occupation and urbanization 
(Guwatudde et al., 2015:1215). This also reflects the level of awareness or diagnosis in the 
population. People often do not realise their blood pressure status early enough because of the 
asymptomatic nature of hypertension (Bell et al., 2015). Hypertension related disease among the 
SSA population includes ischaemic heart diseases, stroke and heart failure, chronic kidney 
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diseases (CKD), vascular dementia (Echouffo-Tcheugui et al., 2015; Owolabi et al., 2015; 
Adeloye, 2014; Mensah, 2008). The increasing prevalence of hypertension and its complications 
in SSA, has been attributed to the individual’s carelessness and negligence (Kayima et al., 
2013:60), the urbanization and population growth in Africa (World Health Organization, 2013b), 
and ageing (Dewhurst et al. 2016:221). An extreme rate of unawareness and undiagnosed 
hypertension aggravates the risk of various cardiovascular diseases which are life threatening, 
like myocardial infarction, renal failure, stroke; among many others (Guwatudde et al., 
2015:1215; Ogah et al., 2013).  
 
2.5.2.3 The Burden of Hypertension in South Africa 
South Africa is not exempted from the growing burden of hypertension and its complications 
(Hasumi & Jacobsen, 2012). It is the leading risk of strokes and heart attacks (Norman et al., 
2007b). More than 6.2 million South Africans are hypertensive with about 53 men and 78 
women dying daily from the effects of hypertension; with a high likelihood of a future increase 
as the population ages (Rayner, 2013). Hypertension in South Africa is reportedly increasing. 
Prevalence increased dramatically from the 1998 South Africa Demographic Health Survey 
(SADHS), 21% to 77.3% in 2008 (Steyn et al., 2001; Peltzer et al., 2013). Moreover, 
hypertension within the country continues to increase even in the rural areas (Ntuli et al., 2015). 
In a study conducted among low to middle income countries, South Africa had the highest 
prevalence of hypertension which was 54.9% (Irazola et al., 2016:53), with variations across 
provinces and regions. In the Eastern Cape Province, there were documented research records of 
46% pre-hypertension and hypertension levels (Nkeh-Chungag et al., 2015:908) and 49.2% 
(Owolabi et al., 2017d) among adults. Lamentably, while the prevalence of hypertension keeps 
increasing, the awareness level is low (Rayner, 2010). Several factors are responsible for this; 
such as epidemiological transitioning, resulting from ageing and urbanization (Ngo et al., 
2014:841), unhealthy dietary practices, sedentary lifestyles, stressful activities (Jiang et al., 
2016:2396; Hall et al., 2015), and obesity (Jiang et al., 2016:2396), education, and family 
history, especially in South Africa (Steyn et al., 2008). Hence, there is an increase burden of 
hypertension in SA with varying factors. 
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2.5.2.4 Hypertension among commercial drivers  
Several studies have reported a high prevalence of hypertension among commercial drivers 
(Nasri & Moazenzadeh, 2006; Kurosaka et al., 2000; Nayak et al., 2014). Nayak et al. 
(2014;121), found a prevalence rate of hypertension among drivers was 46% compared to the 
non-driver workers which was 18%; Shin et al. (2013:37)’s study reported that 53.3% 
commercial drivers were diagnosed with high blood pressure while two separate groups, group A 
and B had a prevalence of 17.6% and 19.7% respectively in Korea. There are few or scarcely 
documented prevalence rates of hypertension among commercial drivers in Africa, with evidence 
of high prevalence ranging from a 9%-33.5% prevalence rate of hypertension in Nigeria (Tobin 
et al., 2013; Erhiano et al., 2015; Olusegun et al., 2016) and even higher among some drivers in 
different parts of the world. Also, among drivers, hypertension is one of the risk factors for 
cardiovascular disease (Hirata et al., 2012). Their study reported that over one third of the 
participants have hypertension. In India, 41.9% and 41.3% of commercial drivers were 
diagnosed with pre-hypertension and hypertension respectively, coupled with a low awareness 
rate, treatment and control (Lakshman et al., 2014). Reports of an exceptionally high prevalence 
of hypertension were also documented among commercial drivers in Hong Kong, Taiwan and 
Korea which were to be 57%, 56% and 53.3 % respectively (Siu et al., 2012:60; Wang & Lin, 
2001:262; Shin et al., 2013;37). Commercial drivers in both developing and non-developing 
countries have a high prevalence of hypertension (Wang et al., 2001; Sangaleti et al., 
2014:1066). Prevalence in other studies was ere16%  and 14.2% (Satheesh et al., 2013; Udayar 
et al., 2015) in India and 42.9% and 16.4% in Iran (Saberi et al., 2011; Izadi et al., 2013). 
Supporting large numbers of family members, and diets especially meals at restaurants with high 
levels of fats and salts, were factors that increased the risk of hypertension (Lakshman et al., 
2014). Also, age, smoking, family history, total and abdominal obesity, lipid disorders and 
duration of driving, in terms of experience or years all contribute to the odds of being 
hypertensive (Olusegun et al., 2016; Tobin et al., 2013). Although several studies have been 
conducted on the prevalence of hypertension in the general population in South Africa, and 
among commercial taxi drivers in other countries, scant information exist on hypertension 
among commercial drivers in South Africa. 
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2.5.3 SMOKING 
Smoking is a social health problem among adults. Smoking is one of the leading causes of 
diseases and mortality (World Health Organization, 2008) and it is also increased from being the 
third risk factor to the second leading cause of the global disease burden (Lim et al., 2012;2224; 
Forouzanfar et al., 2015). Globally, in 2012 and 2015, there were substantial decreases in the 
prevalence rate of smoking from the reported 1990 prevalence rates, yet the numbers of daily 
smokers increases daily (Ng et al., 2014b:168; Reitsma et al., 2017:1901). However, the decrease 
prevalence is not homogenous that is it is not evenly reported. 
Smoking contributes to diseases and deaths. A lot of diseases are caused or aggravated due to 
smoking such as tuberculosis, cancers and CVDs (Ezzati & Riboli 2013). According to 
Forouzanfar et al. (2015:2299), death attributed to smoking increased to 5.8 million in 2013. 
Global mortality due to tobacco this may increase to 10 million deaths by 2030 with an increase 
in the rate of tobacco use as estimated by (World Health Organization, 1999b). Also, according 
to the World Health Organization (2008) report, 5.4 million people die per annum as a result of 
tobacco use which is projected to increase by 2030 to 8 million deaths per year especially in 
developing countries. Smoking accounted for 11.5% of global deaths, the majority of these 
deaths occurred in USA, China, Russia and India. It was ranked the fifth leading risk factor by 
DALYs (Reitsma et al., 2017:1885). Globally there have been reports of uneven decreased 
prevalence of smoking across countries whereas countries such as Congo, Azerbaijan for men 
and Kuwait and Timor-Leste for women still recorded annual increases of smoking prevalence 
(Reitsma et al., 2017). 
In Sub-Saharan Africa, Southern Africa has the highest smoking rate (Van de Vijver et al., 
2013). Smoking in South Africa is more prominent in the urban areas than the rural areas (Van 
de Vijver et al., 2013). 81.4% of smokers observed signs of the negative health impact of 
smoking (Reddy et al., 2015) In South Africa, a large percent of the population use tobacco, 
more common among males than females (Reddy et al., 2015). It could also be recalled that 
smoking accounted for 8%-9% of deaths and 3.7%-4.3% DALYs in 2000 (Groenewald et al., 
2007). While action has been employed to curtail the habit and prevalence of smoking, majority 
of South Africans have adopted the cheap alternative to manufactured cigarette termed ‘roll-
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your-own’ cigarettes, which ironically, of its own accord is increasing the prevalence of smoking 
(Ayo-Yusuf & Olutola, 2013). Also, the prevalence of smoking was reported to be 20.8% while 
the majority presented themselves as daily smokers (Shisana et al., 2013:96), while  Reddy et al. 
(2015) reported a 17.6% prevalence of men smoking in their study with a four times higher rate 
of smoking among men than in women, a likelihood that has increased from the previous three 
times higher rate among men than women. The implication is that prevalence may decrease but 
the number of smokers is increasing. 
The Western Cape (32.9%), the Northern Cape (31.2%) and the Free State (27.4%) were the 
provinces with a higher prevalence of smoking. Notwithstanding that, the exposure rate to 
smoking is high in the Eastern Cape Province, amidst the high prevalence rate.(Owolabi et al., 
2017e) reported 15% current smokers among adults with 39.5% secondary smoking rate. Among 
higher learners in the Eastern Cape 26% were smokers (Awotedu et al., 2006). This presents the 
burden and an increased probability of dire consequences of smoking among active and passive 
smokers.  
 
2.5.3.1 Smoking as a cardio-metabolic risk factor 
The use of tobacco shortens the life of the user. Studies have it that smokers die young on 
average of 8 to 10 years younger than others, as smoking, as a risk factor that causes mortality 
due to cardiovascular diseases and diabetes (Chang, 2012:401). According to the 2014 Surgeon 
General’s Report on smoking and health, smoking causes cardiovascular disease in such a way 
that the cells lining the blood vessels become inflamed and swollen, narrowing down the blood 
vessels. This is caused by the chemicals (tar and nicotine) in cigarette smoke. The action plan of 
a 30% relative reduction has been proposed by the WHO to combat the indiscriminate use of 
tobacco (World Health Assembly WHA, 2013:22). 
Smoking is a risk factor for CVD and diabetes mellitus that is associated with insulin resistance, 
inflammation and dyslipideamia. This increases the risk of diabetes and its complications 
(Chang, 2012:399). Although the way that smoking leads to diabetes is not quite understood, it 
does have a harmful effect causing an increased risk of diabetes and complicates the disease. It 
also aggravates glucose homeostasis (Chang, 2012:399). Further reporting that smoking 
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increases the rate of stroke, especially in individuals with diabetes. In like manner, it increases 
blood pressure (Talukder et al., 2011:H391). The effect of smoking increases as the number of 
cigarettes increases per day. Smoking increases body fat distribution which can also predisposes 
the metabolic syndrome (Chiolero et al., 2008:805; Matsushita et al., 2011:649). 
Cho et al. (2009), in their prospective study described smoking as an independent factor for the 
development of diabetes. Relatively, smoking increase the person’s susceptibility to developing 
T2DM (Maddatu et al., 2017). Quitting smoking also increases the risk of developing Type 2 
diabetes mellitus.This is related to the weight gain experienced after the cessation of smoking 
(Maddatu et al., 2017:102). The severity of diabetes development is based on how heavily an 
individual smokes. Also, increased insulin resistance and inflammation links smoking with the 
development of diabetes (Chang, 2012; Chiolero et al., 2008:806) The effect of nicotine is the 
major factor linking with other social factors, which causes the development of diabetes mellitus. 
It acts on insulin secretion and action, to develop DM (Xie et al., 2009:784; Bergman et al., 
2012:3165). 
Smoking cessation initiates the development of obesity over a certain period, which with lifestyle 
modification, can possibly reduce diabetes (de Munter et al., 2015). However, many find it 
difficult to quit smoking. Heavy smoking has been found to increase abdominal obesity, 
evidenced by increased waist circumference (Morris et al., 2015). Among individuals with 
previous type 2 diabetes mellitus, smoking was found to be associated with more abdominal 
obesity in current smokers than in non-smokers and also in heavy smokers than in light smokers 
(Yun et al., 2012:319). The nicotine found in the cigarettes acts as an appetite suppressant. 
Therefore, it can be deduced that smoking increases the occurrence of more abdominal obesity 
than total obesity. 
 
2.5.4 ALCOHOL  
Alcohol is also a social and medical problem. It increases the chances of disease and aggravates 
existing health problems (World Health Organization, 2014c). It affects both the young and 
adults in developing countries, causing about 2.5 million annual deaths and diseases like cancer, 
cardiovascular diseases, liver cirrhosis and injuries (National Council on Alcoholism and Drug 
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Dependence, 2011). Alcohol was quoted as the sixth major risk factor for global burden of 
diseases in 2013, and it accounted for about 2.8million global deaths (Forouzanfar et al., 2015). 
Alcohol consumption serves as a component cause for various chronic diseases and resultant 
deterioration. 
South Africa holds the leading rank for alcohol use in Africa (Peer, 2009). Alcohol intake is a 
social aspect of various economic groups in South Africa. It is a source of pleasure and 
recreation. South Africans have an acceptable abstinence level, however the percentage of 
alcohol consumers who have an indiscriminate drinking habit is increasing (Peltzer et al., 2011; 
Peer et al., 2014b; Peltzer & Ramlagan, 2009). South Africa is considered a hard-drinking 
country (World Health Organization, 2014c; Owolabi et al., 2017c; Owolabi et al., 2017e). The 
enormous burden of alcohol use goes with  financial implication in South Africa (Matzopoulos et 
al., 2014; Seggie, 2012). Alcohol use is a major cause of CVD and CVD related mortality (Zatu 
et al., 2016). In South Africa, alcohol use and tobacco smoking are among the leading risk 
factors and are attributable to DALYs (Norman et al., 2007a). South Africa is also experiencing a 
rise in the burden of road traffic crashes and this has been highlighted as impeding socio-
economic development in the country and also impacts on the wellbeing of the populace (Wheel 
24, 2017; Taylor, 2016). 
Alcohol consumption has both social and health consequences for individuals whereby relatives 
and the public partakes of it. Alcohol use has been reported as one of the risk factors of 
communicable diseases (infectious diseases) (Rehm et al., 2010; Samokhvalov et al., 2010b),  
non-communicable diseases (Parry et al., 2011) and injuries (Zhao et al., 2015; Cherpitel et al., 
2015). Excessive alcohol use could also be a cause of respiratory depression and death (Agarwal, 
2002). Although moderate alcohol intake was reported to have some cardiovascular health 
benefits (O’Keefe et al., 2007), the majority consume it excessively. Nonetheless, the negative 
implications of alcohol use override its benefits.  
 
2.5.4.1 Prevalence of substance use (alcohol and smoking) among commercial drivers 
Probably because of stress and other factors, commercial drivers indulge in substance abuse 
(alcohol and smoking). The prevalence of substance abuse (alcohol and smoking) is high among 
commercial drivers, with variations in its level and effects in different countries. The self-
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reported prevalence rates of smoking among commercial drivers in Nigeria were as follows 32%, 
25.8% and 39.4% (Ozoh et al., 2014; Adekoya  et al., 2011:870; Fasasi et al., 2014); Brazil  
(29%) (Sangaleti et al., 2014:1063), Colombia (20.3%) (Useche et al., 2017); while Bangladesh 
drivers had an exceptionally high prevalence rate of 93% (Goon & Bipasha, 2014b). Likewise, 
the prevalence of alcohol use in Nigeria is high (93.7%) (Akpan &Ikorok (2014), and 84.5% 
(Bello et al., 2011). In Colombia, 27.9%  of the commercial drivers reported using  alcohol 
(Useche et al., 2017) while 66.8% use alcohol in Brazil (Sangaleti et al., 2014). Abiona et al. 
(2006), further analysed the pattern of alcohol consumption in their study as heavy drinkers, 
moderate drinkers and mild or occasional drinkers (47%, 15.3% and 37.7%) respectively out of a 
total prevalence rate of 67.2% alcohol users.  
Bello et al. (2011); Akpan et al. (2014), stated that young age, environment (such as the use by 
family and friends), sale of alcohol around the workplace, and years of driving, influence the use 
of alcohol and probably other substances. In an attempt to reduce or minimise the involved job 
strain, stress and frustrations, some of the commercial drivers resorted to using psychoactive 
drugs such as alcohol and cigarettes (Makanjuola et al., 2014; Abiona et al., 2006; Useche et al., 
2017). There is an anticipated benefit of smoking being the relief of stress, and keeping alert and 
awake for several hours at a time. Unknown to these drivers, the use of such psychoactive 
substances impair their driving performance, their problem solving skills as well as their sense of 
judgement in the face of an unexpected incident, thus contributing to crashes (Adekoya  et al., 
2011; Zhao et al., 2014a). The use of alcohol and other psychoactive substances has also been 
implicated as a driving force for the increasing burden of road traffic crashes. Although the 
literature is replete with studies on the prevalence and pattern of psychoactive substance use 
among drivers in Africa; Nigeria (Makanjuola et al., 2014; Adekoya  et al., 2011; Bello et al., 
2011), Iran (Heydari et al., 2016); Ghana (Asiamah et al., 2002), There are hardly any studies on 
South African commercial taxi drivers, which is surprising when one considers the high 
prevalence of alcohol, cigarettes and other substance abuse in South Africa.  
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2.5.5 PHYSICAL INACTIVITY 
Physical inactivity is simply a lack of exercise or being insufficiently physically active. It can 
also be defined as the inability to meet required physical activity recommendations 
(O'Donovan et al., 2010:574). Physical activity is an exercise or bodily movement produced 
by skeletal muscles that requires energy expenditure. Physical inactivity globally (Lim et al., 
2012) is the fourth highest risk factor leading to chronic diseases and mortality. According to 
the WHO guideline healthy adults should have at least 150  minutes of moderate-intensity 
aerobic physical activity throughout the week or do at least 75  minutes of vigorous-intensity 
aerobic physical activity throughout the week or an equivalent combination of moderate and 
vigorous-intensity activity (World Health Organization, 2010). In addition, adults with disease 
conditions who have rightly met the standard physical activity recommendation may also 
increase to 300 min or more of moderate-intensity aerobic activity each week, or 150 min or 
more of vigorous-intensity aerobic activity each week, or equivalent combinations of 
moderate and vigorous-intensity aerobic activities, which may be applicable to adults with an 
increased risk of cardiovascular disease or type 2 diabetes (O'Donovan et al., 2010:575). 
 
2.5.5.1 Burden of physical inactivity  
The rising physical inactivity levels worldwide have the dangerous implication of increasing 
non- communicable disease among the general population (World Health Organization, 2010). 
Guthold et al. (2008), found a prevalence range of physical inactivity among countries to be from 
1.6% to 51.7% in 2007. According to Dumith et al. (2011:26), crude prevalence of physical 
inactivity was 21.4%  which implies that one in five adults are physically inactive. Hallal et al. 
(2012), indicated that 31.1% of the world population groups are physically inactive. Physical 
inactivity is less prevalent in the developing countries and more prevalent in developed country 
and among the affluent (Dumith et al., 2011:25). Also, there is a disparity in the prevalence 
within the developed countries as opposed to developing countries. For instance, prevalence of 
physical inactivity is was 27.5% in Africa, 43.3% in America, 43.2% in theEastern 
Mediterranean, 34.8% in Europe 33.7% in theWestern Pacific while it is was low in southern 
Asia (17%) (Hallal et al., 2012:248). Physical inactivity caused approximately  cause 27% 
diabetes and 30% ischemic heart disease burden (World Health Organization, 2010). Physical 
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inactivity has an adverse effect on health; it increases and worsens the occurrence of NCDSs. 
Lee et al. (2012:225), highlighted that physical inactivity accounts for 6%-10% of the disease 
burden for coronary heart disease, diabetes, cancers and 9% of premature death globally, while it 
also decreases quality of life. (Lee et al., 2012). About 3.2million death per year 2.8% of DALYs 
was recorded in 2010 as a result of physical inactivity (World Health Organisation, 2017; Lim et 
al., 2012:2235). It was observed that women are more physically inactive than men (Guthold et 
al., 2008:488; Hallal et al., 2012:247). A targeted 10% reduction by 2025 has been planned by 
WHO (World Health Organisation, 2017), this could avert 533000 deaths while 25% reduction 
could avert over 1.3 million deaths (Lee et al., 2012). This suggests that physical activity is an 
essential part of healthy living. Hence, it has a contributory role in the prevention and 
management of non-communicable diseases and the mortality attributable to them (Durstine et 
al., 2013). It is an act that boosts cardiovascular health which in turn, reduces the chances of 
developing cardiovascular disease. Physical activity is evident in lowering the risk of 
cardiovascular diseases by 20-30%, especially leisure time physical activities (Li & Siegrist, 
2012). Agarwal (2012:543), affirms that it is the most convenient, the cheapest and the best 
protective way of life against disease. Physical inactivity also relates to the cost burden of 
chronic diseases, as one of the cogent modifiable risk factors (Pratt et al., 2014), its direct and 
indirect cost estimate was $67.5 billion globally (University of Sydney, 2016). 
 
2.5.5.2 Developing countries and physical inactivity 
In developing countries, the burden of physical inactivity is also increasing which contributes to 
the high rate of obesity and diseases (Bhurosy et al., 2014). Advances in technology and devices 
have reduced the amount of labour and total energy expended in implementing the activities of 
daily living. The result is reduction in activity levels (Hallal et al., 2012:247). Xu et al. (2014), 
reported in their study that in China an increase in the mortality rate attributed to the increased 
physical inactivity rate in the country. There was a 27.5% prevalence of physical inactivity in 
Africa (Hallal et al., 2012). In Africa, physical activity is also the fourth leading risk factor in the 
region (Lim et al., 2012:15). There are various factors leading to the increased rate of inactivity 
in developing countries. Koyanagi et al. (2017), highlighted some of the factors such as the 
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female gender, marital status, high level of education, wealth, sometimes unemployment, and 
some health conditions such as respiratory diseases and visual impairment. 
South Africans have been found to have a high rate of physical inactivity, which is ranked as the 
ninth risk factor for diseases and the twelfth risk factor for DALYs (Joubert et al., 2007) with a 
44.7% physical inactivity rate (Guthold et al., 2008). According to the South African National 
Health and Nutrition Examination Survey (SANHANES), 27.9% men and 45.2% of women are 
physically inactive (Shisana et al., 2013b:131).South Africa has one of the highest rates of 
physical inactivity in the African region (Guthold et al., 2008:489). In the Study of Global 
Ageing and Adult Health (SAGE) 2008, 55.0% of the participants reported no vigorous or 
moderated physical activity at work, 89.1% reported no vigorous or moderated physical activity 
during leisure and 57.5% did not walk or cycle, indicating a limited enthusiasm of people for 
physical activity (Peltzer & Phaswana-Mafuya, 2012). In the 2000 estimation of the burden of 
diseases by Joubert et al. (2007), physical inactivity in the country was associated with 30% of 
ischaemic heart disease, 27% of colon cancer, 22% of ischaemic stroke, 20% of type 2 diabetes, 
and 17% of breast cancer. It also accounted for deaths. With the resulting burden and 
complications due to insufficient physical activity, it is also exhibited among the younger age 
group (Mokabane et al., 2014; McVeigh & Meiring, 2014). 
 
2.5.5.3 Physical inactivity among commercial drivers 
Commercial drivers also present with high rates of physical inactivity; driving is a sedentary job 
(Varela-Mato et al., 2017). During work days, which comprises most hours and days of the week 
commercial drivers spend 97% of their daily time seated or being sedentary (Varela-Mato et al., 
2016). In a study in Brazil, the drivers presented with 72.8% physical inactivity rate (Sangaleti et 
al., 2014:1063). Also in Brazil, comparing drivers with postmen, Sena et al. (2008), found that 
80.8% (55.8% of the total are sedentary, 25.0% insufficiently). In Nigeria, 44.6% of commercial 
drivers reported being physically inactive (Odeyinka & Ajayi, 2017).Commercial drivers often 
show a reluctant attitude towards physical activity. Those with off breaks do not engage in any 
physical activity, while drivers generally perform less than the recommended physical activity 
level (Turner & Reed, 2011). Although physical activity enhances driving performance and 
safety, mostly, it is not practiced (Marmeleira et al., 2009). 
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2.5.5.4 Physical inactivity as a cardio-metabolic risk factor 
Physical inactivity is a predisposing factor for accumulation of body fat or weight gain. In a 
prospective study, Ekelund et al. (2011:832), suggested physical activity as an intervention for 
reducing central and total obesity, as insufficient physical activity predicts obesity among those 
with normal weight and  increases weight gain more among overweight and obese individuals. 
Being physically active is protective of cardio-metabolic health by lowering the body mass index 
(Braun et al., 2016). Knight (2012), maintained that physical inactivity increases the risk of 
coronary heart and cerebrovascular diseases, type 2 diabetes mellitus, and hypertension. Hunter  
et al. (2013:1336), pointed at physical inactivity as one of the four common risk factors for some 
NCDs. In a randomized control trial Flynn et al. (2009:1457) found that being physically active 
improves health management among patients with heart failure. Physical activity is effective in 
the primary and secondary prevention of cardiovascular diseases that is; it could prevent the 
likelihood of developing CVDs or it could slow down the progress of diseases (Alves et al., 
2016;Hamer et al., 2012) similarly, moderate to vigorous activity lowers the risk of myocardial 
infarction unlike low or no physical activity level or strenuous jobs which does not have any 
significance with lowering the condition (Held et al., 2012:463).  
In a prospective study by Hjerkind et al., (2017), a decrease in physical activity level increases 
the rate of obesity, which was significantly correlated with an increase in diabetes mellitus. In Al 
Tunaiji et al. (2014)’s systematic review, diabetes also was attributable to physical inactivity. 
Active exercise improves insulin action; this preventing the development of diabetes mellitus 
(Colberg et al., 2016:2066). 
 
2.5.5 METABOLIC SYNDROME 
Metabolic syndrome (METs) can be referred to as insulin resistance syndromes or syndrome X.  
It is defined as the clustering of three or more of these components, abdominal or central obesity, 
atherogenic dyslipidemia, high blood pressure, insulin resistance with or without glucose 
intolerance, pro-inflammatory state and pro-thrombic states, which are the major predictors of 
diabetes and cardiovascular diseases (Grundy et al., 2004; Beilby, 2004; Zubair et al., 2014; 
Wiley & Carrington, 2016; O’Neill & O’Driscoll, 2015). The complexity of the metabolic 
syndrome is due to two major strong linking factors; obesity and insulin resistance. Developing 
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these two conditions can lead to diabetes, hypertension, dyslipidemia, or microalbuminuria 
(Zubair et al., 2014).  
 
2.5.6.1 Diagnostic criteria for metabolic syndrome 
There were controversies in the diagnostic criteria of metabolic syndromes, based on different 
organizations, namely: World Health Organization (WHO), National Heart Lung Blood 
Institute/American Heart Association (NHLBI/AHA) and the International Diabetes Federation 
(IDF). The World Health Organization (1999a:33), defined the metabolic syndrome which was 
then opened for modification; as the presence of glucose intolerance, impaired glucose tolerance 
or diabetes mellitus and or insulin resistance with other two components. According to the IDF 
criteria, the metabolic syndrome is diagnosed as central obesity (≥ 94cm for men and ≥ 80cm for 
women) and any two components of METs. The National Cholesterol Education Program’s 
Adult Treatment Panel III (ATP III) defined its criteria for diagnosing metabolic syndrome as the 
presence of any three or more of the risk factors (Grundy et al., 2004:435). However, a 
consensus was reached as to the common diagnostic criteria for metabolic syndrome as the 
clustering of any three of these, without prioritizing any one component (Alberti et al., 
2009:1641). This is referred to as Joint Interim Statement (JIS) criteria. The different diagnostic 
criteria are indicated in Table 2.1 
Table 2.1: Diagnostic criteria for metabolic syndrome  
 Components  WHO   NCEP-ATPIII   IDF  JIS  
Blood pressure > 140/90 mmHg  
or HTN treatment 
> 130/85 
mmHg 
> 130/85 mmHg or 
HTN treatment 
> 130/85 mmHg or 
HTN treatment 
Anthropometrics WHR  
male > 0.9 
  female > 0.85  
and/or BMI > 30 kg/m2 
WC (cm) 
 male> 102 
female > 88  
WC (cm) 
male> 94 
female > 80 
WC (cm) 
male> 94 
female > 80 
Glucose *Diabetes Mellitus,IGT or 
Insulin Resistance 
FBG > 110 
mg/dL 
FBG > 100 mg/dL 
or DM history 
FBG > 100 mg/dL 
Triglyceride *> 150 mg/dL 
 
> 150 mg/dL > 150 mg/dL > 150 mg/dL 
Low HDL 
cholesterol (mg/dL) 
male < 35  
female < 39 
male < 40  
female < 50 
male < 40  
female < 50 
male < 40  
female < 50 
MET s Criterion DM, IGT or Insulin 
Resistance +2 other 
components 
3 or more 
components 
WC plus 2 
components 
3 or more 
components 
Impaired Glucose Tolerance (IGT) or Diabetes Mellitus (DM), HTN- Hypertension, Waist to Hip Ratio (WHT) 
Waist Circumference (WC), Body Mass Index (BMI), Metabolic syndrome (METs). * Glucose or triglycerides can 
be used interchangeably 
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2.5.6.2 Prevalence of metabolic syndrome in South Africa 
There is an increase in the prevalence and burden of METs in developing countries, especially in 
Africa (Misra & Khurana, 2008; Okafor, 2012; Batsis et al., 2007). This is increasing alongside 
the high prevalence of obesity. Notably, obesity and diabetes mellitus which has a strong bond 
with metabolic syndrome has become a burden in the developed countries, increasing their 
prospects of increases (Ellulu et al., 2014; Buowari, 2013:133). In South Africa, studies 
conducted across various population settings have shown a high prevalence of METs, ranging 
from 21.8% to as high as 55.4% (Erasmus et al., 2012; Owolabi et al., 2017b; Peer et al., 2015a; 
Motala et al., 2011). Several factors associated with the increasing burden of METs include age, 
gender, income, unemployment (Owolabi et al., 2017b; Peer et al., 2015a; Kaduka et al., 2012; 
Hajian-Tilaki et al., 2014), obesity, physical inactivity and other unhealthy lifestyle behaviours 
such as harmful alcohol use and smoking, which is linked to urbanization and globalisation (Peer 
et al., 2015b; Zhao et al., 2014b; Xi et al., 2013; Hajian-Tilaki et al., 2014). 
 
2.5.6.3 Prevalence of metabolic syndrome among commercial drivers 
Metabolic syndrome among commercial taxi drivers is a significant public health concern, 
considering its effect on the health of drivers and the entire public. Commercial drivers have a 
high prospect of developing the metabolic syndrome. For instance, Sieber et al. (2014) found 
62% of commercial drivers reported having two or more risk factors such as Hypertension, 
obesity, smoking, high cholesterol, physical inactivity, six or fewer hours of sleep daily. In a 
systematic review among commercial truck drivers, it was found that drivers have a high 
prevalence of risk factors of the metabolic syndrome which fell within the range of a 19–74% 
prevalence of abdominal obesity, overweight and obesity (23–53%) and (15–70%) respectively, 
hypertension (5–48%) dyslipidemia (7–46%) and prevalence of diabetes (1–22%) (Erin Mabry et 
al., 2016:413). The most prominent risk factor of METs among commercial drivers is abdominal 
obesity, one of the strongest risk factors of the metabolic syndrome (Erin Mabry et al., 
2016:420). 
Metabolic syndrome is prevalent among commercial drivers country-wide .However, such 
studies among commercial drivers are scarce in Africa. Among countries that have recorded the 
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prevalence of metabolic syndrome are Iran, USA, Hong Kong, Taiwan, Brazil and Korea. As 
documented in Iranian studies there is a high prevalence of the metabolic syndrome among 
commercial drivers. Ebrahimi et al. (2016), reported using three different criteria  according to 
ATP III, IDF,  and AHA, the prevalence rate of metabolic syndrome among the drivers was 
26.1%, 35.2% and 31.6% respectively. Mohebbi et al. (2010:37), who presented 32.4% 
commercial drivers with metabolic syndrome using ATP III criteria, indicated that overtime 
driving increases the odds of drivers developing metabolic syndrome. Also using ATP III, about 
thirty-six percent of commercial drivers were reported to have metabolic syndrome in Iran with 
abdominal obesity being the highest prevalence risk of METs (Saberi et al., 2011). In a larger 
population study using IDF criteria, Mohebbi et al. (2012) also reported a crude prevalence rate 
of 30.5% and an age adjusted rate of 32.4%. The prevalence rate of metabolic syndrome differs 
is based on different regions within a region. However, a high prevalence of the metabolic 
syndrome among commercial drivers in the country was ascertained, with no wide margins. 
Apparently, metabolic syndrome is high among commercial drivers in both the LMICs and in the 
HICs. Studies reported a prevalence rate of metabolic syndrome in Taiwan as 43.1% (Chen et al., 
2013), Hong Kong, 26.8% (Siu et al., 2012:62), UK, 34% (Varela-Mato et al., 2017), South 
Korea, 49.9% (Shin et al., 2013) and 29.9% in USA (BC Legal News, 2017) for HICs. In  
LMICs, Cavagioni et al. (2008), reported that 24% of commercial drivers in Brazil have 
metabolic syndrome,  also, there is a reported prevalence in Iran.  
The lifestyle pattern of commercial drivers is typically characterised by risk factors such as 
irregular sleeping patterns and hours, a sedentary lifestyle, unhealthy dietary practices as well as 
physical and mental stress. These put commercial drivers at a high-risk of cardio-metabolic 
disorders and METs. Some of the associated risk factors for METs among commercial drivers 
according to the literature were said to be obesity, smoking, age, diabetes, hypertension, driving 
experience and duration (Mansur et al., 2015; Saberi et al., 2011; Mohebbi et al., 2012). 
Abdominal obesity which is the most prioritized component of METs has also been shown to be 
high among commercial drivers (Shin et al., 2013; Sena et al., 2008; Montazerifar et al., 2016) 
and is the most common risk factor for METs (Erin Mabry et al., 2016; Mohebbi et al., 2012). 
Conversely, high triglyceride and low HDL-C levels were found to be the prominent risk factors 
for METs among commercial drivers (Saberi et al., 2011). Apart from an increased risk for 
chronic diseases, METs has also been documented as associated with sleep apnea; one of the 
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leading causes of road crashes (Mansur et al., 2015). However, while several studies on METs 
are conducted among various population groups in South Africa (Kruger & Nell, 2017; Saloojee et al., 
2016; Owolabi et al., 2017b; Motala et al., 2011; Muluvhu et al., 2014; De Lucia Rolfe et al., 
2015; Peer et al., 2015a), where none exist on commercial drivers; an economically important sub-group, 
providing a fundamental role in the transport industry by virtue of the services they provide. 
Seemingly, their physical biomarkers for health risk assessment have not been documented in 
South Africa as elsewhere. 
In summary, the burden of cardio-metabolic risk factors persist and keeps on increasing across 
various regions. Drivers in particular are at great risk as a result of the nature of their occupation, 
yet with limited time to access healthcare. A high prevalence of cardio-metabolic risk factors is 
found among commercial drivers. This poses significant threat on their health as well as that of 
the entire population, considering the significant role they play in the society.  
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CHAPTER THREE 
RESEARCH METHODOLOGY 
3.1 INTRODUCTION 
This chapter provides a perspective of the design and methodologies used for the study. This 
section describes the research setting, research design, population, sampling of the study. Also, 
the research instruments, validity and reliability, pilot study, data collection procedure, ethical 
considerations and analysis. 
 
3.2 DESIGN OF THE STUDY 
A cross-sectional study, quantitative, descriptive research approach was adopted to screen for 
cardio-metabolic risk factors among commercial drivers in Buffalo City Metropolitan 
Municipality (BCMM), East London, South Africa. 
 
3.3 SETTING OF THE STUDY  
This was a cross-sectional study involving 403 commercial taxi drivers selected across different 
taxi ranks in BCMM, Eastern Cape Province of South Africa. Buffalo City Metropolitan 
Municipality is one of the eight districts in the Eastern Cape Province. It is made up of some 
towns in the Eastern Cape which include East London, Bisho, King Williams Town and 
Mdanstane and it is largely populated (85.2%) by Black South Africans. The transport industry 
makes up 12% of its economic sector (Main, 2017). A taxi industry is the most readily available 
mode of transportation for the public, covering both short and long distance trips, through urban, 
rural and intercity journeys. The taxi rank is the station where taxis collect and drop passengers. 
It is situated at strategic centres, close to shops, offices and institutions in the city which are 
easily accessible to all. 
The taxi industry is a critical pillar of the South African public transport sector. Currently, the 
taxi industry is the most available mode of transport to the largest number of transport 
‘customers’ across a variety of income and need segments. As such, taxis carry 65% of the 2.5 
billion annual passenger trips in the urban environment and serve as the base-load public 
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transport carrier, both during peak and off-peak transport times. Presently, the taxi fleet consists 
of approximately 130 000 vehicles operating with legal transport permits. Approximately 95 000 
are used for short and medium distance trips in the urban environment, and the remainder for 
rural and inter-city transport. 
The five taxi associations (MELTA, ELTA, META, ELDISTA and UNCEDO) operating under 
the umbrella of SANTACO in BCMM were considered for the study at ten conveniently selected 
taxi ranks. The ten taxi ranks were Gillwell taxi rank, Shoprite taxi rank, Mdanstane local taxi 
rank, Highway mdanstane, Ok taxi rank, old boxers’ taxi rank, Vincent taxi rank, St. Johns taxi 
rank, Rhino taxi rank and Quigney taxi rank which are all in BCMM. 
 
3.4 TARGET POPULATION 
The target population for the study was minibus taxi drivers from the age of 20 years and older 
operating at the taxi ranks in Buffalo City Metropolitan Municipalities, East London and 
Mdanstane. 
 
3.4.1 Inclusion Criteria 
Participants were included in the study if they were commercial drivers, 20 years and above; a 
member of a recognized taxi association; worked for at least six months and had fasted eight 
hours prior to the day of data collection.  
 
3.4.2 Exclusion Criteria 
Participants were excluded from the study if they had less than six months experience as minibus 
taxi driver, if they were on any drugs that could cause weight gain e.g anti-retroviral, if ill or 
disabled in such a way that obtaining anthropometric measurements was difficult. 
 
3.5 SAMPLE AND SAMPLING TECHNIQUE 
A convenience sample of 403 drivers were included in the study. Numbers of registered vehicles 
were used to determine the number of minibus taxi drivers. According to the statistics retrieved 
from Eastern Cape Department of Transport, the numbers of registered commercial vehicles in 
East London, operating under East London district Taxi Association (ELDISTA) are 315 and 
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East London Taxi Association (ELTA) are 765, while the numbers of vehicle registered for 
Mdanstane includes, Mdantsane  East London Districts Taxi Association (MELTA) are 1514, 
Mdantsane East London Taxi association (META) 288 and Mdantsane UNCEDO service Taxi 
Association (UNCEDO) are 677; these totals up to 3,559 vehicles, making the numbers of 
vehicle drivers in East London and Mdantsane. The sample size for this study was based on the 
estimated number of drivers in the district. The estimated number of commercial taxi drivers was 
approximately 4000 (Eastern Cape Department of Transport).The appropriate sample size was 
determined using the Creative Research Systems sample size calculator (Creative Research 
Systems, 2015) at a confidence level of 95%. The required sample size was 351 participants. 
However, 403 drivers recruited from ten conveniently selected taxi ranks across the district were 
included in the study. All commercial taxi drivers who were available, willing and met the 
inclusion criteria were recruited into the study. This study was conducted in March-April, 2017.  
 
3.6 DATA COLLECTION INSTRUMENT 
An extract of the World Health Organisation STEPwise approach questionnaire was used for 
collecting demographic and socio-behavioural data (WHO, 2011b: 15)(ANNEXURE 1). It is the 
recommended framework by the World Health Organization for risk factors and non-
communicable diseases surveillance for its member countries. It has been used by various 
countries in all the regions of the world (WHO, 2015i). The questionnaire was adapted to suit the 
local context. 
The WHOSTEPwise instrument is made up of three models (Core, Expanded and Optional) and 
the three steps are: 
Step 1: This involves self-reported information. Close ended questions were asked in order to 
obtain information on socio-demographic data such as lifestyle behaviours, dietary pattern, 
smoking, alcohol use, physical activities and fruits and vegetable consumption. 
Step 2: This comprises objective reports obtained through physical and anthropometric 
measurements which were weight, height, hip circumference, waist circumference and blood 
pressure measurements. Derived measurements of obesity and abdominal obesity were 
calculated from the anthropometric measurements, these are body mass index, waist-to-hip ratio 
and waist-height-ratio. 
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Step 3: The third step involved objective information obtained through biochemical measure 
which is the fasting blood glucose. 
 
3.7 VALIDITY AND RELIABILITY 
The WHO STEPs tool used in the study is a validated and reliable research instrument used in 
different regions and countries (Virgin Island Ministry of Health and Social Development, 2010; 
Asgari, Mirzazadeh & Heidarian 2007; Riley, Guthold, Cowan, Savin, Bhatti, Armstrong, & 
Bonita, 2016), prepared to suit various settings. 
 
3.7.1 Selection and Training of Research Assistants 
The study involved ten research assistants. The research assistants were qualified nurses and 
students in health care related fields who were currently in the tertiary institutions and who could 
speak either Xhosa or Afrikaans. They were enlightened about the study and trained by the 
researcher and the supervisor (Prof DT Goon), a medical doctor and other experts in the field. 
The training was organised for the individual research assistant understanding of the 
questionnaires and enabling of accurate anthropometric, blood pressure and blood glucose 
measurements. Each person was allocated to a specific role to enhance consistency of the 
measurement and prevent role conflict. The research assistants were trained to work as a team. 
 
3.7.2 Pilot Study  
A pilot study was conducted prior to the main data collection. This was done in order to test the 
tool for logistical, administrative and measurement procedures on 20 commercial minibus drivers 
who were not a part of the main study. The pilot study also determined the effectiveness of the 
research assistants and the suitability of the instrument in the research settings. To validate the 
questions to meet the purpose of the study, it was reviewed and adjusted based on relevant 
suggestions and contributions. The reliability of the tool had already been established in various 
studies and at different settings (Virgin Island Ministry of Health and Social Development, 2010; 
Asgari, Mirzazadeh & Heidarian 2007; Riley, Guthold, Cowan, Savin, Bhatti, Armstrong, & 
Bonita, 2016). No significant changes was made to the questionnaire.  
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3.8 DATA COLLECTION PROCEDURE 
3.8.1 Procedure for Anthropometric Measurements 
Anthropometric measurements were taken according to the International Society for the 
Advancement of Kinanthropometry recommendations (Marfell-Jones et al., 2006). The 
procedure was explained to the participant before measurement. 
3.8.1.1 Body weight 
Body weight was measured in light clothes to the nearest 0.01kg in the standing position using a 
SECS Scale (without shoes) (Marfell-Jones et al., 2006).  
3.8.1.2 Body height 
Height was measured using a standard standiometer while the subject stands with no shoes. 
Subject will be asked to put both hands by the sides, feet closed to each other and looking 
straight ahead. Measurement will be taken to the nearest centimeters (without shoes) (Marfell-
Jones et al., 2006).. 
3.8.1.3 Waist circumference 
Waist circumference was measured just between the lowest ribs above the iliac crest according to 
standardized techniques. Participants were asked to stand erect in a relaxed position with both 
feet together on a flat surface. Circumferences were measured with a non-elastic tape to the 
nearest 0.1 cm, in a standing position. One layer of light clothing was used for the measurement. 
The participant will be relaxed, and the measurements were taken at the end of a normal 
expiration. Two consecutive measurements were recorded to the nearest tenth of a centimeter; 
the average of the two measures was used to determine waist circumference for analysis. 
3.8.1.4 Hip circumference 
Hip measurement was taken at the greatest circumference at the level of greater trochanters (the 
widest portion of the hip) on both sides. Measurements were made to the nearest 0.1 cm. The 
participant stood with feet close together, arms at the side and body weight evenly distributed, 
with light clothing. 
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3.8.1.5 Neck circumference (NC) 
Neck measurement was taken at the midway of the neck, between mid-cervical spine and mid 
anterior neck. For men with a laryngeal prominence (Adam's apple), measurement was taken just 
below the prominence. Participant was asked to look straight, with the subjects standing upright 
with shoulders down, but not hunched. While taking this reading care was taken not to involve 
the shoulder/neck muscles (trapezius) in the measurement and subjects with any thyroid disorder. 
Non-stretchable plastic tape was used to take readings. It is a marker of upper body subcutaneous 
adipose tissue distribution. 
3.8.2 Blood pressure measurement 
Blood pressure was measured in accordance with standard protocols(Seedat et al., 2014)with a 
Medic+ Digital Blood Pressure Monitor. Hypertension was defined according to JNC-8 criteria 
as the average of two systolic blood pressure of > 140mmHg and diastolic of > 90mmHg or 
history of hypertension (Bell et al., 2015). 
3.8.3 Blood Glucose tests 
Fasting blood glucose of each participant was measured with a validated ACCU-CHEK glucose 
monitoring apparatus in fasting state. Readings were taken to the nearest 0.1mmol/l. Fasting 
blood glucose of each participant was measured with a validated ACCU-CHEK glucose 
monitoring apparatus in fasting state.  
 
3.8.4 Derived Measurements 
 
3.8.4.1 Body mass index (BMI) 
This was calculated by dividing a person’s weight in kilograms by the square of their height in 
meters (m2). It was used to measure overweight and total obesity. 
3.8.4.2 Waist-to-Hip ratio (WHR) 
This was calculated by dividing the waist circumference by the hip circumference. It was used to 
measure abdominal fat distribution. 
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3.8.4.3 Waist-to-height ratio (WHtR) 
This was calculated by dividing waist circumference by height. It measures central obesity. 
 
3.8.5 Definition of Risk Factors 
3.8.5.1 General obesity 
This was defined using Body mass index [BMI], a measure of excess weight; this was used to 
determine overweight and obesity. Overweight and generalized obesity was defined as BMI of 
25.0kg/m2 – 29.9kg/m while, obesity was defined as BMI of ≥30kg/m2 (CDC, 2016). 
3.8.5.2 Abdominal obesity  
Abdominal obesity was defined using four anthropometric indices as follows: 
i. Waist circumference (WC): WC of ≥ 94 cm for men and WC ≥80 cm for women (World 
Health Organization, 2011f). 
ii. Waist-to-hip ratio (WHR): WHR of ≥0.90 for men and ≥0.85 for women (World Health 
Organization, 2008a). 
iii. Waist-to-height ratio (WHtR): WHtR of >0.5 will be used to define central obesity 
(Ashwell et al., 2016). 
iv. Neck circumference (NC): NC of >38cm for males and >34cm for females (Aswathappa 
et al., 2014b). 
3.8.5.3 Pre-hypertension and hypertension 
Pre-hypertension was defined as systolic blood pressure of 120-139 mmHg and diastolic blood 
pressure of 80-89 mmHg. Hypertension was defined as the elevation of arterial pressure more 
than the classified stipulated figures (Giles et al., 2009:611) and this is classified using the 
updated 2014 eighth Joint national Committee (JNC-8) as follows: 
Hypertension: systolic blood pressure ≥ 140mmHg and diastolic ≥ 90mmHg or a history of 
hypertension or anti hypertensive medication use (Bell et al., 2015:4). 
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3.8.5.4 Pre Diabetes and Diabetes 
Pre diabetes was defined as fasting blood glucose between (100 mg/dl to 125 mg/dl) or 
(5.6mmol/L to 6.9mmol/L) 
Diabetes mellitus (DM) was diagnosed if the fasting blood glucose is ≥ 126mg/dl or 7.0mmol/L  
(American Diabetes Association, 2014). 
 
3.8.5.5 Physical inactivity:  
This was define as lack of exercise (Al Tunaiji et al., 2014) i.e. not meeting up to the 
recommended WHO physical activity of adults aged 18–64 years, of 150 minutes of moderate-
intensity aerobic physical activity throughout the week or do at least 75 minutes of vigorous-
intensity aerobic physical activity throughout the week or an equivalent combination of 
moderate- and vigorous-intensity activity (WHO, 2016). 
3.8.5.6 Metabolic syndrome 
Metabolic syndrome was defined as having at least three of the following metabolic 
abnormalities according to the modified National Cholesterol Education’s Adult Treatment Panel 
III (NCEP-ATP III): elevated fasting blood sugar ≥ 100 mg/dl (5.6mmol/l), high blood pressure:  
systolic blood pressure ≥ 130mmHg, diastolic blood pressure ≥ 85 mmHg or on current 
treatment for high blood pressure, waist circumference: ≥94 cm in men and ≥ 88 cm in women, 
elevated triglycerides ≥ 150mg/dl (1.7mmol/l), low HDL; <40 mg/dl (1.03mmol/l) in men and 
<50mg/dl (1.3mmol/l) in women (Grundy et al., 2005;Grundy et al., 2004). 
 
3.9 ETHICAL CONSIDERATIONS 
The research proposal was submitted to the University of Fort Hare Ethics Committee for ethical 
approval (ANNEXURE 2). Permission was sought from the Eastern Cape Provincial Department 
of Health (ANNEXURE 3), Department of Transport, the association of commercial drivers in 
BCMM and at each taxi rank. The participants were informed about the purpose of the research 
study and to consent voluntarily with the understanding of the research, they were also informed 
about withdrawal from the study whenever they wish without penalty. An informed consent form 
was issued for non-verbal consent and verbal consent was obtained before the commencement of 
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data collection. Participants were assured of a minimum level of inconvenience and 
confidentiality; participant’s privacy was respected and protected. 
 
3.10 DATA ANALYSIS 
Data were captured on measurement form, checked for completeness and accuracy in terms of 
demographic information and measurements. Data were analysed using a combination of 
descriptive and inferential statistics. Descriptive statistics (frequency percentages, mean and 
standard deviation) were used for categorical variables. Inferential statistics (bivariate and 
multivariate logistic regression) were used to identify the significant associated risk factors of 
obesity, hypertension, diabetes metabolic syndrome and their 95% confidence interval (95% CI). 
The logistic regression was also adjusted for confounding factors to determine which of the 
demographic variables ( sex, age, level of education, marital status, income, driving history) and 
behavioural lifestyle variables (smoking, alcohol consumption, physical inactivity, dietary 
intake) independently and significantly predict the risk of developing CMRFs in the participants. 
 
The proportions of participants who were abdominally obese were calculated using four indices. 
Association and agreements among anthropometric indices were examined using pairwise 
correlations and kappa statistics, respectively. Discordances between the indices were analysed 
using cross-tabulations. 
A p-value of < 0.05 was considered statistically significant. All statistical analyses were 
performed with the Statistical Package for Social Sciences (SPSS) version 22.0 for windows 
(SPSS Inc., Chicago, IL, USA). 
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CHAPTER FOUR 
RESULT AND DISCUSSION 
This chapter presents the results of the study and a discussion of the results. The results are 
presented in tables, charts and figures. 
 
4.1 DEMOGRAPHIC CHARACTERISTICS OF PARTICIPANTS 
A total of 403 participants were included in the analysis. Larger percentages of the participants 
were males (98.8%). The mean age of participants was 43.3 (±12.5), age range from 20 to 74 
years. The majority of the participants were black (93.3%), had at least grade 8 level of 
education (73.7%), married (47.1%) and single (45.5%) (Table 4.1) and the majority (47.1%) of 
the participants have been driving for more than 10 years (Table 4.1.1) 
Table 4.1: Demographic characteristics of the participants 
Variables Frequency (n) Percentage (%)  
Sex   
Male  398 98.8 
Female 5 1.2 
Age (years)   
20 to 30  72 17.9 
31-40  103 25.6 
41-50  105 26.1 
Above 50  123 30.5 
Level of education   
No formal education 15 3.7 
Grade 1-7 59 14.6 
Grade 8-12 297 73.7 
Tertiary 32 7.9 
Race   
Black 376 93.3 
Coloured 27 6.7 
Marital Status   
Married 190 47.1 
Separated 8 2.0 
Divorced 16 4.0 
Widowed 6 1.5 
Single 183 45.4 
Duration of driving   
<2 years 30 7.4 
2-5 years 103 25.6 
6-10 years 80 19.9 
> 10 years 190 47.1 
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Table 4.2: Characteristics of study population  
Variables Median (Standard deviation) n=403 
Age  43.3 (12.5) 
Days spent driving in a week  6.4 (0.7) 
Minutes spent driving in a typical day  10.8 (2.9) 
Hours of sleep in a typical day 7.2 (1.6) 
Monthly earning  3650.1 (2503.7) 
 
4.2 BEHAVIOURAL MEASUREMENTS OF PARTICIPANTS 
This aspect describes the behavioural characteristics of the respondents. Behavioural 
characteristics include tobacco use, alcohol consumption as well as fruit and vegetable 
consumption. 
 
4.2.1  Prevalence of tobacco use 
As shown in the Table 4.3, 45% of the participants have a prior history of smoking, while 30% 
are current smokers , 29% of the participants (97% of current smokers) smoke daily taking on 
average 9.2 (SD ± 6.0) sticks of tobacco product. The mean age when participants started 
smoking was 18 (SD ± 4.7) years.  Daily smokers took on average 9.2 (SD ± 6.0) sticks. Ninety 
seven percent of current smokers use manufactured cigarette and hand rolled cigaretteusers 
comprised (2.2%), while the average stick per day was 5.9 (SD ± 3.0) sticks.  
The mean age of smoking initiation was 18 (SD ± 4.7) years. About 20.0% (79) participants had 
stopped smoking more than 8 years ago. The average number of age when participants had quit 
smoking was 15.0 (± 9.2) years. 
Table 4.3: Smoking and alcohol consumption 
 
Questions  
Yes   
n (%) 
No  
n (%) 
Have you ever consumed tobacco products 199 (49) 204 (51) 
Do you currently smoke? 121 (30) 282 (70) 
Do you smoke daily? 117 (97) 4 (3.0) 
Have you ever consumed alcohol? 242 (60) 161 (40) 
Have you consumed alcohol in the past 12 months? 165 (41) 238 (59) 
Have you consumed alcohol in the past 30 days? 149 (37) 254 (63) 
n= Number; %= Percentage 
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4.2.2  Prevalence of alcohol consumption  
Table 4.3 shows the previous history of participants (60%) that has ever consumed alcohol. Forty 
one percent of the participants have consumed alcohol in the past 12 months with 72.5% 
frequency of 1-2 days in a week (figure 4.1). The prevalence of alcohol consumption among the 
participants was 37% those who have consumed alcohol within the past thirty days, with an 
average bottle of 10 (±9.3) bottles per week ranging from 1-50 bottles. 
 
Figure 4.1: Frequency of alcohol consumption 
 
4.2.3  Binge drinking 
Figure 4.2 shows the prevalence of participants who binge drink (consumption of four or more 
drinks for women and five or more drinksfor men at one sitting). Ninety-six participants (24%) 
indulged in binge drinking. 
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Figure 4.2: Prevalence of binge drinking 
 
4.2.4  Dietary pattern 
Table 4.4 shows that, majority of the participants (33.7%) reported that they often eat breakfast 
at home, (31.5%) of the participant do not eat breakfast at home, while (17.9%) and (16.9%) 
sometimes or rarely ate breakfast at home, respectively. About 52.9% of the participants often 
buy food from vendors, while 32.3% reported that they do sometimes buy food from vendors. 
Forty-four percent of the participants sometimes buy food from the fast food outlets and 13.2% 
often patronized the fast food. Most of the participants reported taking fried food (41.9%), while 
36.0% do so often. Most of the participants (67.0%) often take sweet drinks. 
Table 4.4: Dietary pattern 
Variables Never 
n (%) 
Rarely  
n (%) 
Sometimes 
n (%) 
Often  
n (%) 
How often do you eat breakfast at home? 127 (31.5) 68 (16.9) 72 (17.9) 136 (33.7) 
How often do you buy food from the vendors? 23 (5.7) 37 (9.2) 130 (32.3) 213 (52.9) 
How often do you buy fast food? 30 (7.4) 142 (35.2) 178 (44.2) 53 (13.2) 
How often do you eat fried food?  16 (4.0) 73 (18.1) 145 (36.0) 169 (41.9) 
How often do you take sweet drinks? 17 (4.2) 33 (8.2) 83 (20.6) 270 (67.0) 
n= Number; %= Percentage 
 
24%
76%
Yes
No
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4.2.5  Fruit and vegetable consumption 
As shown in the Table 4.5, 49.9% and 48.4% eats vegetables and fruits, respectively for 6-7 days 
in a week. Only a few of the participants do not eat fruit and vegetables (Table 4.5). 
Table 4.5: Fruit and vegetable consumption 
 Number of days 
Questions 0 
n (%) 
1-3 
n (%) 
4-5 
n (%) 
6-7 
n (%) 
How many times do you eat vegetables in a week? 5 (1.2) 118 (29.3) 79 (19.6) 201 (49.9) 
How many times do you eat fruit in a week? 3 (0.7) 113 (28.1) 92 (23.8) 195 (48.4) 
n= Number; %= Percentage 
 
4.2.6 Physical activity participation 
As indicated in Figure 4.3, the participation of participants in physical activity was low. The 
Majority (82%) of the participants were physically inactive. 
 
Figure 4.3: Physical activity participation 
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Yes
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4.3 HISTORY TAKING  
4.3.1  Blood Pressure 
The majority of the participants (62.2%) have checked their blood pressure once and 21.1% have 
been diagnosed with high blood pressure while 11.7% reported being on treatment for blood 
pressure. (Table 4.6). 
Table 4.6: History of raised blood pressure 
Variables Yes  
n (%) 
No 
n (%) 
Have you ever had your BP measured? 250(62.2) 153(38.0) 
Have you ever been diagnosed of BP? 85(21.1) 318(78.9) 
Have you been told in the past 12 months that you raised BP? 63(15.6) 340(84.4) 
In the past weeks, have you taken any drugs for raised BP prescribed by a doctor or other 
health worker? 
47(11.7) 356(88.3) 
Have you ever seen a traditional healer for a raised blood pressure or hypertension? 4(1.0) 399(99.0) 
Are currently taking any herbal or traditional remedy for your raised blood pressure? 4(1.0) 399(99.0) 
n= Number; %= Percentage 
 
4.3.2  Blood sugar 
Less than half of the participants (43.9%) have ever checked their blood sugar level, 11.0% had 
ever been diagnosed with high blood sugar and 7.4%were on medication for treatment; and 4.0% 
were using insulin for treatment (Table 4.7). 
Table 4.7: History of raised blood sugar 
Variables Yes  
n (%) 
No 
n (%) 
Have you ever had your blood sugar measured? 177(43.9) 226(56.1) 
Have you ever been diagnosed of raised blood sugar? 43(10.7) 360(89.3) 
Have you been told in the past 12 months that you have a raised blood sugar? 33(8.2) 370(91.8) 
In the past weeks, have you taken any drugs for raised blood sugar prescribed by a doctor 
or other health worker? 
30(7.4) 373(92.6) 
Are you currently taking insulin for diabetes prescribed by a health worker? 16(4.0) 387(96.0) 
Have you ever seen a traditional healer for a raised blood sugar? 3(0.7) 400(99.3) 
Are currently taking any herbal or traditional remedy for your raised blood sugar? 2(0.5) 401(99.5) 
n= Number; %= Percentage 
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4.3.3  Lifestyle advice  
About fourteen percent of the participants were told to reduce salt and fat in their diet, 11.9% and 
10.7% had been told to lose weight or maintain a healthy body weight and to exercise, 
respectively (Table 4.8). 
Table 4.8: Lifestyle advice  
During the past 3 years, has a health worker advised you to the following: Yes 
n (%) 
No 
n (%) 
Quit using tobacco or don’t start? 33 (8.2) 370 (91.8) 
Reduce salt in your diet? 56 (13.9) 347 (86.1) 
Eat at least 5 servings of fruits and vegetables daily? 65 (16.1) 338 (83.9) 
Reduce fat in your diet? 56 (13.9) 347 (86.1) 
Start or do more physical activity? 43 (10.7) 360 (89.3) 
Maintain a healthy body weight or lose weight 48 (11.9) 355 (88.1) 
n= Number; %= Percentage 
 
4.4 OVERWEIGHT AND OBESITY  
4.4.1  Prevalence of overweight and obesity 
As shown in Figure 4.4, the prevalence of overweight and obesity among the participants was 34% and 
37%, respectively. Less than one third (27%) of the participants had normal weight. About 20% of 
participants had class 1 obesity 12% had class 2 obesity (BMI 35-39.99 kg/m), while 5% had class 3  
obesity (BMI ≥40 kg/m). 
 
Figure 4.4: Prevalence of obesity  
2%
27%
34%
20%
12%
5%
37%
Underweight
Normal Weight
Overweight
Obese stage1
Obese stage 2
Obese stage 3
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4.4.2  Obesity and associated risk factors 
Table 4.9 shows the association between obesity, demographic factors, behavioural and 
cardiovascular risk factors. Age, marital status, period of driving, hypertension and diabetes were 
significantly associated with obesity. The prevalence of obesity increased from age 35years, 
reaching peak at age 66years (60.0%). Participants who do not smoke (44.6%), never took 
sweetened beverages (64.7%) and those who had been driving for more than five years (42.6%) 
had a higher prevalence of obesity compared to smokers (30.2%), those who often drink 
sweetened beverages (34.8%) and those driving for less than five years (27.1%). Obesity was 
found to be higher among participants who had hypertension (50.0%) and diabetes (49.2%) 
compared to those who do not, 21.1% and 35.3%, respectively.   
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Table 4.9: Bivariate analysis showing factors associated with obesity 
Variables Obese  
n (%) 
Not Obese 
n (%) 
p-value 
Age(years)    
25 and below 2 (6.1) 31(93.9)  
26-35 30(31.9) 64(68.1)  
36-45 39(37.5) 65(62.5)  
46-55 48(50.0) 48(50.0)  
56-65 26(39.4) 40(60.6)  
66 and above 6(60.0) 4(40.0) 0.000 
Marital status    
Married 83(43.7) 107(56.3) 0.000 
Separated 2(25.0) 6(75.0)  
Divorced 6(37.5) 10(62.5)  
Widow 2(33.3) 4(33.7)  
Single 58(31.7) 125(68.3)  
Level of education    
No formal school 7(46.7) 8(53.3) 0.286 
Grade 1-7 26(44.1) 33(55.9)  
Grade 8-12 110(37.0) 187(63.0)  
Tertiary  8(25.0) 24(75.0)  
Income     
2000 and below 63(37.5) 105(62.5) 0.537 
Above 2000 88(37.5) 147(62.6)  
Race     
Black  140(37.2) 236(62.8) 0.432 
Coloured 11(40.7) 16(59.3)  
Period of driving    
5 years and below 36(27.1) 97(72.9) 0.002 
Above 5years 115(42.6) 155(57.4)  
Did you ever smoke any tobacco product     
Yes 60(30.2) 139(69.8)  
No 91(44.6) 113(55.4) 0.002 
Have you ever consumed alcohol    
Yes  89(37.1) 151(62.9)  
No  62(38.0) 101(62.0) 0.464 
How often do you take sweet drinks    
Never  11(64.7) 6(35.3) 0.043 
Rarely  10(30.3) 23(69.7)  
Sometimes  36(43.4) 47(56.6)  
Often  94(34.8) 176(65.2)  
Do you do any sports, fitness or recreational 
activities, for at least 10minutes? 
   
Yes  22(29.7) 52(70.3)  
No  129(39.2) 200(60.8) 0.081 
Hypertension     
Yes 114 (50.0) 114 (50.0) 0.000 
No 37 (21.1) 138 (78.9)  
Diabetics    
Yes  31 (49.2) 32 (50.8) 0.026 
No 120 (35.3) 220 (64.7)  
n= Number; %= Percentage 
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4.4.3  Binary logistic regression showing determinants of obesity 
In the logistic regression model analysis, after adjusting for confounders, only age, hypertension 
and not smoking were significant and independent predictors of obesity. Participants who were 
above 35 years old and those who do not smoke were twice more likely to be obese than those 
with an age lower than 35 years and smoking. Hypertensive participants were four times more 
likely to be obese than those were not (Table 4.10). 
Table 4.10: Binary logistic regression showing determinants of obesity 
Variables Beta Wald  Odd Ratio (CI) p-value 
Non-Smokers 0.70 9.76 2.0 (1.3-3.1) 0.002 
Smokers (reference)     
Age above 35 0.50 3.84 1.6 (1.0-2.7) 0.05 
35 years and below (reference)     
Hypertensive 1.28 28.95 3.6 (2.3-5.7) <0.001 
Not hypertensive (reference)     
CI= Confidence interval 
 
4.4.4  Prevalence of abdominal obesity using four anthropometric indices 
The highest prevalence rate of AO was observed in the waist-to-height ratio (WHtR) index 
(80.1%). The prevalence rates by WC, WHR and NC were 61.5%, 67.5% and 65.3%, 
respectively (Figure 4.5). 
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WC=Waist circumference; WHR= Waist-to-hip ratio; WHtR=Waist-to-height ratio; NC =Neck circumference 
Figure 4.5: Prevalence of abdominal obesity using four anthropometric markers 
 
4.4.5  Correlations among anthropometric markers of cardio-metabolic diseases  
There exists a positive correlation among the four anthropometric markers of cardio-metabolic 
conditions. The strongest correlations were between WHR and WC (>0.64); and WHTR and WC 
(>0.62). The weakest correlation was between NC and WHR (>0.35), and NC generally had 
lower correlation with the other anthropometric indices (Table 4.11). 
There exists a good agreement between WC and WHR. Also, a moderate agreement exists 
between WC and WHtR, WC and NC, WHR and WHtR, and WHtR and NC. However, there 
was fair agreement between WHR and NC (Table 4.12). 
Table 4.11: Correlations among anthropometric markers of cardio-metabolic diseases 
 WHTR WHR NC WC 
WHTR 1 .595** .440** .628** 
WHR .595** 1 .355** .644** 
NC .440** .355** 1 .516** 
WC .628** .644** .516** 1 
**. Correlation is significant at the 0.01 level (2-tailed)’ WC=Waist circumference; WHR=Waist-to-hip ratio; 
WHtR=Waist-to-height ratio; NC=Neck circumference  
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Table 4.12: Cohen’s Kappa measure of agreement among anthropometric markers for classifying obesity   
Variables Central obesity 
n (%) 
Cohen’s kappa coefficient Strength of agreement 
WC-WHR 227(91.5) (k=0.64) Good  
WC-WHtR 248 (100.0) (k=0.57) Moderate  
WC-NC 210 (84.7) (k=0.51) Moderate  
WHR-WHtR 263 (96.7) (k=0.56) Moderate  
WHR-NC 210 (76.9) (k=0.35) Fair  
WHtR-NC 244 (75.5) (k=0.41) Moderate  
WC=Waist circumference; WHR=Waist-to-hip ratio; WHtR=Waist-to-height ratio; NC=Neck circumference; n= 
Number; %= Percentage 
 
4.4.6  Abdominal obesity and cardio-metabolic risk factors 
The analysis of the relationships between each of the four anthropometric indices with 
hypertension and diabetes (Table 4.13) indicates that the prevalence of above normal body 
composition for participants with hypertension were 71.0%, 65.9%, 63.2% and 66.5% by WC, 
WHR, WHtR and NC, respectively. However, lower prevalence of above normal body 
composition for participants with diabetes were observed as 20.6%, 19.4%, 17.0% and 18.6% by 
WC, WHR, WHtR and NC, respectively. 
Table 4.13: Association between abdominal obesity and cardio-metabolic risk factors 
Anthropometric indices Diabetes 
n (%) 
p-value  Hypertension 
n (%) 
p-value 
Waist circumference      
Normal 12(7.7) <0.001  52(33.5) <0.001 
Obese 51(20.6)   176(71.0)  
Waist-to-hip ratio      
Normal 10(7.7) 0.001  48(36.9) <0.001 
Obese 53(19.4)   180(65.9)  
Waist-to-height ratio      
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Normal 8(10.1) 0.086  24(30.4) <0.001 
Obese 55(17.0)   204(63.2)  
Neck circumference      
Normal 14(10.0) 0.015  53(37.9) <0.001 
Obese 49(18.6)   175(66.5)  
n= Number; %= Percentage 
 
4.4.7  Logistic regression showing predictors of cardio-metabolic risk factors  
After adjustment for age and sex, WC was a stronger predictor of hypertension and diabetes, 
with odds ratio of 3.7 (95 % CI: 2.3-6.1 and 3.1 (95 % CI: 1.6-6.0), compared to NC, with odds 
ratio of 1.7 (95 % CI: 1.1-2.8) (Table 4.14). 
 
Table 4.14: Logistic regression showing predictors of cardio-metabolic risk factors 
 
Variables 
Hypertension  Diabetics 
Wald OR(95%CI) p-value  Wald OR(95%CI) p-value 
WC >94cm for men or >80cm for women 28.168 3.7 (2.3-6.1) <0.001  11.035 3.1(1.6-6.0) 0.001 
Reference)  1      
NC >38cm for men or >34 for women 4.599 1.7 (1.1-2.8) 0.032     
Reference   1      
WC=Waist circumference; NC=Neck circumference 
 
4.5 PRE-HYPERTENSION AND HYPERTENSION 
4.5.1  Prevalence of pre-hypertension and hypertension 
As shown in Figure 4.6, systolic blood pressure (SBP) was classified into normal, pre-
hypertension and hypertension.  Forty seven percent of the participants had systolic blood 
pressure (≥ 140mmHg) while 44% of the participants had systolic pre hypertension of (SBP= 
120-139mmHg). 
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Figure 4.6: Prevalence of systolic pre-hypertension and hypertension. 
 
The prevalence of diastolic pre-hypertension (DBP= 80-89mmHg) was found to be (29%) while 
diastolic hypertension (DBP ≥90mmHg) is (43%) among the participants (Figure 4.7).
 
Figure 4.7: Prevalence of diastolic pre-hypertension and hypertension 
 
More than half of the participants (57%) had hypertension with the blood pressure of (SBP ≥ 
140) and, or (DBP ≥90) with the history of hypertension and current use of anti-hypertensive 
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medication (Figure 4.8). About 34% of the participants had pre-hypertension (Figure 4.9).
 
Figure 4.8: Prevalence of hypertension 
 
Figure 4.9: Prevalence of pre-hypertension 
 
4.5.2 Hypertension and associated risk factors  
As shown in Table 4.15, in the bivariate analysis, age (p=<0.001), marital status (p= 0.002), level 
of education (p=0.003), duration of driving (p=<0.001), obesity (p=<0.001), alcohol use 
(p=<0.001), consumption of sweet drinks (p =<0.006), diabetes (p=<0.001), and abdominal 
obesity (p=<0.001) were significantly associated with the prevalence of hypertension. In the 
logistic regression, after adjusting for confounding variables, only age, duration of driving, 
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alcohol use, obesity and diabetes were the significant and independent predictors of hypertension 
(Table 4.15). 
Table 4.15: Bivariate analysis showing determinants of hypertension  
Variables HTN  
n (%) 
No HTN  
n (%) 
RR CI p-value 
Age (years)      
>35 179 (64.9) 97 (35.1) 2.9 1.9-4.5 <0.001 
≤ 35  49 (38.6) 78 (61.4)    
Marital status      
Ever married 140(63.6) 80(36.4) 1.9 1.2-2.8 0.002 
Never married 88(48.1) 95(51.9)    
Level of education      
No formal school 12(80.0) 3(20)   0.003 
Grade 1-7 44(74.6) 15(25.4)    
Grade 8-12 155(52.2) 142(47.8)    
Tertiary 17(53.1) 15(46.9)    
Income      
2000 and below 99(58.9) 69(41.1) 1.2 0.8-1.8  0.420 
Above 2000 129(54.9) 106(45.1)    
Race      
Black 212(56.4) 164(43.6) 0.9 0.4-2.0  0.771 
Coloured 16(59.3) 11(40.7)    
Period of driving      
5 years and below 56(42.1) 77(57.9) 2.4 1.6-3.7 <0.001 
Above 5years 172(63.7) 98(36.3)    
Smoking      
Yes 115(57.8) 84(42.2) 0.9 0.6-1.3  0.627 
No 113(55.4) 91(44.6)    
Obesity      
Obese 114(75.5) 37(24.5) 3.7 2.4-5.8 <0.001 
Not obese 114(45.2) 138(54.8)    
Diabetes       
Yes  52 (82.5) 11 (17.5) 4.4 2.2-8.7 <0.001 
No 176 (51.8) 164 (48.2)    
Abdominal obesity      
Yes 176 (71.0) 72(29.0) 0.2 0.1-0.3 <0.001 
No 52(33.5) 103(66.5)    
Have you ever consumed any alcoholic drink      
Yes 153(63.7) 87(36.3) 2.1 1.4-3.1 <0.001 
No 75(46.0) 88(54.0)    
How often do you take sweet drinks      
Never 16(94.1) 1(5.9)   0.006 
Rarely 22(66.7) 11(33.3)    
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Sometimes 46(55.4) 37(44.6)    
Often 144(53.3) 126(46.7)    
n= Number; %= Percentage 
  
4.5.3  Binary logistic regression showing determinants of hypertension 
As illustrated in Table 4.16, the logistic regression, after adjusting for confounders, only age 
(above 35 years) (AOR= 2.2, CI=1.3-3.7), period of driving (above 5 years) (AOR=1.8, CI=1.1-
2.7), alcohol use (AOR=2.8, CI=1.7-4.4), obesity (AOR=3.4, CI= 2.1-5.4)  and diabetes (AOR= 
3.1, CI=1.5 -6.4) were significant and independent predictors of hypertension. 
Participants aged above 35 years were 2.2 times more likely to develop hypertension compared 
with participants who are 35 years old and below. Participants with period of driving above 5 
years are 1.8 times more likely to be hypertensive than other participants with a period of driving 
of 5 years and below. The odds of being hypertensive were 2.8 times higher among alcohol users 
than in non alcohol users. Participants with diabetes had three times the likelihood of developing 
hypertension than participants who were not.  
Table 4.16: Binary logistic regression showing predictors of hypertension 
Variables Beta Wald  Odd Ratio (CI) p-value 
Obesity     
Obese 1.212 24.649 3.4(2.1-5.4) <0.001 
Non-obese (reference)     
Age (years)     
> 35  0.775 8.490 2.2(1.3-3.7) 0.004 
≤ 35 (reference)     
Diabetes      
Diabetes 1.121 8.995 3.1(1.5-6.4) 0.003 
Non-diabetic (reference)     
Duration of driving     
> 5 years 0.561 4.853 1.8(1.1-2.7) 0.028 
≤ 5 years (reference)     
Alcohol use     
Alcohol users  1.022 18.417 2.8(1.7-4.4) <0.001 
Non-alcohol users(reference)     
 
4.5.4  Pre-hypertension, hypertension and cardiovascular risk factors 
The prevalence of hypertension was high among participant with a body mass index of more 
than normal, which increases with an increase in the body mass index. There were significant 
associations between abdominal obesity and hypertension regardless of what parameter was used 
for abdominal obesity. Diabetes mellitus was also significant with hypertension. While 
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abdominal obesity has a significant association with pre-hypertension, obesity and waist to 
height ratio abdominal obesity were not significant with pre hypertension. 
Prevalence of hypertension was high among obese participants (76.8%) and that of pre-
hypertension was higher among participants with normal weight (44.3%) and overweight 
participants (39.1%). Among the participants with abdominal obesity, the prevalence of 
hypertension in participants with a high waist circumference was (71.0%) high. Likewise, the 
prevalence of pre-hypertension was high among participants with high waist circumference 
(46.5%). Participants with high waist to hip ratio and high neck circumference had a high 
prevalence of hypertension (65.9%) and (66.5%) respectively, compared to the high prevalence 
of pre-hypertension among people with normal waist to hip ratio and normal neck circumference 
(45.5%) and (44.3%) respectively. There was high prevalence of hypertension in participants 
with high waist to height circumference (63.2%) which is not significant for pre-hypertension. 
Majority (82.5%) of participants with diabetes had high prevalence of hypertension and 
participants that are not diabetic on the other hand had high prevalence of pre hypertension 
(37.4%). (Table 4.17) 
Table 4.17: Pre-hypertension, hypertension and predictors of obesity 
Variables  Hypertension 
n (%) 
RR(CI) P-value Pre-hypertension  
n (%) 
RR(CI) P-value 
BMI categories       
Underweight  2(25.0)  <0.001 2(25.0)  0.003 
Normal  38(35.8)   47(44.3)   
Overweight  74(53.6)   54(39.1)   
Obese class 1 63(76.8)   16(19.5)   
Obese class 2 37(75.5)   11(22.4)   
0bese class 3 14(70.0)   6(30.0)   
Waist 
circumference 
      
Abdominal obesity 176(71.0) 0.2(0.1-0.3) <0.001 72(46.5) 2.5(1.6-3.8) <0.001 
Normal  52(33.5)   64(25.8)   
Waist-to- hip ratio       
Abdominal obesity 180(65.9) 0.3(0.2-0.5) <0.001 77(28.2) 2.1(1.4-3.3) 0.001 
Normal  48(36.9)   59(45.5)   
Waist to height 
ratio 
      
Abdominal obesity 204(63.2) 0.3(0.2-0.4) <0.001 102(31.6) 1.6(0.9-2.7) 0.054 
Normal 24(30.4)   34(43.0)   
Neck circumference       
Abdominal obesity  175(66.5) 0.3(0.2-0.4) <0.001 74(28.1) 2.0(1.3-3.1) 0.001 
Normal  53(37.5)   62(44.3)   
Diabetes       
Present 52 (82.5) 4.4(2.2-8.7) <0.001 9(14.3) 0.2(0.1-0.6) <0.001 
Not present 176 (51.8)   127 (37.4)   
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4.6 PRE-DIABETES AND DIABETES 
4.6.1  Prevalence of pre-diabetes and diabetes 
As shown in Figure 4.10, the prevalence of pre-diabetes and diabetes was 17% and 16%, 
respectively. Of those who were diagnosed as diabetic (n=63), 43(68%) were aware of their 
diabetes status and 30 were already on treatment. 
 
 
 
 
 
 
 
 
Figure 4.10: Prevalence of pre-diabetes and diabetes 
 
4.6.2  Associated risk factors with diabetes 
Age, marital status, level of education, period of driving, obesity, physical activity and 
hypertension were significantly associated with diabetes mellitus. The prevalence of diabetes 
was higher among participants aged above 35 years (21.4%) compared to participants aged 35 
years and below. The participants who were ever married (24.1%), with no formal education 
(40.0%) and a minimum level of education (grade 1-7) (32.2%) had a higher prevalence of 
diabetes compared to never married participants and those with a higher level of education. Also, 
there was a high prevalence of diabetes among participants who were obese (20.5%) and 
hypertensive (23%). Prevalence of diabetes among physically inactive participants (17.3%) was 
double the prevalence found among the physically active (Table 4.18).  
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Table 4.18: Factors associated with diabetes mellitus 
Variables Diabetes 
n (%) 
Non-diabetes  
n (%) 
OR (CI) p-value 
Age (years)     
Above 35 59 (21.4) 217 (78.6) 8.4 (3.0-23.6) <0.001 
35 years and below 4 (3.1) 123 (96.9)   
Marital status     
Ever married 53 (24.1) 167 (75.9) 5.5 (2.7-11.2) <0.001 
Never married 10 (5.5) 173 (94.5)   
Level of education     
No formal school 6 (40.0) 9 (60.0)  <0.001 
Grade 1-7 19 (32.2) 40 (67.8)   
Grade 8-12 35 (11.8) 262 (88.2)   
Tertiary  3 (9.4) 29 (90.6)   
Income      
2000 and below 32 (19.0) 136 (81.0) 1.5 (0.9-2.7) 0.110 
Above 2000  31 (13.2) 204 (86.8)   
Race      
Black  58 (15.4) 318 (84.6) 0.8 (0.3-2.2) 0.669 
Coloured 5 (18.5) 22 (81.5)   
Period of driving     
Above 5years 50 (18.5) 220 (81.5) 2.1 (1.1-4.0) 0.023 
5 years and below 13 (9.8) 120 (90.2)   
Smoking     
Yes  31 (15.6) 168 (84.4) 1.0 (0.6-1.7) 0.976 
No 32 (15.7) 172 (84.3)   
Obesity     
Obese 31 (20.5) 120 (79.5) 1.8 (1.0-3.1) 0.036 
Not obese 32 (12.7) 220 (87.3)   
Have you ever consumed any alcohol     
Yes  41 (17.1) 199 (82.9) 1.3 (0.8-2.3) 0.331 
No  22 (13.5) 141 (86.5)   
How often do you take sweet drinks     
Never 6 (35.3) 11 (64.7)  0.006 
Rarely 10 (30.3) 23 (69.7)   
Sometimes 9 (10.8) 74 (89.2)   
Often 38 (14.1) 232 (85.9)   
Do you do any sports, fitness or recreational activities     
Yes  6 (8.1) 68 (91.9) 0.4 (0.2-1.0) 0.049 
No  57 (17.3) 272 (82.7)   
Hypertension      
Yes  52 (22.8) 176 (77.2) 4.4 (2.2-8.7) <0.001 
No  11 (6.3) 164 (93.7)   
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4.6.3  Binary Logistic regression showing determinants of diabetes 
In the logistic regression, after adjusting for cofounders, only age, ever married and hypertension 
were the significant and independent predictors of diabetes. Participants aged above 35 years 
were about four times more likely to develop diabetes (AOR=3.6, CI=1.2-11.1) than participants 
aged 35 and below. Participants who were married were three times more likely to develop 
diabetes (AOR=3.3, CI=1.5-7.0) and hypertensive participants had thrice the likelihood of 
developing diabetes (AOR= 3.4, CI=1.7-6.8) (Table 4.19). 
Table 4.19: Binary logistic regression showing determinants of diabetes 
Variables Beta Wald  Odd Ratio (CI) p-value 
Age     
Age above 35 1.292 5.196 3.6 (1.2-11.1) 0.023 
≤ 35 years (reference)     
Marital status     
Ever married  1.181 9.212 3.3 (1.5-7.0) 0.002 
Never married (reference)     
Hypertension status     
Hypertensive  1.210 11.275 3.4 (1.7-6.8) 0.001 
Non-hypertensive (reference)     
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4.7 PREVALENCE OF METABOLIC SYNDROME  
The prevalence of metabolic syndrome among the study participants was 22% (Figure 4.11).  
 
Figure 4.11: Prevalence of metabolic syndrome 
 
4.7.1  Associated risk factors for metabolic syndrome  
Age (p=<0.001), marital status (p=<0.001), level of education (p=0.001), period of driving 
(p<0.001), were the significant socio-demographic factors associated with metabolic syndrome 
(METs). The prevalence of metabolic syndrome was higher among participants who were above 
35 years of age (29.3%). Consumption of sweet drinks (p=0.031) and physical inactivity 
(p=0.013) were the significant behavioural factors associated with METs. Participants with the 
minimum level of education (grade 1-7) had a higher prevalence of METs (40.7%), compared 
with well-educated participants (12.5%). The Prevalence of metabolic syndrome was higher 
among participants with periods of driving above 5 years (27.8%) compared to participants with 
periods of driving of 5 years and below (9.0%). There was a high prevalence of METs amongst 
married participants (32.3%) and amongst participants who did not engage in physical activities 
(Table 4.20). 
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Table 4.20: Factors associated with metabolic syndrome 
Variables Metabolic syndrome 
(%) 
No Metabolic syndrome 
(%) 
p-
value 
Age (years)    
Above 35  81(29.3) 195(70.7) <0.001 
35 years and below 6(4.7) 121(95.3)  
Marital status    
Ever married 71(32.3) 149(67.7) <0.001 
Never married 16(8.7) 167(91.3)  
Level of education    
No formal school 5(33.3) 10(66.7)  
Grade 1-7 24(40.7) 35(59.3) 0.001 
Grade 8-12 54(18.2) 243(81.8)  
Tertiary  4(12.5) 28(87.5)  
Race     
Black  81(21.5) 295(78.5) 0.934 
Coloured 6(22.2) 21(77.8)  
Period of driving    
Above 5years  75(27.8) 195(72.2) <0.001 
5 years and below 12(9.0) 121(91.0)  
Smoking    
Yes  54(22.5) 186(77.5) 0.589 
No 33(20.2) 130(79.8)  
Have you ever consumed alcohol    
Yes  54(22.5) 186(77.5) 0.623 
No  33(20.2) 130(79.8)  
How often do you take sweet drinks    
Never 8(47.1) 9(52.9) 0.031 
Rarely 10(30.3) 23(69.7)  
Sometimes 16(19.3) 67(80.7)  
Often 53(19.6) 217(80.4)  
Do you do any sports, fitness or recreational 
activities 
   
Yes  8(10.8) 66(89.2) 0.013 
No  79(24) 250(76.0)  
 
4.7.2  Binary logistic regression showing the determinants of metabolic syndrome 
In the logistic regression, only age (>35 years), being married and having been a commercial  
driver for more than 5  years were the independent predictors of METs, after adjusting for 
confounding factors. Participants aged above 35years were 3.8 times more likely to have 
metabolic syndrome than participants aged 35years and below. Ever married participants were 
thrice more likely to have metabolic syndrome than the never married participants. Participants 
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with above 5 years of driving had 2.4 times the likelihood of having metabolic syndrome than 
participants with a driving period of less than 5 years (Table 4.21). 
 
Table 4.21: Binary logistic regression showing determinants of metabolic syndrome 
Variables Beta Wald  Odd Ratio (CI) p-value 
Age above 35 1.322 7.724 3.8(1.4-9.5) 0.005 
35 years and below (reference)     
Ever married above 35 years 1.081 11.282 3.0(1.6-5.3) 0.001 
Never married (reference)     
Period of driving >5 years 0.864 5.988 2.4(1.2-4.7) 0.014 
Period of driving of ≤5 (reference)     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
78 
 
4.8 DISCUSSION 
4.8.1  Overweight and obesity  
This study sought to determine the prevalence and associated factors of obesity among commercial 
drivers in Buffalo City Metropolitan Municipality, South Africa. The prevalence of overweight and 
obesity in this study is 34% and 37%, respectively. The prevalence of obesity found in this study is 
similar to previous reports from Romania and India (Pop et al., 2015; Udayar et al., 2015) and higher than 
the reported prevalence among commercial drivers in Iran (Sieber et al., 2014; Montazerifar et al., 2016; 
Mohebbi et al., 2012; Izadi et al., 2013), Brazil (Reis et al., 2017; Hirata et al., 2012), United State 
(Elshatarat et al., 2016), Italy (Rosso et al., 2015; Rosso et al., 2016), Poland (Marcinkiewicz et al., 2010) 
and Nigeria (Olusegun et al., 2016; Isara & Aigbokhaode, 2017) which ranged from 14.3% - 29.9% and 
less than 53.3% reported in the study by(Thiese et al., 2015) in the United State of America. Also the 
prevalence of overweight found in this study is similar to that found in some studies in the USA, India, 
Iran and Nigeria (Udayar et al., 2015; Montazerifar et al., 2016;Thiese et al., 2015; Olusegun et al., 2016) 
(Table 4.22). 
Table 4.22: Prevalence of overweight and obesity among drivers in previous studies 
Country  Design/Sample size Mean age 
(years) 
Overweight 
prevalence 
Prevalence of 
obesity 
Author 
Iran  Cross-sectional: 
1100 
41.8±10.7 37.9% 14.3% (Montazerifar et al., 
2016) 
Italy  Cross-sectional:497 43±9.3 44.8% 16.8% (Rosso et al., 2015) 
Poland  Cross-sectional 39 45.3% 17.9% (Marcinkiewicz et al., 
2010) 
Brazil  Retrospective 
observational: 659 
41± 6.9 55.6% 19.6% (Hirata et al., 2012) 
Iran Cross-sectional: 
12,138 
37.8±10.1 44.8% 20.8% (Mohebbi et al., 
2012) 
Iran  Cross-sectional: 
1903 
41.55±10.53 41.4% 21.3% (Izadi et al., 2013) 
Italy  Cross-sectional: 335 42.7 ±9.7 45% 21.4% (Rosso et al., 2016) 
Iran  Cross-sectional: 429 36.6 ±10.7 41.0% 23.0% (Saberi et al., 2011) 
United State Cross-sectional: 130 45 ±10.75 43.8% 24.7% (Elshatarat et al., 
2016) 
Nigeria  Cross-sectional: 389 39.0±10.0 35.8% 25.7% (Olusegun et al., 
2016) 
Brazil Cross-sectional: 155 -- 52.3% 27.0% (Reis et al., 2017) 
Nigeria Cross-sectional: 214 45 ±10.0 - 29.9% (Isara et al., 2017) 
India  Cross-sectional: 204 41.38±10.45 36.2% 34.8% (Udayar et al., 2015) 
Romania  Cross-sectional: 84 44.4±7 50.0% 38.09% (Pop et al., 2015) 
United States 
of America 
88,246 46 ±10.4 31.0% 53.3% (Thiese et al., 2015) 
*South Africa Cross-sectional: 
403 
43.312.5 34.0% 37.0% Present study 
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With the exception of the USA, the prevalence of obesity among commercial drivers in South 
Africa compared with the other drivers, in different countries and Nigeria as an African country, 
is high. Also, studies examining the prevalence of obesity in the general population in the 
Eastern Cape Province of South Africa reported a high prevalence of obesity: 60.2% (Adeniyi et 
al., 2015), 38% (Otang-Mbeng et al., 2017) and 46% (Owolabi et al., 2017a). Obesity is affected 
by factors including individual genetic composition, sex, geographical location and socio-
economic status. The high obesity prevalence found among participants in this study could be 
related to some of the lifestyle behaviours, which increased the risk for developing obesity and 
overweight; such as lengthy working hours on the road, unpredictable schedules, physical 
inactivity and a scant opportunity for a healthy diet (Lim et al., 2015). Also, the number of years, 
low educational level and the hours spent driving are risk factors for obesity (Rosso et al., 2015; 
Rosso et al., 2016). The long hours of driving without adequate sleep is another factor that 
should be considered in understanding the prevalence of obesity among the drivers in this study. 
It has been demonstrated that people who did not get much sleep had a 20% higher likelihood of 
being overweight and a 57% greater odds of being obese (Jean-Louis et al., 2014).  
In this study, it was shown that the commercial drivers work under stressful conditions and with 
inadequate hours of sleep (6.21.6) per day. Besides, they smoke cigarettes (30%), drink alcohol 
daily (72.4%), binge drink (24%) and rarely participate in physical activity. These lifestyle 
behaviours could lead to obesity, and the high prevalence of obesity found among the drivers, is 
as expected and a public health concern. Obesity is a major factor for cardiovascular diseases and 
is associated with less participation in work activities, an increase in absenteeism and a loss of 
productivity, with a consequent increase in the use of resources (Udayar et al., 2015). Obese 
individuals often avoid wearing seat belts while driving because of the discomfort and localized 
pressure (Burton et al., 1998; Hamilton et al., 2007) are at higher risk of death  when  involved  
in  car  accidents, compared with normal-weight  individuals. Studies have also shown that 
individuals with BMI >32kg/m2 frequently complain of daytime sleepiness, an obvious danger 
during driving (Hamilton et al., 2007; Frank et al., 2004). As such, given the deleterious health 
implications of obesity, it is necessary to implement preventative interventions in this sub-
population. Potential interventions for taxi drivers, to have the greatest impact, should be multi-
level, addressing individual risk (that is, the screening and prevention, counselling, linkages to 
primary care, and management of obesity) (Gany et al., 2016). 
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Age (>35 years) was found to be associated with obesity among the study participants. This is 
congruent with the findings among Iranian (Montazerifar et al., 2016) and Mexican drivers 
(Aguilar-Zinser et al., 2007), but in contrast to the findings among Italian drivers (Rosso et al., 
2015). The higher prevalence of obesity associated with ageing could be as a result of increased 
energy intake, less energy expenditure or a combination of both, due to insufficient physical 
activity (Amarya et al., 2014). Another possible reason for the higher prevalence of obesity 
found among those above the age of thirty five is the documented increase in fat mass in the 
body, with an accompanying decrease in fat-free mass, which occurs between the ages of 30-
70years (Villareal et al., 2005; Amarya et al., 2014; Barzilai et al., 2012). 
There was a significant association between non-smoking and obesity. This is congruent with the 
study by (Reis et al., 2017) among long distance truck drivers in Brazil, where non-smoking was 
significantly associated with obesity. In contrast, smoking was not associated with obesity 
among Italian drivers(Rosso et al., 2015). Smoking has been found to reduce body weight, 
although it is associated with an increase in central obesity (Canoy et al., 2005; Stokes & 
Preston, 2016; Dare et al., 2015; Liu et al., 2010; Cawley et al., 2004). The weight loss effects of 
smoking is as a result of the increase in energy expenditure (EE) due to the effect of nicotine in 
tobacco (Hofstetter  et al., 1986), which suppresses appetite for food (Chiolero et al., 2008). This 
suppression of appetite leads to less consumption of food and consequently, less weight. 
Nonetheless, the overall effect of smoking on health is detrimental. 
Participants with hypertension in this study have about four times the risk of being obese 
compared to those without hypertension. It is established that overweight and obesity induce the 
development of hypertension and hypertension also increases body weight (Julius et al., 2000; 
Narkiewicz, 2006), describing the obesity and hypertension relationship as vice versa. The use of 
certain anti-hypertensive drugs such as beta blocker has been linked to obesity development 
(Sharma et al., 2001; Pischon & Sharma, 2001). This could be a plausible reason for the higher 
odds for obesity among hypertensive patients. Finally, obesity is a predisposing factor for 
hypertension as a result of its role in the development of endothelial dysfunction and systematic 
inflammation (Guh et al., 2009). Thus, the higher prevalence of obesity among the hypertensive 
drivers is not surprising. 
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4.8.1.1 Abdominal obesity 
This is the first study to examine the prevalence of AO based on four contrasting anthropometric 
indices (WC, WHR, WHtR and NC) among commercial taxi drivers in South Africa. Consistent 
with other studies (Haregu et al., 2016;Ashwell et al., 2012), there were variations in the 
prevalence rates among the four anthropometric indices. The prevalence of AO was based on 
WC, WHR, WHtR and NC was 61.5%, 67.7%, 80.1% and 65.3%, respectively. Irrespective of 
the type of anthropometric indicator, the proportion of AO was high, with discordant results. 
Even among the general population in South Africa, the prevalence of AO has been reported as 
being high (Motala et al., 2011; Matsha et al., 2013; Peer et al., 2015a; Goon et al., 2014a; De 
Lucia Rolfe et al., 2015). Among the four anthropometric indices, the WHtR records the highest 
prevalence rate of AO. The WHtR is a newly introduced anthropometric index, which is a more 
useful clinical screening tool than WC, with a cut-off value of 0.5 applicable to both children and 
adults worldwide. This anthropometric index was postulated by Ashwell et al. (2014),with a 
message “keep your waist circumference to less than half your height.” 
Notably, the working environment of the South African commercial taxi drivers, usually called 
‘Taxi Rank’, are characterized by a rhythm of life, which is faster, noisier and the drivers suffer 
from greater life and work stress. It is postulated that stress reactions are associated with the 
development of abdominal obesity (Bjorntorp, 2001). Also, the participants in this study smoke 
(30%) and drink alcohol daily (72.4%) and binge drink (24%). As reported in other studies 
(Laitinen et al., 2004;Riserus & Ingelsson, 2007), abdominal obesity is more frequent among 
people who smoke and drink alcohol. Additionally, sleep is an important lifestyle indicator 
impacting on health. Other studies have found an association between shorter sleeping time and 
the risk of AO (Lopez-Sobaler et al., 2016; Sperry et al., 2015). The mean sleeping time of the 
drivers in this present study was 6.21.6 hours per day. These working health dynamics could 
explain why the commercial taxi drivers in this present study had higher proportions of AO. 
Ergonomically, the AO of the drivers may impact on some aspects of their ergonomics in terms 
of the sitting position versus the positioning of the wheel steering and, possibly the seatbelt. The 
seat conformation (width and depth) would assume an android or gynoid fat distribution 
(Capodaglio et al., 2010). Research has shown that obese individuals often avoid wearing seat 
belts whilst driving because of the discomfort and localized pressure (Burton et al., 1998; 
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Hamilton et al., 2007) and are at higher risk  of  death  when  involved  in  car  accidents, 
compared  to  normal-weight  individuals. As such, it is postulated that the design of vehicles 
should take this data into consideration (Rodacki et al., 2005; Moreno et al., 2006). Studies have 
demonstrated that individuals with BMI>32 frequently complain of daytime sleepiness, an 
obvious danger during driving (Hamilton et al., 2007; Frank et al., 2004). Research is needed to 
elucidate the impact of AO on the seat position ergonomics of drivers in South Africa. 
Like other anthropometric indicators, other studies have explored the utility of NC as a simple 
and valuable screening tool for identifying individuals with overweight and obesity (Ben-Noun 
et al., 2012; Lou et al., 2012; Yan et al., 2014; Preis et al., 2010; Stable et al., 2013). Of course, 
the NC has shown to be strongly associated with classic obese markers such as BMI and WC; 
and is correlated with cardiometabolic risk factors: blood pressure, fasting plasma glucose levels 
and triglyceride levels (Yan et al., 2014). 
The present study found that, among the four indices, WHR and WC (r=0.644) and WHTR WC 
(r=0.628) are strongly correlated. Previous studies have reported a strong correlation with WHR 
and WC (Guan et al., 2016; Haregu et al., 2016); and in WHTR with WC (Lam et al., 2015; 
Haregu et al., 2016; Guan et al., 2016; Kim et al., 2017; Krakauer & Krakauer, 2016). The high 
correlations between WC and WHTR could be explained in the context of ‘measuring’ obesity in 
an individual. WC is an absolute measure of waist, while WHTR is a relative measure, 
suggesting that the two measurements are strongly related to each other (Haregu et al., 2016). 
Thus, adjusting for WC for height would have little correction effect on WHTR. 
The present study showed that WC was the best predictor of hypertension (OR (95 % CI); 3.7 
(2.3-6.1)) and diabetes (OR (95 % CI); 3.1(1.6-6.0) in the population. Previous studies (Pouliot 
et al., 1994; Krakauer et al., 2016; Haregu et al., 2016; Wei et al., 1997; Dobbelsteyn et al., 
2001) have reported the superiority of WC over other anthropometric indicators in detecting 
cardiometabolic risk factors. Clinically, the WC has been recommended as a diagnostic 
screening tool for both children (Schroder et al., 2014; Goon, 2013) and adults (Nagao et al., 
2013; Kim et al., 2017; Siren et al., 2012). This anthropometric index is easy to measure, and 
requires only a simple tape.  
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4.8.2  Pre-hypertension and hypertension 
Undiagnosed and uncontrolled hypertension contributes significantly to the burden of 
cardiovascular diseases and its complications. It is also an independent risk factor for morbidity 
and mortality (Kayima et al., 2013). We found an alarmingly high prevalence of hypertension 
among commercial taxi drivers in this study. To the best knowledge of the authors, no study has 
been conducted on hypertension among commercial taxi drivers in South Africa. Thus, the 
findings of this study can only be comparable to studies conducted elsewhere. The prevalence of 
hypertension found in this study is higher than the reported prevalence of hypertension among 
commercial taxi drivers across Africa (Erhiano et al., 2015; Tobin et al., 2013; Olusegun et al., 
2016) and several developing countries (Satheesh et al., 2013; Lakshman et al., 2014; Nayak et 
al., 2014; Wang et al., 2001; Saberi et al., 2011; Siu et al., 2012; Izadi et al., 2013; Shin et al., 
2013) which ranged from 9.0% to 46%. The prevalence recorded in this study is only 
comparable with the study among commercial drivers in two developed countries; Hong Kong 
and Taiwan, 57% and 56%, respectively (Table 4.23). Also, the prevalence found among the 
sample in this present study is higher than the reported prevalence (49.2%) among the general 
population in the same district (Owolabi et al., 2017d). The finding in this study affirms the 
assumed higher risk for hypertension among commercial taxi drivers. A thorough comparison of 
prevalence across various studies might be difficult because of variation in study settings and 
methodology. However, the findings of this study mirror the notion of an epidemiological 
transition and the increasing hypertension burden currently sweeping across developing 
countries, and commercial driversespecially are particularly at a higher risk given their unhealthy 
lifestyle behaviour, in terms of sedentarism, excessive alcohol consumption, smoking and other 
illicit health behaviours. Also, the high prevalence of pre-hypertension found among this group 
is a cause for concern. Pre-hypertension indicates a high-risk for hypertension (Wang et al., 
2015; Xu et al., 2016), thus, there is a possibility of a future increase in hypertension burden if 
appropriate interventions are not implemented. There is an urgent need to promote health 
awareness, frequent health screening and implementation of effective interventions targeting 
hypertension among this neglected group, as their health is very crucial to the society at large. 
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Table 4.23: Prevalence hypertension among South African commercial taxi drivers compared with the literature 
Country Design/ Sample size Mean age Percentage  Author 
Abuja, Nigeria Cross- sectional; 389 39.0 ±10.0 9.0% (Olusegun et al., 2016) 
Chittoor, India Cross-sectional; 204 41.38 ±10.45 14.21% (Udayar et al., 2015) 
Bangalore, India Cross- sectional; 500 - 16.0% (Satheesh et al., 2013) 
Iran Cross-sectional;1903 41.55 ±10.43 16.4% (Izadi et al., 2013) 
South-south, 
Nigeria 
Cross-sectional; 112 37.49 ±9.3 21.4% (Tobin et al., 2013) 
Sokoto, Nigeria Cross-sectional; 213 47.48 ±10.18 33.5% (Erhiano et al., 2015) 
India Cross-sectional; 587 46.9 ±6.69 34.8% (Borle et al., 2015) 
Brazil Retrospective 
observational; 659 
41.7 ±6.9 38.2% (Hirata et al., 2012) 
South India Cross- sectional;179 36.5 ±8.4 41.3% (Lakshman et al., 2014a) 
Iran  Cross- sectional; 429 36.6 ±10.7 42.9% (Saberi et al., 2011) 
South Brazil Cross-sectional; 250 41.9 ±10.0 45.2% (Sangaleti et al., 2014) 
India  Cross-sectional 
comparative; 50 
- 46.0% (Nayak et al., 2014) 
Korea  433 - 53.3% (Shin et al., 2013) 
Hong Kong 3376 50.9 ±7.6 57.0% (Siu et al., 2012) 
Taiwan  Cross-sectional; 1761 - 56.0% (Wang et al., 2001) 
South Africa Cross-sectional; 403 43.3 ±12.5 57.0% Present study (2017). 
 
Age, duration of driving, alcohol use, abdominal obesity and diabetes were significant predictors 
of hypertension among the study participants. This corroborates several studies (Satheesh et al., 
2013; Tobin et al., 2013; Lakshman et al., 2014; Udayar et al., 2015). Consistent with other 
studies (Lakshman et al., 2014; Peltzer et al., 2013; Satheesh et al., 2013), a higher prevalence of 
hypertension was found among participants older than 35 years compared to those below 35 
years. Age is an independent risk factor for cardiovascular disorders, especially 
hypertension(Mcdonald et al., 2009). Ageing is often accompanied by changes in the body 
systems, including the cardiovascular system and degeneration of cells (Suastika et al., 2012) 
which increases susceptibility to cardiovascular disorders, including hypertension (Mcdonald et 
al., 2009). This might also be the plausible reason for the higher prevalence found among drivers 
with a longer duration of driving as they constitute those in the higher age group. 
Additionally, both generalized and abdominal obesity and diabetes were found to be 
independently associated with hypertension in the study setting. This is similar to other studies 
(Erhiano et al., 2015; Olusegun et al., 2016). The association between hypertension and obesity 
has long been established (Chiang et al., 1969). Obesity increases the risk of developing 
hypertension(Borrell et al., 2014) due to the activation of the sympathetic nervous system, renin-
angiotensin system, and sodium retention among other abnormalities (Jiang et al., 2016; Re, 
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2009). Obesity, particularly abdominal obesity exerts a deleterious health effect on the 
development of insulin resistance and glucose metabolism (Pinto & Beltrán-Sánchez, 2015), 
which predisposes one to diabetes, later, hypertension and ultimately, cardiovascular diseases 
(World Heart Federation, 2016). Also, hypertension and diabetes share a similar metabolic 
pathways and risk factors such as genetics, physical inactivity, dyslipidemia, insulin resistance 
and obesity. These factors collectively contribute to the development of arterial stiffness, which 
promotes the development of hypertension(Cheung & Li, 2012b;DeMarco et al., 2014).Thus, the 
associative link between obesity, diabetes and hypertension among the study participants is 
expected. This calls for joint intervention programmes targeting all the cardio-metabolic risk 
factors among commercial taxi drivers in the study setting. 
Finally, alcohol usage was significantly associated with hypertension among the study 
participants. This finding agrees with Udayar et al. (2015) study, but contrast with other studies 
(Satheesh et al., 2013; Tobin et al., 2013). Although, controversies exist regarding the impact of 
alcohol on health, and while moderate alcohol drinking has been shown to improve 
cardiovascular function, especially among younger age groups, heavy consumption (more than 
three at a sitting) impacts negatively on cardiovascular health, especially hypertension and atrial 
fibrillation (Pisa et al., 2010; Samokhvalov et al., 2010a). Heavy alcohol consumption increases 
blood pressure(Husain et al., 2014; Sheps, 2015). Thus, the high prevalence of hypertension 
found in this study is not surprising. Anecdotally, most commercial motor drivers in South 
Africa consume excessive alcohol, smoke and indulge in illicit health behaviours, which tend to 
compromise their health status; and South Africa is  reported to be a hard-drinking country 
(Morojele & Ramsoomar, 2016). Most of the factors contributing to the high burden of 
hypertension among commercial taxi drivers are modifiable, and that “prevention is better than 
cure”, intervention strategies are needed to safeguard the health of this special population. 
 
4.8.3 Prevalence and risk factors for diabetes 
The present study determined the prevalence, awareness, treatment and determinants of diabetes 
and pre-diabetes among commercial taxi drivers in BCMM, South Africa. To the best knowledge 
of the researcher, this is the first study reporting the prevalence of diabetes and pre-diabetes 
among commercial taxi drivers in South Africa. Thus, this study can only be compared to studies 
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conducted among commercial taxi drivers outside South Africa. Diabetes mellitus has become a 
global public health challenge not limited to the high income countries but has extended to the 
majority of the low and middle income countries (Zhang et al., 2010) where the prevalence rate 
is growing to a peak and projections increasing (World Health Organization, 2012). Diabetes 
mellitus is a metabolic disorder that poses a significant threat to the life of drivers, passengers 
and other road users. 
The findings of this study revealed an overall prevalence of 16% and 17% for diabetes and pre-
diabetes, respectively. The prevalence of diabetes in this study is higher than studies carried out 
among drivers in countries like Hong Kong, Iran and Brazil; although, Sangaleti et al. ( 2014) 
reported a similar finding (16.4%) among commercial taxi drivers in South Brazil (Table 5). 
Comparison with commercial drivers in other countries may not give an accurate picture or 
might be overemphasizing the burden of diabetes in this study. However, when compared to 
studies conducted among the general population of South Africa, the prevalence rate found in 
this study is more than the 8.3% overall prevalence of diabetes in South Africa (Guariguata et al., 
2014). With the incessant projection of an increase in the prevalence of diabetes, coupled with 
the high prevalence of pre-diabetes found among the study participants, there is a need for 
prompt interventions to curb this growing menace, especially among this high-risk population 
group. 
Table 4.24: Prevalence of diabetes among South African commercial taxi drivers compared with reports of other 
studies 
Country Design   Mean age Percentage Author  
Iran Cross-sectional: 1137 47.7 ±28.7 6.3% (Tofangchiha et al., 2014) 
Iran  Cross-sectional: 1903 41.55 ±10.53 9.1% (Izadi et al., 2013) 
Hong Kong 3376 50.9 ±7.6 8.1% (Siu et al., 2012) 
Iran  Cross-sectional: 429 36.6 ±10.7 7.0% (Saberi et al., 2011) 
Brazil  Retrospective observational: 659 41.7 ±6.9 2.8% (Hirata et al., 2012) 
Brazil 155 _ 11.0% (Reis et al., 2017) 
Brazil Cross-sectional: 250 41.9 ±10.0 16.4% (Sangaleti et al., 2014) 
South Africa Cross-sectional:403 43.3 ± 12.5 16% Present study 
 
With regard to awareness and treatment of diabetes among participants with diabetes, 68% 
(n=43) of them were aware of their diabetes status and of these, the majority, 30 (70%) reported 
being on treatment. This is similar to Sangaleti et al. (2014), who reported an awareness rate of 
63% among drivers in Brazil. The diabetes awareness and treatment rate among the study 
participants is commendable. However, further actions should be taken by district health 
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managers to ensure that the burden of undiagnosed diabetes is drastically reduced among this 
cohort. Also, as practiced in developed nations(Thiese et al., 2015), which was also practiced in 
Iran (Izadi et al., 2013)and Brazil (Hirata et al., 2012), the adoption of a mandatory medical 
fitness test for commercial driving among drivers living with diabetes in South Africa could 
assist in improving awareness, treatment and control. This will also ensure the safety of the 
commercial drivers, passengers and other road users. 
The independent predictors of diabetes according to this study were older age, being ever 
married and hypertension. Ageing increases susceptibility to diabetes (Gunasekaran & Gannon, 
2011). This finding is similar to that of other studies conducted among drivers in Iran (Izadi et 
al., 2013) and Hong Kong (Siu et al., 2012). Obesity is a common predisposing factor for 
diabetes and the link between increasing age and diabetes could be as a result of both generalized 
and central obesity found among the older adults, as a result of reduction in physical activity 
levels (Amati et al., 2009a).This is evidenced by the significant association found between 
physical inactivity and diabetes in this study. Also, ageing has been reported to be associated 
with a higher incidence of insulin resistance, inflammation and impaired insulin secretion 
precipitated by impairment in the functioning and proliferative capacity of the islet cells with a 
resultant development of diabetes (Maedler et al., 2006b; Amati et al., 2009a; Kirkman et al., 
2012). Thus, the American Diabetes Association (American Diabetes Association, 2013), 
specified the need for regular diabetes screening among older adults. This is also a call for action 
for district health managers to regularly organize screening programmes for diabetes among 
commercial taxi drivers, especially, the older ones in order to reduce the burden associated with 
diabetes and its complications.  
A higher prevalence of diabetes was also found among the married, obese and physically 
inactive commercial taxi drivers. This is similar to the findings of (Owolabi et al., 2016) among 
adults in BCMM, South Africa. The association between diabetes and marriage is unclear. It 
could be due to the influence of other clusters of modifiable and non-modifiable risk factors 
among the study participants (Leong et al., 2014). Also, it might be that married participants 
have better and regular access to staple foods like maize meal coupled with regular snacking and 
unhealthy diets commonly eaten at various taxi ranks. Additionally, most of the commercial taxi 
drivers usually sit for long hours (sedentarism) without engaging in any physical activity. They 
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work in a stressful environment and with less hours of sleep (6.371.6) (Razmpa et al., 2011). 
These lifestyle behaviours could lead to obesity and the development of diabetes (Marks & 
Landaira, 2015; Al-Quwaidhi et al., 2013). 
Surprisingly, a higher prevalence of diabetes was found among participants who reported not 
taking sweet beverages. This is contrary to several studies which purported the harmful effects of 
sweet beverages and their negative effect on type 2 diabetes (Hu, 2013; Vartanian et al., 2007; 
Imamura et al., 2015). Although, we cannot specifically state that the consumption of sweet 
drinks does not have a negative effect on diabetes development, the higher prevalence found 
among those who reported not consuming them could be due to other underlying factors. They 
might have stopped consuming such drinks after the diagnosis of diabetes or they might have 
other underlying conditions that predispose them towards diabetes.  
Finally, hypertension was found to be associated with diabetes among the study participants. 
This is not surprising. Several studies have also reported similar association among drivers 
across various countries such as Iran (Izadi et al., 2013), Poland (Marcinkiewicz et al., 2010) and 
Hong Kong (Siu et al., 2012). This association is often linked to the similar metabolic pathways 
between both conditions, as well as their shared risk factors, which range from genetics, 
behavioural, metabolic, and demographic factors to physiological factors (Landsberg & Molitch, 
2004; Cheung et al., 2012; Tekola-Ayele et al., 2013). 
Education also has a significant association with diabetes mellitus shown by its impact in the 
increase of diabetes mellitus in this study. Education plays a vital role in being informed health 
wise; it supports health literacy, as a low level of education often results in low health literacy or 
health illiteracy (van der Heide et al., 2013). A higher level of education with resultant health 
literacy gives individuals a conscious understanding of proper dietary modification, healthy 
living and behaviours and a need to assess health care facilities for health consultation, with the 
knowledge of what results are from a deviation from wellness (Zimmerman et al., 2015; Smith et 
al., 2011). This is consistent with the literature, (Sacerdote et al., 2012; Agardh et al., 2011; Flor 
& Campos, 2017; Shang et al., 2013) which has previously been documented in the study area 
(Owolabi et al., 2016). Type 2 diabetes was more prevalent among participants with a low level 
of education and this could contribute to poor prognosis of the disease(Berkman et al., 2011), 
unlike individuals with a high level of education (van de Sande et al., 2007). Not furthering the 
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education of the participants in this study could have contributed to an increase prevalence of 
type 2 diabetes mellitus among this group of commercial drivers. Mostly, this is linked with low 
socio-economic status and income, which could influence their everyday life, making them 
susceptible to developing type 2 diabetes mellitus. Also, low level of education could be a 
contributory factor to the high odds among the confounders of diabetes in this study. 
Being obese increases the prevalence of type 2 diabetes mellitus in this study. Obesity 
individually, is a proximate factor of non-communicable diseases that is it serves as a driver of 
chronic diseases. Obesity specifically increases the mechanism and substances that could aid the 
development of diabetes in an individual who is obese, compared with a person of normal 
weight. Due to obesity it becomes so easy for the beta cells to dysfunction and the body becomes 
insensitive to insulin action (Al-Goblan et al., 2014), which will eventually results in to type 2 
diabetes mellitus. This finding is in accordance with several study findings in South Africa 
reporting strong correlation between obesity and diabetes (Owolabi et al., 2016; Matsebula & 
Ranchhod, 2016; Kruger et al., 2007). It could also be noted that, often, physical inactivity goes 
with obesity and traditionally, physical inactivity predisposes to different diseases, which is one 
of the outcomes of this study’s findings. The prevalence of diabetes was greater and more 
significantly correlated with reports of participants being physically inactive. This may be related 
to the rate at which sedentarism as a result of lifestyle and the nature of the job of commercial 
drivers leads to obesity (Choi et al., 2010). Physical inactivity in this study can also be linked to 
the long period of driving among commercial drivers that could have consumed most of their 
time thus precluding physical activity. Having a constant routine of sitting behind the wheel for 5 
years or more, without engaging in some sort of active physical activity as recommended can 
pose a serious health threat. 
 
4.8.4  Prevalence and risk for metabolic syndrome 
This is the first study in South Africa to determine the prevalence of metabolic syndrome among 
South African commercial taxi drivers. The prevalence of metabolic syndrome in this study is 
22%. The finding in this study is close to the reported findings of 24% among Brazilian 
(Cavagioni et al., 2008) and 26.8% among Hong Kong drivers (Siu et al., 2012). However, the 
prevalence rate in this study is lower than that of the USA having 29% (BC Legal News, 2017), 
Korea 49.9% (Shin et al., 2013), Taiwan 43.1% (Chen et al., 2013) and Iran (26.1%-35.9%) 
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(Mohebbi et al., 2012; Mohebbi et al., 2010; Ebrahimi et al., 2016; Saberi et al., 2011) (Table 
4.25). The absence of lipid disorders in defining criteria for METs in this study, might have 
underestimated the prevalence among study participants. Notwithstanding, the observed 
prevalence of metabolic syndrome among the taxi drivers in this study is high and could be 
ascribed to the working conditions and the unhealthy lifestyle behaviours (sedentarism, 
unhealthy dietary practices, smoking, excessive alcohol consumption), as well as work-related 
stress (Apantaku-Onayemi et al., 2012; Siedlecka, 2006; Chen et al., 2013; Ebrahimi et al., 2016; 
Mohebbi et al., 2010).With the nutritional transition in South Africa, there have been reports of 
high abdominal obesity (Peer et al., 2015b; Motala et al., 2011) which is a predisposing factor for 
metabolic syndrome. Also, a constant source of income when having a job (Peer et al., 2015a) 
whereby there is money to feed and probably overfeed, this can increase the development of 
metabolic syndrome.  
Table 4.25: Prevalence of metabolic syndrome among drivers in past studies 
Country Method Mean age Prevalence Author 
USA 115/262 - 29% (BC Legal News, 
2017) 
Iran Cross-sectional: 1018 42.17 ± 10.65 26.1% ATP III, IDF 
35.2%, 31.6% AHA. 
(Ebrahimi et al., 2016) 
Iran Cross-sectional: 429 36.6 ± 10.7 35.9% (Saberi et al., 2011) 
Hong Kong 3376 50.9 ±7.6 26.8% (Siu et al., 2012) 
Iran  12,138 37.8 ±10.1 30.5% (Mohebbi et al., 2012) 
Taiwan 421 46.5 ± 9.4 43.1% (Chen et al., 2013) 
Brazil  Cross-sectional: 258 37.5 ± 10.1 24% (Cavagioni et al., 
2008) 
Iran Cross-sectional: 626 38.8± 10.07 32.4% (Mohebbi et al., 2010) 
Korea  Cross-sectional: 443  49.9% (Shin et al., 2013) 
South Africa  Cross-sectional: 403  22% Present study  
 
Generally, there has been an increase in the prevalence of metabolic syndrome in developing 
countries (Misra et al., 2008) and South Africa is no exemption. Several studies have reported 
high prevalence of  metabolic syndrome in South Africa, ranging from 21.8% to 62% (Peer et al., 
2015a; Owolabi et al., 2017b; Motala et al., 2011; Erasmus et al., 2012; Prakaschandra & 
Naidoo, 2016) and its prevalence is high when compared with other African countries (Hoebel et 
al., 2012; Motala et al., 2011). This mirrors the epidemiological, nutritional and socio-economic 
transition taking place across developing countries (Kabudula et al., 2017) and in South Africa.  
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A low level of education was associated with a higher prevalence of METs. This finding is 
similar to the finding of Owolabi et al. (2017) among South African adults, as well as the finding 
of Hajian-Tilaki et al. (2014) among Iranians. There is a documented resultant increase in 
knowledge, associated with education. Also, it is speculated that the more educated an individual 
is, the more knowledgeable they are about their health, and the more receptive they become to 
information obtained regarding their health (Cutler & Lleras-Muney, 2010; Deaton et al., 2006). 
Whether this mirrors the situation of the drivers in this present study is debatable. It could be 
inferred that such increased knowledge resulting from increased levels of education, which, in 
turn, might have influenced the health behaviours of the more educated drivers, and perhaps, 
reduced their vulnerability to cardio-metabolic risk. 
Older participants and those with a period of driving for more than five years, had a higher 
prevalence of METs. Ageing is an established risk factor for cardio-metabolic health 
compromise (Okafor, 2012). All the components of METs have been linked with increasing age 
(Amati et al., 2009b; Owolabi et al., 2016; Kirkman et al., 2012). Less physical activity, 
increased food consumption, reduction in lean body mass and an increase in body fat and 
visceral adiposity found among the older adults resulted in an increased predisposition to obesity, 
which is also a predisposing factor to other cardio-metabolic risk factors (Yamamoto et al., 2011; 
Amati et al., 2009b). In addition, ageing is accompanied by a decline in islet cells functioning as 
well as changes in the cardiovascular system, which brings about the development of diabetes 
and hypertension, respectively (Rankin & Kushner, 2009; Maedler et al., 2006a). Thus, the 
higher prevalence of METs among the older adults is not surprising. This might also be the 
underlying reason behind the higher prevalence found among those with longer periods of 
driving. Aside from this, an accumulation of work-related stress, unhealthy diet and inactivity 
among the drivers with longer duration of driving could also contribute to the higher odds for 
METs (Chandola et al., 2006; Apantaku-Onayemi et al., 2012; Siedlecka, 2006). 
There was a three-fold increase in metabolic syndrome among married participants in this study. 
There is no clear-cut explanation regarding the association between marriage and METs. 
Although some authors documented similar higher odds for METs among married individuals 
(Bhanushali et al., 2013; Owolabi et al., 2017b), Hosseinpour-Niazi et al. (2014), reported no 
significant association between marriage and METs. Troxel et al. (2005), on the other hand, 
92 
 
identified marital quality as the link between marriage and METs. In addition, higher prevalence 
of the various components of METs, often seen among married individuals, might also be 
responsible for this finding. Even age might be an underlying factor, as most married people are 
usually older than the singles. Also, an improper change in eating patterns of married individuals 
could consequently increase the chances of developing obesity. This could subsequently, with 
the presence of other associated factors, lead to METs. 
Finally, the consumption of sweet beverages and physical inactivity were the behavioural factors 
associated with METs in this study population. This was anticipated as unhealthy beverages and 
physical inactivity are leading causes of obesity, a predisposing factor to other components of 
METs. This finding is similar to that found among Taiwanese drivers by Chen et al. (2013). 
 
4.8.5  Prevalence of alcohol, smoking and physical inactivity 
This was an on-site screening among commercial taxi drivers in Buffalo City Metropolitan 
Municipality, South Africa, to assess the prevalence of unhealthy lifestyle behaviours such as 
alcohol use, smoking and physical inactivity. These factors all contribute to the development of 
non-communicable diseases, as well as road traffic crashes and injuries, which constitute a 
significant health and socio-economic threat.  
 
4.8.5.1 Smoking 
In this study, 30% of the commercial drivers were current smokers with majority smoking daily. 
The prevalence in this study is similar to the reported prevalence among drivers in Nigeria (32%) 
(Ozoh et al., 2014) and Brazil (29%) (Sangaleti et al., 2014). It is however slightly higher than 
that observed among drivers in Colombia (20.3%) (Useche et al., 2017) and some other parts of 
Nigeria (25.8%) (Adekoya  et al., 2011). Some authors documented a higher prevalence than the 
one observed in the study, a prevalence ranging from 39.4% in Nigeria (Fasasi et al., 2014) to as 
high as 93% among Bangladesh drivers (Goon et al., 2014b). The prevalence of smoking among 
this study’s participants is however higher than the reported national prevalence of 17.6% 
(Reddy et al., 2015). Likewise, (Owolabi et al., 2017e) in their study on the general populace in 
this same setting reported a prevalence as low as 15% among adults in this setting. These all 
establish the fact that commercial taxi drivers participate in the illicit use of harmful 
psychoactive substances like cigarettes more than the general population. Most likely, 
93 
 
commercial taxi drivers smoke cigarettes in a bid to ease the stress involved in their work, to 
relax, be active or keep their weight in check (Okpataku, 2015; Usman & Ipinmoye, 2016). This, 
however, is disastrous both for drivers and for the populace at large. Also, other factors such as 
male dominance of the occupation (Reddy et al., 2015), urban location (Vellios & van Walbeek, 
2016), low literacy level (Goon et al., 2014b; Owolabi et al., 2017e), might also have contributed 
to the high prevalence of smoking observed. There is a need for sensitisation among this group 
by the Department of Health in collaboration with the Department of Transport with regards to 
the harmful effects of cigarette smoking. Also, there is a need for the better enforcement of 
existing laws regarding cigarette smoking. 
 
4.8.5.2 Alcohol 
A high prevalence (37%) of alcohol use was found among the commercial drivers in this study. 
Several studies (Useche et al., 2017; Abiona et al., 2006; Akpan et al., 2014; Adekoya  et al., 
2011; Sangaleti et al., 2014) have also documented a high prevalence of harmful alcohol use 
among commercial drivers. Thus, the finding in this study is not shocking. The prevalence found 
among the commercial taxi drivers is higher than the reported national prevalence in South 
Africa (Peltzer et al., 2011). Commercial taxi drivers in this setting, do not just drink, they binge 
drink. Generally in this setting, a high prevalence of binge drinking has been reported (Owolabi 
et al., 2017c). The high prevalence of binge drinking among commercial drivers is not surprising 
and is concerning, given the fact that drinking while driving is associated with injuries and 
deaths related to road traffic crashes. The existing policies on alcohol use, as well as the 
legislation that applies to the commercial drivers need to be revisited, re-evaluated and 
reinforced. As it is, it does not seem that these drivers are aware of the existing policies and 
legislation regarding drunk driving and this should be corrected to protect the lives of drivers and 
the passengers that they carry.  
 
4.8.5.3 Physical inactivity 
Another lifestyle risk factor assessed among this group is physical inactivity. Physical inactivity 
contributes to non-communicable diseases and road traffic injuries by stimulating obesity. The 
majority (82%) of the study participants were inactive. This prevalence is twice the prevalence 
recorded among the general South African population (46%) (Peer, 2013). Several other studies 
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have also highlighted the huge burden of physical inactivity among commercial drivers 
(Sangaleti et al., 2014; Hirata et al., 2012; Varela-Mato et al., 2017; Varela-Mato et al., 2016; 
Sena et al., 2008). These scholars related this high burden of physical inactivity to the nature of 
the work of commercial drivers, which entails long hours of sitting, while driving, and even 
when not driving. Physical activities promote cardio-metabolic health and reduce the incidence 
of cardio-metabolic diseases (Kolbe-Alexander et al., 2013; Wilmot et al., 2012; Puhkala et al., 
2015). Also, obese drivers might not be able to assume a comfortable position while driving and 
this might increase the chance of getting involved in road crashes. There is therefore a need to 
encourage the drivers to engage in physical activities. Thus, proper health education and 
awareness creation programmes are required for this group, in this regard. 
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CHAPTER FIVE 
SUMMARY, CONCLUSION AND RECOMMENDATIONS 
INTRODUCTION 
A summary of the study, the conclusion, the study’s limitations and strengths and 
recommendations will be presented in this chapter. 
 
5.1 SUMMARY 
Cardio-metabolic risk factors have been researched in South Africa, in the Eastern Cape 
Province of the country, in Buffalo City Metropolitan Municipality (BCMM); but there are no 
studies on the cardio-metabolic risk profile of commercial drivers in the Eastern Cape Province 
of the Country. The main aim of the study was to determine the prevalence and correlates of 
cardio-metabolic risk factors (CMRFs) among minibus taxi drivers in Buffalo City Metropolitan 
Municipality, East London, South Africa. Cardio-metabolic risk factors are basically factors that 
raise the individual’s susceptibility to cardiovascular diseases and diabetes mellitus.  
The specific aims of the study were to: 
i. Determine the prevalence and risk factors of overweight and obesity among commercial 
drivers in BCMM; 
ii. Determine the prevalence and risk factors of hypertension and pre-hypertension among 
commercial drivers in BCMM; 
iii. Determine the prevalence and risk factors of type 2 diabetes mellitus and pre-diabetes among 
commercial drivers in BCMM; 
iv. Assess age, duration of driving, educational level, socio-economic differences in CMRFs, 
risk factors and prevalence rates among commercial drivers in BCMM; and, 
v. Examine the association of CMRFs risk factors with lifestyle characteristics (smoking, 
alcohol consumption, physical activity, dietary intake) among commercial drivers in BCMM. 
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The research questions for the study were: 
i. What is the prevalence and risk factors of overweight and obesity among commercial drivers 
in BCMM? 
ii. What is the prevalence and what are the risk factors of hypertension and pre-hypertension 
among commercial drivers in BCMM? 
iii. What is the prevalence and what are the risk factors of type 2 diabetes Mellitus and pre-
diabetes among commercial drivers in BCMM? 
iv. Would age, duration of driving, educational level, and other socio-economic variables predict 
the risk of CMRFs among commercial drivers in BCMM? 
v. Would smoking, alcohol consumption, physical activity, and dietary intake have any 
significant effect on the risk of developing CMRFs, among commercial drivers in BCMM?  
 
The study was a cross-sectional, quantitative survey among commercial drivers registered in the 
existing taxi associations in ten selected taxi ranks in BCMM. The study used a convenient 
sample technique for the study participants. A sample size of 403 commercial drivers 
participated in the study with completed questionnaires. The WHO STEPwise questionnaire 
(World Health Organization, 2003) was used for data collection. The WHO questionnaire 
involves self-reported information socio demographic (sex, age, level of education, race, 
education, marital status, income and work experience) and lifestyle behavioural risk factors 
(smoking, alcohol consumption, physical inactivity, dietary intake).  
The second aspect of the instrument focused on objective reports concerning anthropometric 
measurements which include weight, height, waist circumference, hip circumference, neck 
circumference and blood pressure. The third aspect involved objective information obtained 
through biochemical measures. This comprised the fasting blood glucose level. The WHO 
STEPS recommended instrument has been validated through several studies which used the same 
standardised questions and protocol in different regions and countries (Virgin Island ministry of 
Health and Social Development, 2010: Fereshteh et al., 2007; Kingsley, 2003; WHO, 2015). 
The study involved ten research assistants. The research assistants were qualified nurses and 
students in health-care-related fields. Training was organized for the research assistants to 
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facilitate competency in all aspect of the study (questionnaire administration, anthropometric, 
blood pressure and blood glucose measurements). During training, each person was allocated to 
a specific aspect of measure for consistency. There were team leaders for each unit who 
coordinated the activities of the units. 
Due explanations about the aim, nature and the procedures of the study were given to the 
participants before data collection. Information on the demographics, behavioural characteristics 
and dietary patterns (fruit and vegetable consumption) was obtained from the participants 
through the questionnaire administration. The body mass index, waist to hip ratio and waist 
height ratio were derived from the anthropometric measurements. 
Data were analysed using a combination of descriptive and inferential statistics. Descriptive 
statistics (frequency percentages, mean and standard deviation) were used for categorical 
variables. Inferential statistics (bivariate and multivariate logistic regression) were used to 
identify the significant associated risk factors of obesity, hypertension, diabetes metabolic 
syndrome and their ninety five percent confidence interval (95% CI). The logistic regression was 
also adjusted for confounding factors, to determine which of the demographic variables (sex, 
age, level of education, marital status, income, driving history) and behavioural lifestyle 
variables (smoking, alcohol consumption, physical inactivity, dietary intake) independently and 
significantly predicted the risk of developing CMRFs in the participants. A p-value of < 0.05 was 
considered statistically significant. All statistical analyses were performed with the Statistical 
Package for Social Sciences (SPSS) version 22.0 for Windows (SPSS Inc., Chicago, IL, USA). 
 
Major Findings 
The major findings of the study were: 
i. A high prevalence of overweight (34%) and obesity (37%) exists among the participants. 
ii. Age, marital status, period of driving, smoking, sweet drinks consumption, hypertension 
and diabetes were significantly associated with overweight and obesity among the study 
participants. However, after adjusting for confounding variables, only age, smoking and 
hypertension were independent predictors of obesity among the study participants. 
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iii. There was a high prevalence of pre-hypertension (34%) and hypertension (43%) among 
the study participants. 
iv. Age, marital status, level of education, period of driving, alcohol, sweet drinks 
consumption, obesity and diabetes were significantly associated with hypertension. 
However after adjusting for confounders, only age, obesity, diabetes, alcohol and period 
of driving were independent predictors of hypertension among the study participants. 
v. There was a high prevalence of hypertension among participants with a lower education 
(below grade 8), participants who were obese and those who reported not to take sweet 
drinks. 
vi. There was a high prevalence of diabetes (16%) and pre-diabetes (17%) among the study 
participants 
vii. Awareness of among participants with diabetes was 63% and 43% were on treatment. 
viii. Age, marital status, level of education, period of driving, sweet drinks consumption, 
obesity physical activities and hypertension were significantly associated with diabetes. 
However after adjusting for confounders, only age, being married and hypertension were 
independent predictors of diabetes among the study participants. 
ix. The prevalence of diabetes was high among participants with level of education below 
grade 8.  
x. There was a high prevalence (22%) of metabolic syndrome among the participants. 
xi. Age, marital status, level of education, period of driving, sweet drinks consumption and 
physical activities were significantly associated with metabolic syndrome. However after 
adjusting for confounders, only age, being married and period of driving were 
independent predictors of metabolic syndrome among the study participants. 
xii. There was a high prevalence (82%) of physical inactivity among the study participants 
xiii. The prevalence of smoking among the participants was 30% among which 97% are daily 
smokers 
xiv. There was a high prevalence (37%) of alcohol consumption among participants 
xv. Prevalence of participants that binge drink was 24% 
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5.2 LIMITATIONS 
The limitations to the study should also be noted. First, this was a cross-sectional study. 
Therefore, causal associations cannot be ascertained, but can only be interpreted as hypothetical 
causal relations as this did not allow for a causal relationship between the risk factors and 
(obesity, hypertension and diabetes). Also, the present study involved commercial drivers 
operating in ‘Taxi ranks’ in BCCM, Eastern Cape Province and, therefore, may not necessarily 
represent the entire group of commercial drivers in South Africa. Diagnosis of diabetes among 
the participants without previous history was based on a single fasting blood glucose test. 
Additional tests such as glycosylated haemoglobin or oral glucose tolerance test could have 
validated the diagnosis of diabetes in the study.  
Additionally, standard criteria of METs include abdominal obesity, hypertension, 
hypertriglyceridemia, low HDL-cholesterol level, and hyperglycemia (Kassi et al., 2011); 
however, this study assessed only three criteria. Thus firstly, there is a possibility of 
underestimating the prevalence of METs among the commercial drivers. The participants self-
report of information may be inaccurately reported due to social desirability (for example 
reporting being physically active or eating fruits and vegetables), or embarrassment (for example 
under-reporting alcohol use) (Elshatarat et al., 2016). Second, the questionnaire was self-
reported; as such some recall bias cannot be overruled. Third, there was no gold standard to 
compare all indices. Finally, some of the abdominal obesity cut-off points were developed for 
different population groups and may not necessarily suit the population in this study. 
 
5.3 STRENGTHS  
This study is the first survey conducted to screen for CMRFs among commercial taxi drivers in 
South Africa. Besides, it is a unique study, because it provides important baseline information 
about the significant correlates of CMRFs among commercial taxi drivers. Additionally, multiple 
BP readings were obtained; and all the measurements were done in the field. Measurements were 
done according to standard protocols. Participants with abnormal BP and glucose levels were 
advised regarding appropriate medical care. Given the paucity of data on the clustering of these 
cardio-metabolic risk factors among commercial drivers in BCMM, this study provides a 
snapshot of the metabolic health of this neglected group in health biomarkers assessment 
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compared to the general population in South Africa. It also serves as comparable baseline data 
for health intervention among this unique population. Research assistants were properly trained 
to ensure the quality of data collection. Height, weight and waist and hip circumferences were 
measured, not self-reported, which is a more accurate assessment procedure that adds strengths 
to the data. Also, to the best of the researcher’s knowledge, no study exists on the prevalence and 
predictors of abdominal obesity among taxi drivers in South Africa. 
 
5.4 CONCLUSION 
The prevalence report of overweight and obesity, pre-hypertension and hypertension and pre-
diabetes and diabetes among commercial taxi drivers in BCMM is alarmingly high. This implies 
that the commercial taxi drivers are more predisposed to cardiovascular and metabolic diseases; 
this is worrisome, as it may have a dangerous effect on their health and thus may affect the safety 
of the public who travel with them and share the same road network with them. 
The study shows that age, marital status, period of driving, smoking, sweet drinks consumption, 
hypertension and diabetes are significantly associated with overweight and obesity among the 
participants. Also, there was a high prevalence of abdominal obesity. 
Age, marital status, period of driving, level of education, period of driving, obesity, alcohol, 
sweet drinks consumption and diabetes is significantly associated with hypertension 
Also, there are significant associations between age, marital status, level of education, period of 
driving, sweet drinks consumption, physical activities, obesity and hypertension among the study 
participants. 
The findings reveal that there is a high rate of physical inactivity, smoking and alcohol 
consumption prevalence. 
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5.5 RECOMMENDATIONS 
According to the findings of this study, the following recommendations are made: 
i. There is a need for continual awareness creation and screening for cardiovascular risk 
factors among commercial drivers across the country. Effective interventions targeted at 
the reduction of modifiable lifestyle behaviours should be implemented among this high-
risk group.  
ii. There is an urgent need for interventions tailored towards weight reduction among this 
important, but neglected population group. This may possibly assist in the reduction of 
non-communicable diseases, crashes and injuries related to obesity among commercial 
drivers. 
iii. There is a need to further encourage and organize opportunistic screening for diabetes 
among this cohort to further reduce the burden of undiagnosed diabetes. 
iv. Efforts should be made to promote participation in physical activities among commercial 
drivers in this study, using workplace health education to raise the awareness of its health 
benefits and the health and social hazards of smoking and alcohol intake 
v. Age is one important associated factor of all the cardio-metabolic risk factors screened 
for in this study; hence commercial drivers should be encouraged to have constant health 
check-ups as they age and as their period of driving increases. 
vi. On-site health education should focus on healthy behaviours and living at different taxi 
ranks in collaboration with the department of health. 
vii. Future studies examining total or abdominal obesity in this special population group 
should endeavour to include cardiovascular risk variables such as total cholesterol, 
triglycerides, and fasting blood glucose. This will aid understanding of the relationship of 
obesity with physiological variables often associated with increased metabolic risk, 
among South African commercial taxi drivers. 
viii. Studies on cardio-metabolic risk factors among commercial drivers in various settings 
and provinces in the country are also recommended, and should be regularly updated on 
the health profile of commercial drivers in South Africa.  
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Step 1   Demographic Information 
 
CORE: Demographic Information 
Question Response Code 
Sex (Record Male / Female as observed) 
 
Male 1 
C1 
Female 2 
What is your date of birth?     
Don't Know 77 77 7777 
 
 
└─┴─┘ └─┴─┘ └─┴─┴─┴─┘ If known, Go to C3 
     dd              mm                year 
C2 
 
 
EXPANDED: Demographic Information 
What is the highest level of education you have completed? 
 
 
No formal schooling 1 
 C3 Grade 1-7 2 
Grade 8-12 3 
Tertiary 4 
 
Refused 88 
What is your racial group 
Black 1 
C4 
Coloured 2 
White 3 
Refused 88 
What is your marital status? 
 
 married 1 
C5 
Separated 2 
Divorced 3 
Widowed 4 
Single 5 
Refused 88 
How long have you been working as a mini bus taxi driver 
 
 
Less  than 2years 
 
1 
C6 
2-5 years 2 
6-10 years 3 
> 10 years 4 
Refused 88 
How many days do you drive in a typical week? 
 Number of days 
└─┴─┘ 
days           
C7 
How much time do you spend driving on a typical day? 
 
Hours : minutes 
└─┴─┘: └─┴─┘ 
    hrs                mins 
C8 
How many hours of sleep do you get on a typical day Hours : minutes 
└─┴─┘: └─┴─┘ 
    hrs                mins 
C9 
How much do you earn in a month (RAND) 
 
Per Month └─┴─┴─┴─┴─┴─┴─┘    Go to T1 C10a 
Refused 88 C10b 
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Step 1    Behavioural Measurements 
 
 
 
CORE:  Tobacco Use 
Now I am going to ask you some questions about tobacco use. 
Question Response Code 
In the past, did you ever smoke any tobacco products?  
(USE SHOWCARD) 
 
Yes 1 
T1 
No 2      If No,  go to A1 
 
Do you currently smoke any tobacco products, such as 
cigarettes, cigars or pipes? 
 
 
Yes 1      If Yes,  go to T4 
T2 
No 2      If No,  go to T3 
When did you quit smoking 
                                     └─┴─┘   └─┴─┘ 
                                          Years          Months 
      T3 
Do you currently smoke tobacco products daily?  
 
Yes 1 
T4 
No 2 
How old were you when you first started smoking? 
 
Age (years) 
└─┴─┘ If Known, go to T7a 
T5 
Don’t know  77 
Do you remember how long ago it was? 
(RECORD ONLY 1, NOT ALL 3) 
Don’t know 77 
 
In Years 
└─┴─┘ If Known, go to T7a 
T6a 
OR       in Months 
└─┴─┘ If Known, go to T7a 
T6b 
 
OR        in Weeks └─┴─┘ 
T6c 
On average, how many of the following products do you 
smoke each day? 
 
(IF LESS THAN DAILY, RECORD WEEKLY) 
 
(RECORD FOR EACH TYPE, USE SHOWCARD) 
 
Don’t Know  7777 
 
 
                          DAILY↓                 WEEKLY↓ 
Manufactured cigarettes 
└─┴─┴─┴─┘└─┴─┴─┴─┘ 
T7a 
Hand-rolled cigarettes 
└─┴─┴─┴─┘└─┴─┴─┴─┘ 
T7b 
Pipes full of tobacco 
└─┴─┴─┴─┘└─┴─┴─┴─┘ 
T7c 
snuff 
└─┴─┴─┴─┘└─┴─┴─┴─┘ 
T7d 
Other 
  
└─┴─┴─┴─┘└─┴─┴─┴─┘                                                          
If Other, go to T7other 
T7e
Other (please specify): 
└─┴─┴─┴─┴─┴─┘ 
T7other 
 
 
CORE:  Alcohol Consumption 
The next questions ask about the consumption of alcohol. 
Question Response Code 
Have you ever consumed any alcohol such as beer, wine, spirits 
or [add other local examples]? 
(USE SHOWCARD OR SHOW EXAMPLES) 
Yes 1 
A1 
No 2    If No, go to B1 
Have you consumed any alcohol within the past 12 months? 
 
Yes 1    If Yes, go to A3 
A2 
No 2    If No, go to B1 
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During the past 12 months, how frequently have you had at 
least one standard alcoholic drink? 
(READ RESPONSES, USE SHOWCARD) 
 
Daily 1 
A3 
5-6 days per week 2 
3-4 days per week 3 
1-2 days per week 4 
1-3 days per month 5 
Less than once a month 6 
Have you consumed any alcohol within the past 30 days? 
 
Yes 1 
A4 
No 2    If No, go to B1 
During the past 30 days, on how many occasions did you have 
at least one standard alcoholic drink? 
 
 
Number  
Don't know 77 
└─┴─┘ 
A5 
During the past 30 days, when you drank alcohol, how many 
standard drinks on average did you have during one drinking 
occasion? 
(USE SHOWCARD) 
 
Number  
Don't know 77 
└─┴─┘ 
A6 
During the past 30 days, what was the largest number of 
standard drinks you had on a single occasion, counting all types 
of alcoholic drinks together? 
 
Largest number 
Don't Know 77 
└─┴─┘ 
A7 
During the past 30 days, how many times did you have  
five or more standard drinks in a single drinking occasion? 
 
Number of times 
Don't Know 77 
└─┴─┘ 
A8 
 
CORE: Diet 
The next questions ask about the foods you usually eat. I have a nutrition card here that shows you some examples of local food. As you 
answer these questions please think of a typical week in the last year.  How often do you do the following  
Question Response Code 
FOOD NEVER   RARELY  SOMETIMES OFTEN D1 
Take breakfast in your house      
a 
Buy food from vendors?     b 
 you buy fast foods ( KFC, 
Steers) 
    c 
Eat fried food     d 
Do you take sweet drinks 
(Twist) 
    e 
How many times do you eat vegetables 
Number  
Don't know 77 
└─┴─┘  └─┴─┘ 
Week           Month 
 
D2 
How many times do you eat fruits 
Number  
Don't know 77 
└─┴─┘  └─┴─┘ 
Week           Month 
D3 
 
 
 
 
 
 
 
 
 
148 
 
 
 
 CORE:  Physical Activity; Recreational activities 
The next questions exclude the work and transport activities that you have already mentioned. 
Now I would like to ask you about sports, fitness and recreational activities (leisure) [Insert relevant terms]. 
Do you do any sports, fitness or recreational (leisure) activities that cause 
large increases in breathing or heart rate like [running or football] for at 
least 10 minutes continuously?  
[INSERT EXAMPLES]   (USE SHOWCARD) 
 
Yes   1 
P1 
No 2      If No, go  to H 1 
In a typical week, on how many days do you do sports, fitness or 
recreational (leisure) activities? Number of days 
└─┘ 
P2 
How much time do you spend doing sports, fitness or recreational activities 
on a typical day? 
 
Hours : minutes └─┴─┘: └─┴─┘ 
    hrs                mins 
P3 
(a-b) 
 
CORE: History of  Raised Blood Pressure 
Question Response Code 
Have you ever had your blood pressure measured by a doctor or 
other health worker? 
Yes 1 
H1 
No 2       If No, go to H6 
Have you ever been told by a doctor or other health worker that 
you have raised blood pressure or hypertension? 
 
Yes 1 
H2a 
No 2       If No, go to H6 
Have you been told in the past 12 months? 
 
Yes 1 
H2b 
No 2  
In the past two weeks, have you taken any drugs (medication) for 
raised blood pressure prescribed by a doctor or other health 
worker? 
 
Yes 1 
H3 
No 2 
Have you ever seen a traditional healer for raised blood pressure 
or hypertension? 
 
Yes 1 
H4 
No 2 
Are you currently taking any herbal or traditional remedy for your 
raised blood pressure? 
 
Yes 1 
H5 
No 2 
 
CORE: History of  Diabetes 
Question Response Code 
Have you ever had your blood sugar measured by a doctor or 
other health worker? 
Yes 1 
H6 
No 2       If No, go to H12a 
Have you ever been told by a doctor or other health worker that 
you have raised blood sugar or diabetes? 
 
Yes 1 
H7a 
No 2       If No, go to H12a 
Have you been told in the past 12 months? 
 
Yes 1 
H7b 
No 2  
In the past two weeks, have you taken any drugs (medication) for 
diabetes prescribed by a doctor or other health worker? 
 
Yes 1 
H8 
No 2 
Are you currently taking insulin for diabetes prescribed by a 
doctor or other health worker? 
 
Yes 1 
H9 
No 2 
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Have you ever seen a traditional healer for diabetes or raised 
blood sugar? 
 
Yes 1 
H10 
No 2 
Are you currently taking any herbal or traditional remedy for your 
diabetes? 
 
Yes 1 
H11 
No 2 
 
CORE:  Lifestyle Advice 
Questions Response Code 
During the past three years, has a doctor or other health worker advised you to do any of the following? 
(RECORD FOR EACH) 
Quit using tobacco or don’t start 
Yes 1 
H12a 
No 2 
Reduce salt in your diet 
Yes 1 
H12b 
No 2 
Eat at least five servings of fruit and/or vegetables each 
day 
Yes 1 
H12c 
No 2 
Reduce fat in your diet 
Yes 1 
H12d 
No 2 
Start or do more physical activity 
Yes 1 
H12e 
No 2 
Maintain a healthy body weight or lose weight 
Yes 1      If C1=1 go to M1 
H12f 
No 2      If C1=1 go to M1 
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Step 2    Physical Measurements 
CORE:  Blood Pressure 
Cuff size used 
 
Small 1 
M1 Medium 2 
Large 3 
Reading 1 
 
                   Systolic ( mmHg) └─┴─┴─┘ M2a 
Diastolic (mmHg) └─┴─┴─┘ M2b 
Reading 2 
 
Systolic ( mmHg)  └─┴─┴─┘  M3a 
Diastolic (mmHg) └─┴─┴─┘ M3b 
Reading 3 
Systolic ( mmHg) └─┴─┴─┘ M4a 
Diastolic (mmHg) └─┴─┴─┘ M4b 
During the past two weeks, have you been treated for raised blood 
pressure with drugs (medication) prescribed by a doctor or other 
health worker? 
Yes 1 
M5 
No 2 
CORE:  Height and Weight 
Question Response Code 
Height in Centimetres (cm) 
└─┴─┴─┘. └─┘ 
M6 
Weight   in Kilograms (kg) 
└─┴─┴─┘.└─┘ 
M7 
CORE:  Waist 
Waist circumference    in Centimetres (cm) 
└─┴─┴─┘.└─┘ 
M8 
CORE:  Neck 
Neck circumference    in Centimetres (cm) 
└─┴─┴─┘.└─┘ 
M9 
 
EXPANDED: Hip Circumference and Heart Rate 
Hip circumference   in Centimeters (cm) └─┴─┴─┘.└─┘ M10 
Heart Rate 
 
 
Reading 1 Beats per minute └─┴─┴─┘ M11a 
Reading 2 Beats per minute └─┴─┴─┘ M12b 
Reading 3 Beats per minute └─┴─┴─┘ M13c 
Step 3    Biochemical Measurements 
 
CORE:  Blood Glucose 
Question Response Code 
During the past 12 hours have you had anything to eat or drink, 
other than water? 
Yes 1 
B1 
No 2 
Random blood glucose 
[CHOOSE ACCORDINGLY: MMOL/L OR MG/DL] 
 
mmol/l └─┴─┘. └─┴─┘ B2 
mg/dl └─┴─┴─┘.└─┘ 
Today, have you taken insulin or other drugs (medication) that 
have been prescribed by a doctor or other health worker for 
raised blood glucose? 
Yes 1 
B3 
No 2 
 
 


  
 
Eastern Cape Department of Health 
 
Enquir1es: Madoda Xokwe 
 
Date: 18 November 2016 
e-m ail address: madoda.xokwe@echealth.gov.za 
 
Dear Ms. A. Adedokum 
Tel No: 040 608 0830 
 
                 043 642 1409 
 
Re: Screening For Cardio-Metabolic Risk Factors among Minibus Taxi Drivers in East London, South Africa. 
(EC_2016RP29_402)   
 
The Department of Health would like to inform you that your application for conducting a research on the 
abovementioned topic has been approved based on the following conditions: 
1. During your study, you will follow the submitted protocol with ethical approval and can only deviate from it after 
having a written approval from the Department of Health in writing. 
2. You are advised to ensure, observe and respect the rights and culture of your research participants and maintain 
confidentiality of their identities and shall remove or not collect any information which can be used to link the 
participants. 
3. The Department of Health expects you to provide a progress on your study every 3 months (from date you 
received this letter) in writing. 
4. At the end of your study, you will be expected to send a full written report with your findings and implementable 
recommendations to the Epidemiological Research & Surveillance Management. You may be invited to the 
department to come and present your research findings with your implementable recommendations. 
5. Your results on the Eastern Cape will not be presented any w here unless you have shared them with 
the Department of Health as indicated above. 
 
Your compliance in this regard will be highly appreciated. 
 
 
SECRETARIAT: EASTERN CAPE HEALTH RESEARCH COMMITTEE 
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Ethics Research Confidentiality and Informed Consent Form 
 
SCREENING FOR CARDIOMETABOLIC RISK FACTORS AMONG COMMERCIAL 
DRIVERS IN BUFFALO CITY METROPOLITAN MUNICIPALITY, EASTERN CAPE, 
SOUTH AFRICA. 
 
PRINCIPAL INVESTIGATOR: Miss A.O. ADEDOKUN (BNSc RN, RM) 
SUPERVISOR: Prof D.T GOON (Department of Nursing Science, University of Fort Hare, 
East London). 
 
Dear Research Participant, 
You are invited to participate in a research study that forms part of my formal Master’s in 
Nursing Science (M cur) degree programme. This information Leaflet will help you to decide 
whether you will like to participate before you agree to take part unless you are completely 
satisfied with all aspect of the study. 
 
WHAT IS THE STUDY ALL ABOUT? 
Cardio-metabolic risk factors are clusters of various factors that lead to cardiovascular diseases 
(CVD) and type 2 diabetes mellitus (Leiter, et al., 2011:e1), and cause of about 67% 
cardiovascular diseases and diabetes mortality worldwide in 2010 (Danaei, et al., 2014:634). 
Cardiovascular diseases are the leading cause of 31% of all death globally, killing about 17.3 
million per year; and the number one global cause of death in the developing and the non-
developed countries (World Health Organization [WHO], 2016; International Alliance for 
Responsible Drinking [IARD], 2016:1). Non-communicable diseases (NCDs) account for about 
29% of deaths and 11% as a result of CVD in South Africa (WHO 2011). Cardio-metabolic risk 
factors are classified into non-modifiable risk factors include age, race and ethnicity, gender, and 
family history; and modifiable risk factors include obesity, inflammation, hypertension, smoking, 
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physical inactivity, unhealthy diet, insulin resistance, dyslipidemia and hyperglycaemia (Wang, 
2015). 
Driving profession has a great impact in the transportation industry and of great benefit to the 
public and their safety (Sangaleti, et al., 2014). Lim and Chia (2015:92), submitted that some of 
the routine activities of vehicle drivers that precipitate obesity and overweight are their lengthy 
working hours on the road, unpredicted schedules, physical inactivity and a rare option for 
healthy diet. Anecdotally, commercial drivers in South Africa exhibits poor lifestyle health 
behaviour, in terms of sedentarism, excessive alcohol consumption, smoking and other illicit 
health behaviours. However, unlike other population groups in South Africa, their physical and 
biomarker risks health assessment have not been documented in South Africa as elsewhere. 
Therefore, the present study will examine the correlates of developing cardio metabolic 
abnormalities minibus taxi drivers in East London metropolitan. 
 
WHAT WILL YOU BE REQUIRED TO DO IN THIS STUDY? 
If you decide to take part in this study, you will be required to do the following: 
 Sign this informed consent; 
 Complete a World Health Organization STEPwise questionnaire which comprise of 
demographic information (Age, Education, Race, marital status and work) behavioural life 
style (Tobacco use, smoking, alcohol consumption and diet) and physical activity 
involvement; 
 Complete the questionnaire in a designated conducive place to be provided by the 
chairperson of each taxi rank. This should take 30 minutes to be completed; 
 Sit for ten minutes before blood pressure is being measured three times; 
 Have your weight, height, waist, hip and neck circumferences measured; 
 
ARE THERE CONDITIONS THAT MAY EXCLUDE YOU FROM THE STUDY? 
You will not be eligible to participate in this study if you have less than three months experience 
as a commercial driver. 
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WHAT ARE THE RISKS INVOLVED IN THE STUDY OR CAN ANY OF THE STUDY 
PROCEDURES RESULT IN PERSONAL DISCOMFORT OR INCONVENIENCE? 
Questionnaire: The study and procedure involves no foreseeable physical discomfort or 
inconvenience for you or to your family. Due to the personal nature of the questions, you may 
experience some emotional discomforts. 
Blood pressure: The procedure will not be painful as it is not invasive and will not involve any 
discomfort. 
Anthropometric Measurements: The procedure will not be painful as it is not invasive and will 
not involve any discomfort. 
 
WHAT ARE THE POTENTIAL BENEFITS OF PARTICIPATING IN THIS STUDY? 
The benefits of participating in this study are: 
 You will make contribution towards broadening of academic knowledge and understanding 
towards cardio-metabolic risk factors among commercial drivers in Buffalo city metropolitan 
municipality, South Africa. 
 You will receive personal information concerning your cardio-metabolic health status and 
individuals at risk of cardio-metabolic co-morbidities.  
 It can direct efforts and reform in the prevention and management of cardio-metabolic risk 
factors among drivers. 
 The data may also proof useful in epidemiological studies that correlate behavioural lifestyles 
with cardio-metabolic risk factors among drivers. 
 The findings will create awareness of the health conditions of commercial drivers in Buffalo 
city metropolitan municipality, South Africa. 
 
WILL YOU RECEIVE ANY FINANCIAL COMPENSATION OR INCENTIVE FOR 
PARTICIPATING IN THE STUDY 
Please, note that you will not be paid for participating in the study. 
 
 
157 
 
WHAT ARE YOUR RIGHTS AS A PARTICIPANT IN THIS STUDY? 
Your participation in this study is entirely voluntary. You have the right to withdraw at any stage 
without any penalty or future disadvantage whatsoever. You don’t have to provide reason for 
such decision. You may also be asked to withdraw from the study if you do not adhere to the 
study protocol. 
 
HOW WILL CONFIDENTIALITY AND ANONIMOTY BE ENSURED IN THE STUDY? 
Confidentiality of data will be maintained such that your identity will only be known to the 
researcher. I will remove or mask all identifying data on transcriptions and final report 
documents e.g thesis and journal articles. Thus your identity will not be revealed during or after 
the study, even when the study is use in any format. 
 
IS THE RESEARCHER QUALIFIED TO CARRY OUT THE STUDY? 
The researcher is a qualified, registered nurse and midwife who has previously completed similar 
research studies. Also, she has received training in Nursing Science from the University of Fort 
Hare, South Africa. 
 
HAS THE STUDY RECEIVED ETHICAL APPROVAL? 
Yes. The University of Fort Hare Research Ethics Committee (UREC) have approved the formal 
study proposal. All parts of the study will be conducted according to international accepted 
ethical principles. 
 
WHO CAN YOU CONTACT FOR ADDITIONAL INFORMATION REGARDING THE 
STUDY? 
The principal investigator, Miss A.O. Adedokun, can be contacted on her cellular phone at 
0737357980. The supervisor, Prof D.T. Goon, can be contacted during office hours at Tel 
(043)704-7368. Should you have any question regarding the ethical aspects of the study, you can 
contact the Dean of research, University of Fort Hare, Prof Gideon De Wets, during office hours 
at Tel (043)704-7512. 
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DECLARATION: CONFLICT OF INTEREST 
There is no conflict of interest that may influence the study procedures, data collection, data 
analysis and publication of results. 
 
A FINAL WORD 
Your co-operation and participation in the study will be greatly appreciated. Please sign the 
underneath informed consent if you agree to partake in the study. 
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INFORMED CONSENT 
 
I hereby agree to participate in research regarding Screening for cardio-metabolic risk factors among 
commercial drivers in Buffalo City Metropolitan Municipality, Eastern Cape, South Africa. I understand 
that I am participating freely and without being forced in any way to do so. I also understand that I can 
stop this interview at any point should I not want to continue and that this decision will not in any way 
affect me negatively. 
 
I understand that this is a research project whose purpose is not necessarily to benefit me personally. 
 
I have received the telephone number of a person to contact should I need to speak about any issues 
which may arise in this interview. 
 
I understand that this consent form will not be linked to the questionnaire, and that my answers will 
remain confidential. 
 
I understand that if at all possible, feedback will be given to my community on the results of the 
completed research. 
 
 
…………………………….. 
Signature of participant    Date:………………….. 
 
I hereby agree to the tape recording of my participation in the study  
 
 
…………………………….. 
Signature of participant    Date:………………….. 
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